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Abstract 
Objectives: To review, apply and compare existing publication bias methodology. To 
extend the selection model methods that adjust combined estimates and to develop 
models to adjust for publication bias and heterogeneity simultaneously. ' 
Methods: Methodologies that test for the existence of publication bias, estimate the 
number of missing studies, and adjust combined estimates for publication bias are 
reviewed. Parametric weighted distribution methodology is developed further. The 
existing family of distributions is extended to include a logistic function. Weight 
functions previously limited to modelling selection based on two-tailed p-values have 
been restructured for one-tailed p-values. The selection mechanism model has been 
developed to incorporate both p-values and precision. The model for effect size has 
been developed to incorporate linear predictors, so heterogeneity and publication bias 
can be modelled simultaneously. 
Data: Two systematic reviews taken from the Cochrane Library and simulation studies. 
Results: Methods that test for the existence of publication bias or estimate the number 
of missing studies are limited by the strength of their assumptions and low power. 
Weighted distributions offer the only way to directly assess the impact of publication 
bias. In data sets in which there is heterogeneity or the true treatment effect is null, 
modelling the selection mechanism on p-values only can lead to over-adjusted estimates 
and considerable variability between estimates with wide confidence intervals. 
Extending the selection model to include precision reduces this. It is then possible to 
include other covariates such as study quality or type. The effect-size model can be 
extended in a similar way to include linear predictors. Combination of these two models 
allows simultaneous consideration of the influence of publication bias and 
heterogeneity. 
Conclusions: Weighted distributions offer a flexible approach to modelling publication 
bias. Inclusion of precision in the selection model reduces sensitivity of the model to the 
shape of the selection model improving consistency of results. No selection model 
should be used on its own but in conjunction with others to allow a sensitivity approach. 
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Chapter 1 
Introduction 
1.1 Evidence-based medicine 
Evidence-based medicine (EBM), whose philosophical origins extend back to mid- 
19th century Paris and earlier, is the conscientious, explicit and judicious use of 
current best evidence in making decisions about the care of patients (Sackett, 
1996). Traditionally, the primary job of medical research has been to understand 
the pathophysiological process of a disorder and to produce new treatments, while 
concerns about the effectiveness of new treatments or their implementation have 
been secondary. This has resulted in many new treatments taking years to become 
part of routine practice while ineffective treatments have been widely used (Smith, 
1995; Sackett and Rosenberg, 1995). 
For decades people have been aware of the gaps between research evidence and 
clinical practice, and the consequences in terms of expensive, ineffective, or even 
harmful decision making (Chalmers et al., 1992). The medical profession has been 
criticised because only 10-20% (Ellis et al., 1995) of interventions being used had 
a firm basis in such evidence. Despite many interventions now having a firm basis 
in such research (Gill et al., 1996; Ellis et al., 1995), there are significant delays in 
incorporating their use in medical practice (Haines and Jones, 1994). As demands 
for limited health resources continue to increase, available resources should be used 
to support those treatments that have been shown in properly designed evaluations 
23 
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Table 1.1: Main 
CHAPTER 1. INTRODUCTION 
of evidence-based medicine 
1. Formulate a clear clinical question from a patient's problem. 
2. Search the literature for the best external evidence. 
3. Critically appraise available evidence for its validity and usefulness. 
4. Apply the evidence in clinical practice 
to be effective. 
Practising evidence-based medicine 
The practice of EBM applies systematic and rigorous methodology to the process of 
identifying, critically appraising and applying the best available evidence in making 
decisions about the care of patients (Smyth, 1998). The main steps involved 
are given in table 1.1 (Sackett et al., 1997), and the research network of EBM 
summarised in figure 1.1. 
Figure 1.1 shows that once a research question has been formulated and relevant 
evidence accumulated, EBM can have implications for clinical practice and research. 
Inevitably EBM will expose gaps in the evidence, highlighting areas where research 
is needed. This enables available research funds to be directed towards areas where 
research is needed, allowing unnecessary duplication of research to be avoided. 
Barriers to evidence-based medicine 
In obtaining evidence, clinicians have identified four problems (Covell et al., 1985): 
1. they lack time necessary to keep up to date with the vast volume of papers 
published 
2. it is impossible to sift out which research may be useful 
3. their journals are too disorganised to be useful 
4. their text books are out of date. 
1.1. EVIDENCE-BASED MEDICINE 
Figure 1.1: Evidence-based medicine research network 
new technologies 
and interventions 
in health care 
Methodological 
developments 
Research Question 
does the intervention 
do more good than 
harm? 
Research Synthesis 
" write protocol 
" identify studies 
" assemble data 
" update reviews 
Systematic Reviews 
New trials 
implications 
for research 
(anon (1997)) 
existing health 
care practices 
implications 
for practice 
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The rate of change in medical knowledge is accelerating. The amount of information 
contained in journals has become unmanageable, with doctors needing to read 
more than nineteen articles per day, every day, to keep up with their area of 
interest (Davidoff, 1995). Estimates suggest that biomedical knowledge base will 
double in approximately 19 years (Wyatt, 1991). This implies that medical 
knowledge will increase four fold during a professional lifetime. Due to the 
volume of medical literature, much of which will be invalid or irrelevant, extracting 
clinically important information to answer specific questions is difficult. Previously 
clinicians have been forced to rely on the advice of colleagues in the majority 
of situations where access to information is needed quickly (Covell et at., 1985; 
Williamson, 1989). This situation has improved with the development of large 
bibliographic databases and software to rapidly locate relevant evidence (Smyth, 
1998). 
Sound decisions on health care should be based on a high a proportion as possible 
of the available evidence, but once studies of interest have been identified, clinicians 
need to determine which studies are flawed due to unsystematic research and which 
offer unbiased reliable information. 
Hierarchy of evidence 
In the pursuit of EBM, it is the `best external evidence' that is sought. RCTs 
are considered to provide the strongest form of available evidence. Sackett et 
al. (1996) define an RCT as an epidemiological experiment in which subjects 
in a population are randomly allocated into groups to receive or not receive an 
experimental, preventive or therapeutic procedure or intervention. It is the process 
of randomisation that ensures that the differences and outcomes observed between 
the intervention and comparison groups are due to the intervention and not patient 
characteristics, clinical preference or other biases. There are various key design 
elements of RCTs such as the method of randomisation and blinding, and these 
design features and features of various trial designs are described by Pocock (1983). 
1.1. EVIDENCE-BASED MEDICINE 27 
Figure 1.2: Hierarchy of strength of evidence concerning efficacy of treatments 
Anecdotal case reports 
Case series without controls 
Series with literature controls 
Analyses using computer databases 
Case-control observational studies 
Series based on historical control groups 
Single randomised controlled trial 
Confirmed randomised controlled clinical trials 
(Green and Byar, 1984) 
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Although RCTs are considered the strongest single trial design their design is 
not applicable to all situations. Figure 1.2 displays a hierarchical list in descending 
order of strength with systematic reviews of multiple RCTs replacing single RCTs 
as the gold standard of research. 
1.2 Systematic reviews 
Searches of the literature frequently reveal multiple RCTs of the same intervention. 
Independent RCTs that assess the same health care intervention often have 
differences in study design, and patient population giving varying estimates of 
effect size and conclusions. Systematic reviews of primary research have become an 
essential way of condensing the literature by integrating existing information. While 
a clinical trial evaluates a particular intervention, given for a specified duration to 
patients who fulfilled the selection criteria, a systematic review offers results that 
have greater generalisability by including studies that vary in their design but are 
still comparable. 
Clinicians tend to be conservative about new therapies and may not be prepared 
to implement a new treatment on the basis of a single RCT and so clinicians and 
policy makers are increasingly turning to reviews rather than primary research for 
information to guide decisions. This makes it essential that the same scientific 
principles that are applied to the design and conduct of primary research should 
also be applied to the process of reviewing that research (Chalmers et al., 1992). 
Oxman and Guyatt (1988) state that the fundamental difference between a review 
and a primary study is the unit of analysis, not the scientific principles that apply. 
Guidelines and checklists exist to help readers assess the scientific quality of a review. 
These concentrate on definition of the question, the comprehensiveness of the search 
strategy, the methods of combining results and reaching appropriate conclusions, see 
table 1.2 (Oxman and Guyatt, 1988). 
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Table 1.2: Critical appraisal of a systematic review 
1. Were the questions and methods clearly stated? 
2. Were comprehensive search methods used to locate relevant studies? 
3. Were explicit methods used to determine which articles to include in the review? 
4. Was the validity of the primary studies assessed? 
5. Was the assessment of the primary studies reproducible and free from bias? 
6. Was variation in the findings of the relevant studies analysed? 
7. Were the findings of the primary studies combined appropriately? 
8. Were the reviewers' conclusions supported by the data cited? 
1.3 Cochrane Collaboration 
The Cochrane Collaboration is an international organisation that aims to prepare 
and maintain systematic reviews of RCTs of health care interventions, and to make 
this information readily available to decision makers at all levels of health care 
systems. The Cochrane Collaboration formed in response to the ideas of Archie 
Cochrane who was one of the most influential voices to criticise medical thinking. 
In his book Effectiveness and efficiency: random reflections on health services, 
published in 1972, Cochrane attributed the lack of effectiveness of medical services to 
the poor use of scientific methods in medicine, highlighting the importance of RCTs 
in evaluating therapeutic interventions (Sackett, 1996). With the rapid exponential 
growth of medical literature Cochrane realised that doctors who wanted to make 
more informed decisions about health care would have problems keeping up with 
recent advances. In 1979 he wrote : 
"It is surely a great criticism of our profession that we have not 
organised a critical summary, by speciality or sub speciality, adapted 
periodically, of all relevant randomised controlled trials" 
The reviews of the Cochrane Collaboration are published on the Cochrane database 
of systematic reviews (CDSR) and have become a major source of systematic reviews 
of health care interventions. The CDSR is published quarterly and contains the 
reviews and protocols of 50 registered collaborative review groups (CRGs). Each 
CRG specialises in conducting reviews of a specific disease or organ system. In 
the 2000 Issue 2 of the CDSR 47 groups have published complete reviews and 49 
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groups have registered protocols for reviews in preparation. The CDSR contains a 
total of 795 complete reviews and 738 registered protocols. This electronic form of 
publication allows reviews to be updated as new evidence emerges; it also allows 
correction of mistakes in response to comments and criticisms. Dissemination of 
Cochrane reviews will help to avoid the unnecessary duplication of research. This has 
resulted in the recommendation that a systematic review of trials of the same therapy 
should be undertaken before the start of a new trial, and the results examined to 
help determine the design of a new trial or determine whether a new trial should be 
undertaken at all (Chalmers and Lau, 1996). 
1.4 Evidence-based medicine and statistics 
The shift in medical practice towards an evidence-based approach has placed an 
emphasis on systematic reviews. Finding and analysing all therapeutic trials in a 
given field has become a difficult and specialised task (Antman et al., 1992). The rise 
of interest in this area has necessitated a large amount of methodological, theoretical, 
and empirical work. Despite advances made, there remain many fundamental 
practical difficulties. Three of the main areas of statistical analysis in systematic 
reviews are meta-analysis, heterogeneity, and publication bias. Meta analysis is 
the quantitative synthesis of the results of multiple trials. Individual trials may 
have been too small to identify differences between treatments. In combining 
results of multiple trials statistical power and precision are increased enabling 
greater confidence in results. Statistical methodology of meta-analysis has primarily 
considered the synthesis of data from RCTs. However there has been an increasing 
interest in expanding the use of systematic reviews and meta-analyses to encompass 
areas such as observational studies, diagnostic and screening tests, and longitudinal 
data. 
The combination of information from independent trials in a meta-analysis also 
introduces uncontrolled variation between the environments and populations of each 
trial component. This variation between trials is called heterogeneity. Heterogeneity 
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may be clinical, methodological or statistical. Clinical heterogeneity arises from 
differences between patients or interventions being compared, methodological 
heterogeneity arises from differences in study designs, while statistical heterogeneity 
is defined as heterogeneity in the results above that compatible with chance. The 
existence of heterogeneity within a meta-analysis results in complexities in the 
analysis but also difficulties in making valid inferences. Continuing developments 
in statistical techniques permit investigation of sources of heterogeneity to answer 
important questions such as whether the treatment benefit varies according to the 
underlying risk of disease to be answered. 
Publication bias has been described as possibly the greatest methodological threat 
to the validity of meta-analysis (Begg, 1994). Publication bias occurs when there is 
a differential incentive to submit or accept for publication results of trials based on 
their attainment of statistical significance. The validity of a meta-analysis rests upon 
the trials that have been included. Meta-analyses that include only published papers 
will give a poor approximation of the truth if there are a number of unpublished 
trials that differ systematically from those published. Developments in this area 
have focused on identification of publication bias, estimation of the numbers of 
unpublished studies, and adjustment of effect estimates. 
1.5 Structure of thesis 
In chapter two, empirical research of publication bias will be reviewed and its 
damaging influence on the results of meta-analysis discussed. In chapter three, a 
set of examples will be introduced and used to illustrate and compare meta-analysis 
and publication bias methodology throughout this thesis. This set of examples 
is comprised of two real examples taken from the CDSR and three simulations. 
Chapter four introduces odds ratios as a summary measure of effect for a single 
trial with binary data and presents meta analytic methods that are used to provide 
combined estimates of the results of multiple RCTs. Chapter five reviews current 
methodology which identifies the existence of publication bias, and methods that 
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quantify the potential impact of publication bias by providing estimates of the 
number of missing studies. Chapter six reviews methodology that adjusts combined 
effect estimates by modelling the selection mechanism that causes publication 
bias. Chapter seven extends the parametric weight function methodology to model 
the selection process on p-values and precision, and chapter eight develops this 
methodology further to allow the selection process and heterogeneity to be modelled 
simultaneously. Chapter nine contains conclusions and further work. 
Chapter 2 
Empirical evidence of publication 
bias 
In the previous chapter the ideas behind evidence-based medicine, and the role of 
systematic reviews and meta analyses were introduced. In this chapter the empirical 
evidence of publication bias and its undermining influence on the reliability of meta- 
analytic results is reviewed. The main purpose of this review is to demonstrate the 
existence of publication bias and assess its impact, and to highlight the continuing 
rise of interest in this phenomenon. 
2.1 Introduction 
Despite meta-analyses being hailed as the gold standard of research evidence, their 
results are not infallible. Discrepancies have been found, for example, between 
some meta-analyses and subsequent large trials. It has been suggested that possible 
reasons behind this could be variable quality of trials included, heterogeneity, or 
publication bias (Chalmers et al., 1987; Egger and Smith, 1995; Ioannidis et al., 1998; 
Borzak and Ridker, 1995; Cappelleri et al., 1996; Villar et at., 1995; LeLorier et 
at., 1997). Publication bias is defined as the selective submission and acceptance 
of positive over negative studies, where positive trials are defined as those that 
show a statistically significant difference between the test and control treatment 
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(Dickersin et al., 1987). If publication bias exists then published literature will 
form a non-random sample from the population of all research. Consequently it will 
be misrepresentative of research findings as a whole, giving a biased and extreme 
view. Empirical research into publication bias has tried to quantify its existence and 
impact, and to discover which factors affect the likelihood of publication. 
2.2 Evidence of publication bias 
Originally publication bias was identified as a problem in the social sciences literature 
by Sterling (1959). Sterling reported that in four prominent psychological journals, 
for the year 1955-56, the majority of published studies, reporting significance testing, 
quoted a statistically significant result (see table 2.1). This work in the social 
and behavioural sciences has been confirmed by others in the field (Smart, 1964; 
Bozarth and Roberts, 1972; Greenwald, 1975; Coursol and Wagner, 1986). Sterling 
repeated his work in the same four psychological journals covering the year 1986- 
1987, but also included four medical journals. He found no improvement in the 
psychological journals, and found that the same problem is apparent in the medical 
and public health literature (Sterling et al., 1995) (see table 2.1). Sterling's work in 
this area has been reviewed by Dickersin and Min (1993). 
Sterling's work shows that there is a high percentage of papers whose main results 
reject the null hypothesis at the a=0.05 level. This could only be expected if the 
majority of treatments investigated were beneficial. 
Surveys of statistical power in psychological journals have suggested that 25%- 
85% of the studies would be expected to yield statistically significant results (Chase 
and Chase, 1976). This implies that even if a true treatment benefit exists then 
15%-75% of studies would be unable to detect it. This evidence suggests that the 
high proportion of significant results contained in the literature is due to a large 
proportion of type I errors, where a type I error is defined as the probability of 
rejecting the null hypothesis when it is true. The probability of an article with 
a type I error reaching publication depends on the many stages of research. This 
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Table 2.1: Percentage of statistically significant articles in psychology and medical 
journals' 
Articles 
Reviewed in 
1986-87 
% Rejecting 
Ho 
1986-87 
% Rejecting 
Ho 
1955-56 
Psychology Journals 
Experimental Psychology 165 93.5 99.1 
Comparative and Physiological and 119 97.1 96.8 
Psychology 
Consulting and Clinical Psychology 83 97.5 95.2 
Personality and Social Psychology 230 95.6 96.9 
Medical Journals 
American Journal of Epidemiology 141 80.9 N/A 
American Journal of Public Health 97 88.1 N/A 
New England Journal of Medicine 218 87.9 N/A 
" Table reproduced from Dickerein & Min (1993) 
process of research and publication is represented in figure 2.1. 
Evidence exists of systematic differences between published and unpublished 
research. Studies which have compared effect size estimates have found that the 
effects in unpublished reports are smaller than their published counterparts (Smith, 
1980; White, 1982; Champney, 1983; Dawes et al., 1984). The remainder of this 
section forms a brief review of the literature addressing publication bias in medical 
journals. 
2.2.1 Search strategy 
The search strategy used to identify research literature for this section has been 
previously well defined for use in various bibliographic databases (Song, 2000). The 
primary interest of this review is evidence of publication bias in the medical sciences, 
consequently the search has been restricted to Medline bibliographic database (see 
appendix table C. 1). The search strategy and the results of the search strategy are 
given in the last line of table C. 1. These results show a rapidly increasing interest 
in publication bias from the mid 1980's onwards. While this is encouraging figure 
2.2 shows a comparison between the explosion in reports of meta-analysis and the 
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Figure 2.1: Model of the research and publication system 
FORMULATE 
PROBLEM 
more limited increase in reports of publication bias. 
This graph was constructed from the number of research papers identified by 
searching Medline for the words meta-analysis or meta-analyses, and publication bias 
only. All returns were included. This search is not as extensive as the search detailed 
in appendix C. 1, and is not meant to give an accurate reflection of the number of 
publications relating to meta-analysis or publication bias, but to highlight that 
although publication bias has recently received an increasing amount of attention it 
is not yet routinely considered in meta-analyses. 
The rest of this section will examine empirical evidence of publication bias. 
Individual meta-analyses that have considered the possible influence of publication 
bias on their results are excluded. Throughout this section positive and negative 
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Figure 2.2: The rise of meta-analysis and publication bias 
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results are defined as those with p-values of p<0.05 and p>0.05 respectively. 
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Research into publication bias in the medical literature has mainly followed 
publication of research from two intercepts: approval from an ethics committee, 
or full publication of abstracts initially presented at conference proceedings. Tables 
2.2 and 2.3 give details of studies, identified by the search strategy in appendix D, 
which followed research to publication from these intercepts respectively. Alternative 
designed studies and articles which have reviewed this research are given in tables 
2.4 and 2.5. 
IW O IJou IDOL IWO'f IUOD IUOO IUUU IUUc IUU4 IUUD IUUO 
year 
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Table 2.2: Empirical research of abstracts presented at conference proceedings 
Authors Title 
Dudley (1978)** Surgical research: master or servant 
Goldman (1980)** Fate of cardiology research originally published in 
abstract form 
Meranze et al. (1982)** Publication resulting from anesthesia meeting abstracts 
McCormick and Publication of research presented at pediatric meetings 
Holmes (1985)** 
Weintraub (1987) Are published manuscripts representative of the surgical 
meeting abstracts? An objective appraisal 
Koren (1989) Bias against the null hypothesis: the reproductive 
hazards of cocaine 
Chalmers et al. (1990)** A cohort study of summary reports of controlled trials 
Juzych et at. (1991)** Pattern of publication of ophthalmic abstracts in peer 
reviewed journals 
De Bellefeuille The fate of abstracts submitted to a cancer meeting: 
et al. (1992)** factors which influence presentation and subsequent 
publication 
Juzych et at. (1993)** Whatever happened to abstracts from different sections 
of the Association for Research in Vision and 
Opthalmology? 
Yentis et at. (1993)** Publication of abstracts presented at anaesthesia meetings 
Scherer et al. (1994)** Full publication of results initially presented in abstracts 
Callaham et at. (1998) Positive outcome bias and other limitations in the outcome 
of research abstracts submitted to a scientific meeting 
Weber et at. (1998) Unpublished research from a medical specialty meeting. 
Why investigators fail to publish 
Cheng et at. (1998) Time to publication as full reports of abstracts of 
randomized controlled trials in cystic fibrosis 
ee 
contained in review by Scherer st al. (1998): see table 2.5 for details 
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Table 2.3: Empirical research following studies from ethic committee approval 
Authors Title 
Easterbrook et al. (1991)*, *** Publication bias in clinical research 
Dickersin et al. (1992)*1*** Factors influencing publication of research results 
Stern (1996)*** Publication bias-an Australian perspective: A review of 801 
research proposals submitted to the Royal Prince Alfred 
Hospital Ethics Committee between 1979 and 1988 
Stern and Simes (1997) Publication bias: evidence of delayed publication in a cohort 
study of clinical research projects 
Bardy (1998) Bias in reporting clinical trials 
contained in review by Dickersin and Min (1993): see table 2.5 for details 
** contained in review by Dickersin (1997): see table 2.5 for details 
Table 2.4: Alternative designs of empirical research investigating publication bias 
Authors Title Design 
Dickersin et at. Publication bias 318 authors of published trials 
(1987) and clinical trials where asked about participation 
in any unpublished research 
Simes (1987) Confronting publication comparison of registered 
bias: a cohort and published trials 
design for 
meta-analysis 
Dickersin and Min NIH clinical trials follow up of clinical trials funded by the 
(1993)*, *** and publication bias National Institutes of Health in 1979 
Ioannidis (1998) Effect of the follow up of randomised efficacy trials 
statistical significance conducted by 2 trialist groups 
of results on the time to between 1986 and 1996 
completion and 
publication of 
randomized efficacy trials 
Misakian and Bero Publication bias identification of research projects by 
(1998) and research on contact with funding bodies 
passive smoking likely to sponsor research in to passive 
smoking 
contained in review by Dickersin and Min 
(1993): see table 2.5 for details 
* ýk * contained in review by Dickersin (1997): see table 2.5 for details 
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Table 2.5: Reviews of empirical research in publication bias 
Authors Title Included studies 
Dickersin and Min (1993) Publication bias: studies contained in this review 
the problem that are indicated with a* in 
wont't go away the tables above 
Scherer et al. (1994) Full publication of studies contained in this review 
results initially are indicated with a ** in 
presented in abstracts the tables above 
Dickersin (1997) How important is studies contained in this review 
publication bias? are indicated with a*** in 
A synthesis of the tables above 
available data 
2.2.2 Conference proceedings 
Conference meetings provide an important contribution to communication of 
scientific findings with the presentation of original research being one of the steps 
frequently taken prior to full publication of completed work. Due to the increasing 
numbers of participants at these meetings, the process of abstract selection provides 
a forum for logistic constraints similar to medical journals (Grouse, 1981). 
Acceptance of abstracts for presentation 
Koren (1989) considered acceptance rates for presentation of 58 abstracts submitted 
to the Society of Pediatric Research between 1980 and 1989 which evaluated foetal 
outcome after gestational exposure to cocaine. Only 1/9 (11%) abstracts that 
indicated no adverse effect were accepted for presentation compared with 28/49 
(57%) abstracts that indicated harmful effects of cocaine exposure. In a similar study 
Bellefeuille et al. (1992) considered the fate of abstracts submitted to a 1984 cancer 
meeting. Classifying each of the 197 submitted abstracts as neutral/descriptive, 
negative, or positive he found that the proportion of abstracts accepted were 31/101 
(31%), 11/31 (35%), and 39/65 (60%) respectively. Callaham et al. (1998) found 
that the best predictors of meeting acceptance were positive results (OR 1.99 95% 
CI (1.07 , 3.84)) and a subjective "originality" factor (OR 2.07 95% CI (1.13,3.89)). 
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Table 2.6: ßi111 Dublication of results initia. lly nrc. antPd n. c a. hctra. rtc 
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Authors Discipline follow-up 
in months 
NO 
abstracts 
NO published 
in full (%) 
Dudley (1978) Surgery 36 51 29(57) 
Goldman and Cardiology 37 276 137(50) 
Loscalzo (1980) 
Meranze et al. (1982) Anesthesiology 27 379 122(32) 
McCormick and Pediatrics 36 355 172(48) 
Holmes (1985) 
Chalmers et at. (1990) Perinatology 48 176 64(36) 
Juzych et al. (1991) Vision research 54 175 105(60) 
De Bellefeuille Oncology 66 197 115(58) 
et at. (1992) 
Juzych et at. (1993) Vision research 78 327 206(63) 
Yentis et at. (1993) Anesthesiology 60 215 108(50) 
Scherer et at. (1994) Vision research 36 93 61(66) 
Cheng et at. (1998) Cystic fibrosis variablea 178 57(32) 
Callaham et at. (1998) Emergency medicine 60 179 111(66) 
a see section on time tu puuucaticu in tuna mean. 
Full publication of abstracts 
Positive results have been found to influence acceptance of research abstracts at 
scientific meetings, yet rates of subsequent full publication have been found to be 
low. Research across disciplines has found that only approximately half of all studies 
originally presented in abstract form are subsequently published as full length reports 
(see table 2.6). 
Factors found to influence full publication of research submitted to conference 
proceedings are positive results, and selection for presentation at the meeting (OR 
2.49 (1.49 , 4.35)) 
(DeBellefeuille et al., 1992). These results were supported 
by Callaham et al. (1998) who found the best predictor of full publication to be 
acceptance of the abstract at a scientific meeting but also identified large sample size 
as an influential factor (OR 2.26 (1.23,4.31). Neither study characteristics or quality 
have been found to influence publication (Callaham et al., 1998; Weber et al., 1998; 
Chalmers et al., 1990). 
Reasons for non-publication have been identified as lack of time, insufficient 
priority, and funds (DeBellefeuille et al., 1992). Weber (1998) found that non- 
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publication of research abstracts was mainly due to failure to submit a complete 
manuscript for publication. However, due to the relationship between abstract 
acceptance and subsequent publication Weber reasons that this may be caused 
by investigators being pessimistic about chances for publication if their research 
has been rejected by a meeting and hence making less effort to publish. This 
view is consistent with Greenwalds model of the research and publication process 
(Greenwald, 1975) (see figure 2.1). 
Are published manuscripts representative of the original abstract? 
Abstracts submitted to meetings are often work in progress while published 
manuscripts represent the completed project, but concern about the quality 
of abstracts submitted to meetings and the limited peer review process has 
focused attention on whether original abstracts are representative of the published 
manuscripts. Bellefeuille et at. (1992) compared 18 published RCTs with their 
conference abstracts and found good correlation between the conclusions of 15/18 
(83%). Weintraub (1987) compared 33 published articles with their conference 
abstracts, he found similar conclusions in 23/33 (70%) but in the remaining ten 
found conclusions were not only different but in the conference abstracts were 
routinely weaker. Discrepancies were also found with titles, authors, and numbers 
of patients. These discrepancies may be explained by the stage of the trial when the 
abstract was submitted for presentation (see figure 2.3). 
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Figure 2.3: Possible stages of abstract submission 
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2.2.3 Ethics committee follow up 
The most complete evidence of publication bias is provided by follow up of 
experiments from approval by research ethics committees (REC) and institutional 
review boards (IRB). Although not a legal requirement, in the UK every research 
proposal involving human participants undergoes review by a REC, whose aim is 
to safeguard the rights, safety and well-being of all study participants (Williamson 
et at., 2000). Research that has focused on abstract submission, acceptance and 
subsequent publication rates cannot provide information on the selection process 
that occurs before submission of abstracts to conference proceedings. 
Four studies have been conducted which followed research from approval at five 
IRBs (Easterbrook et at., 1991; Dickersin et at., 1992; Dickersin and Min, 1993b; 
Stern, 1996). These studies were performed prospectively with each researcher 
having full knowledge of the other studies. Consequently each of these studies 
has a similar design using similar data collection methods and are reviewed by 
Dickersin (1997). Individually and collectively these studies provide direct evidence 
of publication bias with a combined OR 2.54 and 95% CI (1.44 , 4.47) for full 
publication of significant results. Other risk factors associated with publication bias 
were examined: study design, source of funding, sample size, and number of clinical 
centres, but these were not found to be consistently associated with publication. 
Each of these studies found considerable evidence of failure to publish research but 
similarly to Weber (1997) found that failure to publish appeared to be primarily 
related to failure to submit a manuscript and not editors' rejection. The proportion 
of unpublished manuscripts associated with rejection ranged from 0% to 20% for 
each of the review boards. 
2.2.4 Time to publication 
Empirical research has shown that studies with positive results are more likely to 
be published in full. Negative studies do reach publication, although less frequently 
than positive studies, and investigators of publication bias have questioned whether 
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Table 2.7: Summary of empirical research using survival analysis to investigate time 
to uublication of clinical trials 
Authors Discipline NO trials 
included 
Definition 
of time to 
publication 
Median time to 
publication (years) 
sig vs nonsig 
Stern and Simes (1997) varied 520 ethics committee 4.8 vs 8.0* 
approval to 
publication 
Misakian and Bero (1998) Passive 61 start of funding 3.0 vs 5.0 
smoking to publication 
Ioannidis (1998) HIV 109 start of patient 4.3 vs 6.5* 
enrollment to 
publication 
Cheng et al. (1998) Cystic 178 presentation of NA 
fibrosis abstract 
to publication 
v denotes a statistically significant result at p<0.06 
there may also be a difference in the time taken to reach publication between positive 
and negative research. If completion and publication of RCTs with negative results 
are delayed then medical evidence may be biased over time. 
Scherer (1994) in a review of eight studies which followed publication of 
abstracts, initially presented at scientific meetings, estimated that around 50% 
of all abstracts reached publication within two years. Four studies have been 
conducted which investigate the possibility of a time lag to publication (see 
table 2.7) (Stern and Simes, 1997; Misakian and Bero, 1998; Cheng et at., 1998; 
Ionnidis, 1998). These studies have used survival analysis to allow for varying follow 
up time treating publication as the event of interest, recording studies which remain 
unpublished at the time of analysis as censored. 
Stern and Simes (1997) retrospectively examined studies submitted to a hospital 
ethics committee over ten years. Unlike previous research in publication bias Stern 
and Simes split the p-value range into three intervals: p<0.05, p >_ 0.10, and 
0.05 <p<0.10, to denote studies with positive, negative and indefinite conclusions 
respectively. Their results supported findings of previous research: positive results 
were more likely to be published than negative results hazards ratio (HR) 2.32 
(1.47,3.66) p<0.01, however when considering indefinite conclusions they found 
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these results tended to have an even lower publication rate than studies with negative 
results, HR 0.39 (0.13,1.12) p=0.08. Further to the differences identified for the 
rate of publication they also identified a statistically significant result for the median 
time to publication between positive and negative studies (see table 2.7). Again 
studies with indefinite conclusions appeared to fare worse with their median time 
to publication being greater than both positive and negative studies, however this 
tendency was not statistically significant. 
Misakian and Bero (1998) investigated publication bias and time lag bias in 
research on passive smoking. Information of published and unpublished studies 
funded between 1981 and 1995 were obtained by contacting funding organisations 
with an interest in research on passive smoking. The direction of their results 
supported the findings of Stern and Simes with non-significant studies having a 
longer median time to publication than positive studies. This result was not 
statistically significant however this study contained a much lower number of trials, 
and hence number of events, than the study of Stern and Simes. 
Cheng et al. (1998) considered time to publication of 180 RCTs presented at 
international conferences on cystic fibrosis between 1965 and 1995. A median value 
for time to publication was not reached, however the proportions of all studies, 
positive and negative, published before 12 months, 2 years and 5 years were 8.1%, 
29%, and 40% respectively. No statistically significant difference was identified for 
time to publication between positive and negative trials (p = 0.54). 
Ioannidis (1998) followed a prospective cohort of 109 randomised trials conducted 
by two trialist groups from 1986 to 1996. Considering the length of time taken from 
the start of funding to publication he identified a statistically significant difference 
for the median time to publication between positive and negative studies. This 
difference was found to be mostly attributable to differences in the time taken 
from completion of the study to subsequent publication ( median 3.0 vs 1.7 years, 
p<0.001). After trial completion positive trials were also found to be submitted for 
publication, and subsequently published after submission more rapidly than negative 
trials (median 1.0 vs 1.6 years, p=0.01) and (median 0.8 vs 1.1 years, p=0.04) 
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respectively. 
Influence of study sample size on time to publication 
Each of these papers investigated the influence of study sample size as a predictor of 
time to publication. Misakian and Bero (1998) found study size less than or equal 
to 500 (p=0.01) to be positively predictive of time to publication when human and 
animal trials were analysed together, but this was no longer apparent when human 
participants were analysed separately. 
Cheng et al. (1998) found no evidence that time to publication was influenced by 
study sample size. The investigation of the effects of sample size in this study was 
limited due to the spread of sample size being heavily distributed at the lower end: 
out of 172 reports in which sample size was stated, 147 had a sample size below 50. 
Stern and Simes (1997) did not find sample size to be statistically significant but 
they did find that studies with a larger sample size, defined as >100, continued to 
published until the end of their ten year study period. At the end of ten years 90% 
of studies and clinical trials with a sample size > 100 had been published, compared 
with only about 64% with a sample size < 100. 
A problem with comparing these studies is variability of each study's definition 
of time to publication, (see table 2.7). However, Ioannidis(1998) considered time to 
publication from a number of different intercepts: time to publication from the start 
of patient accrual, trial completion to publication, trial completion to submission 
for publication, and submission to publication. He found that although large trials 
tended to take a longer time to complete than smaller trials (p=0.12) their time 
to publication after completion was significantly shorter (p=0.02). He also found 
that by using study accrual as a continuous variable, the rate at which a trial was 
completed decreased, HR 1.8 (95% CI , 1.0 , 3.3) per 1000 patients, but the rate at 
which a trial was subsequently published after completion increased, HR 2.5 (95% 
CI, 1.3 , 4.5) per 
1000 patients. It is intuitive that large studies take longer to 
complete and this suggests the possibility that Misakian and Bero, and Stern and 
Simes (1997) may have identified a time difference attributable to sample size if they 
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had looked at time of trial completion to publication. 
2.3 Practical strategies to reduce publication bias 
2.3.1 Registers of clinical trials 
Prospective registration 
Knowledge of all trials, published and unpublished, is clearly the ideal and trial 
registers have long been suggested as the only practical solution to the problem of 
publication bias (Sterling, 1959; Simes, 1986; Chalmers et at., 1990; Meinert, 1988; 
Piantadosi and Byar, 1988; Dickersin, 1988; Chalmers et at., 1990; Begg and Berlin, 
1988). Simes (1986,1987) investigated the use of trial registers in reducing the effects 
of publication bias by conducting a meta-analysis of trials comparing alkylating 
agent monotherapy with combination chemotherapy in advanced ovarian cancer. 
The meta-analysis of published trials only yielded a large and significant survival 
advantage for combination chemotherapy, but this was not substantiated when all 
studies in the International Cancer Research Databank, an unbiased list of published 
and unpublished trials, were used. This example illustrates the potential benefits 
of trial registers, and while an international registry of trials has yet to be formed, 
moves towards this goal have been made. 
In Spain and France physicians are required to register all drug trials with 
their respective ministries of health, while in Japan it is mandatory to publish the 
results of every such trial (Anon, 1991; Dickersin and Garcia-Lopez, 1992). The 
US and UK have no similar system enforced despite the mechanism to enforce 
registration already being in place. RECs have been highlighted as the most 
efficient way to capture trial details at inception (Begg and Berlin, 1988). All 
trials must pass through a REC prior to enrolling patients. Setting registration as 
a requirement for trial approval would ensure rapid development of a register. A 
potential problem with this method is that some funding organisations, especially 
pharmaceutical companies, may wish to restrict information about their trials, 
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fearing that competitors might gain an unfair advantage (Anon, 1991). 
The pharmaceutical industry is known to hold a large source of clinical trials 
information that traditionally has not been accessible in the public domain. A 
major advancement towards collaboration has been made by Glaxo Wellcome's 
commitment to registering their clinical trial protocols, urging the rest of the 
industry to join this initiative (Sykes, 1998). 
Prospective registration of all trials has not yet taken place although speciality 
trial registers have been developed. More than 20 registries of trials in various areas 
already exist, including the Medical Editors Trial Amnesty, as do directories of such 
registers (Dickersin, 1992; Easterbrook, 1992). It is a possibility that government 
legislation may enforce prospective registration of trials in the future, but until then 
funding bodies could provide an alternative way of forming a register. Dickersin 
(1988) noted that if the National Institutes of Health required registration of the 
trials it funds then this would account for registration of a large proportion of trials 
conducted in the US. 
Registering clinical trials at inception would not ensure publication or even 
completion of every trial undertaken, but it would provide information about 
the number of clinical trials undertaken, and contact details of the principal 
investigators. It will not provide an instant solution. Meta-analyses of therapies 
including trials evaluated before compulsory registration will still be subject to 
publication bias. Therefore publication bias will remain a problem until the current 
scientific literature is out dated and can no longer contribute to the evaluation of 
clinical interventions. 
Amnesty for unpublished trials- retrospective registration 
While prospective registration has not been enforced attempts have been made 
to register trials retrospectively. The Medical Editors Trials Amnesty represents 
a recent international attempt at retrospective registration. The purpose of the 
amnesty was two fold: to make the details of unpublished trials available on the 
Cochrane Library, but also to underline the importance of including all RCTs in 
ýý ýliý 
iE 
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systematic reviews. Over 100 medical journals around the world invited readers 
to send information on unpublished trials, with each journal printing an editorial 
detailing the amnesty and an `unreported trial' registration form (Smith and 
Roberts, 1997). By the end of the first year of the amnesty only 165 unpublished 
trials containing 32000 patients (Roberts, 1998) had been registered. This is a 
disappointing number for a world wide effort, and this can be seen when viewed in 
comparison with a study by Dickersin et al. (1987) who discovered 178 completed 
but unpublished RCTs by contacting 156 authors of previous published trials. 
Naylor (1997) commented that the journal editors are offering registration, not 
publication, and the pay off from registration is obscure. The amnesty has also 
highlighted editor's disregard for studies that have not been peer reviewed (Roberts, 
1998). Cook (1993) surveyed authors of meta-analyses and found that 78% felt 
that the results of unpublished studies should definitely or probably be included in 
meta-analyses compared to only 47% of editors. Cook also reported that 53% of 
meta-analyses identified between 1989 and 1991 reported searching for unpublished 
studies, and 30% included unpublished data. 
An advantage of prospective registration over retrospective registration is that 
trials are registered at their inception so their inclusion cannot be influenced by their 
results or study characteristics. The ratio of trials to patients in the unpublished 
trials amnesty register indicates that only the larger unpublished trials have been 
registered, while small negative trials that are thought to predominate publication 
bias have not. 
2.3.2 Peer review 
The validity and usefulness of any meta-analysis rests on the quality of the trials 
that have been included and while some accept the importance of publication bias 
others are concerned about inclusion of trials which have not been peer reviewed 
(Eysenck, 1994). 
Published clinical research goes through a process of peer review, which is a means 
of ensuring the quality of that research. Peer review has two purposes: to serve 
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the editor by substantiating the quality of the manuscript, and to give the author 
constructive criticism. Chalmers et al. (1987) believe that estimates from a meta- 
analysis that contain unpublished studies will be biased because data will be included 
that has not been through a formal publication process which ensures its validity. 
Despite the peer review system being in process to ensure that the highest quality 
research reaches publication, concern has arisen that the system exerts a biased 
influence (Chalmers et al., 1990). Confirmatory bias is the tendency to emphasize 
and believe experiences that support one's views and to ignore or discredit those that 
do not. Mahoney (1977) studied confirmatory bias by asking 75 journal reviewers 
to referee manuscripts which described identical experimental procedures but which 
reported positive, negative, mixed or no results. This study found poor inter-rater 
agreement and strong bias against manuscripts that reported results contrary to 
reviewers own theoretical perspectives. It has also been suggested that reviewers and 
editors are influenced by the reputation of institutions from which manuscripts are 
submitted (Kaufman, 1992). Garfunkel (1994) addressed the issue of institutional 
prestige on reviewer's recommendations and editorial decisions. He found that 
institutional prestige influenced the decision to publish brief reports, but there was 
no similar tendency with major manuscripts. Calls have been made to change the 
peer review process to eliminate potential conflicts of interests (Sharp, 1990). These 
have included blinding the reviewer to the names, positions, and institutions of the 
authors, but most importantly blinding of the results section forcing attention to 
be focused on the methods section ensuring high quality (Liberati, 1992). Blinding 
of reviewers to names and affiliations of authors has been shown to be feasible at a 
number of journals (Lock, 1986), and has also been shown to be beneficial, leading 
to better reviews (McNutt et al., 1990). 
2.3.3 Location bias 
Bias also exists within the distribution of the published literature. This is known 
as location bias. Published studies with significant results are more likely to be 
published repeatedly, and this is known as multiple publication bias, see Trainer et 
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al. (1997). Other biases within the published literature occur, and these include 
language bias and citation bias. Language bias is caused by statistically significant 
results being more likely to be published in the English language (OR 3.75(1.25 , 
11.3)), and this bias may be introduced in reviews and meta analyses if they are 
restricted to English (Egger et al., 1997). Examples of language bias can be found 
in Moher et al. (1996), Gregoire et al. (1995), and Vickers et al. (1998). 
Citation bias is caused when statistically significant studies are more likely to 
be cited in other research papers. This could be a consequence of publication bias, 
or it could be caused by investigators referencing work which supports their own 
findings or beliefs (Gotzsche, 1987). This has important implications for retrieving 
literature from reference lists in research papers as this may produce a biased sample 
of articles. 
Multiple publication bias, language bias and citation bias have been mentioned 
here for completeness, see Egger and Smith (1998) for a more detailed description 
of these and other sources of location bias. 
2.3.4 Statistical methods 
The problem of publication bias will remain a threat to the validity of meta-analyses 
for a long time even after compulsory prospective registration of trials. In the 
absence of an established register of trials such as the International Cancer Research 
Databank used by Simes (Simes, 1987; Simes, 1986), systematic reviewers must rely 
on their search strategy to obtain all relevant trials. 
Retrieval of all relevant published literature is difficult (Dickersin et at., 1985; 
Dickersin et al., 1994; McDonald et al., 1996) but retrieval of unpublished research 
is even more problematic. Until it becomes possible to prevent publication bias 
it will be necessary to rely upon statistical methodology that is being developed 
to detect and adjust for its influence. These procedures depend on understanding 
and modelling the selection process that causes publication bias and are discussed 
in detail in the following chapters. Chapter five looks at techniques that provide 
tests for the existence of publication bias and methods that attempt to provide an 
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estimate of the number of unpublished studies. Chapter six looks at methods that 
model the selection process to provide a combined effect size estimate that has been 
adjusted for the influence of publication bias. 
2.4 Discussion 
Publication bias has been named as a major causal factor for discrepancies between 
meta-analyses and subsequent large trials (Chalmers et at., 1987; Egger and Smith, 
1995; Ioannidis et at., 1998; Borzak and Ridker, 1995; Cappelleri et at., 1996; 
Villar et at., 1995; LeLorier et at., 1997). Empirical evidence has shown that trials 
with statistically significant results are more likely to be accepted for presentation 
at research meetings and for full publication. The majority of blame for the 
selection process favouring positive trials has traditionally been given to editors of 
journals, but publication bias research has shown that it is the failure of investigators 
to write up and submit results of negative trials that is largely responsible 
(Dickersin et at., 1987). Editors may have contributed to this by previously 
stating statistical significance as a requirement for publication (Editorial, 1980; 
Melton, 1962). 
The incentives for investigators to publish their work are great with pressure 
to achieve academic promotion being dependent on number of publications. Begg 
and Berlin (1989) believe that it is this pressure which encourages demonstration of 
statistical significance to "prove" theories. 
Negative studies present difficulties in interpretation of results. Lack of evidence 
of efficacy is not the same as evidence that it is not effective. Insufficient sample size 
may mean that the study is underpowered to detect an effect, and negative trials 
are often criticised for having enrolled too few patients (Detsky and Sackett, 1985), 
and may be subject to greater scrutiny by peer reviewers. Significant results have 
been shown to lead to an increased chance of publication and a shorter time to reach 
publication. They have also been shown to lead to a greater number of duplicate 
publications. Neider (1999) places blame with the `p-culture' and hypothesis testing. 
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He believes that a possible reason for the ready acceptance of significance tests is 
that they go with yes-no reasoning, and that many people are happy with such firm 
qualitative conclusions rather than quantitative assertions and inferences associated 
with confidence intervals. Prospective registration may provide the only true 
solution to publication bias in the long term, but changes to implement prospective 
registration are slow. This places a reliance on statistical procedures to identify and 
adjust meta analyses that may be influenced by publication bias. Chapters five and 
six show that publication bias methodology has typically been limited to assuming 
publication is based on p-values only, yet the empirical research contained in this 
chapter shows that there may be other influential factors. In chapters seven and 
eight new methodology is developed to incorporate this information. In the next 
chapter examples will be introduced which will be used throughout to illustrate and 
compare publication bias methods. 
Chapter 3 
Examples 
In this chapter a set of examples will be introduced. These examples contain 
two real meta-analysis data sets taken from the CDSR and three simulated meta- 
analysis data sets. Implementation of publication bias methodology contained in 
the following chapters will be based on these data sets. 
3.1 Examples from the Cochrane database of 
systematic reviews 
3.1.1 Prophylactic corticosteroids for preterm delivery 
Respiratory distress syndrome (RDS) is a serious complication of prematurity that 
causes significant immediate and long-term mortality and morbidity. To prevent 
RDS of the newborn a short course of prophylactic intravenous corticosteroids is 
administered to pregnant women who are expected to deliver prematurely. This 
trial compares the effects of giving corticosteroids in comparison to standard care. 
The logo of the Cochrane Collaboration (see figure 3.1 and section 1.3) illustrates a 
systematic review of seven RCTs, of which the first was conducted in 1972. While 
the 95% confidence intervals of the individual trials, represented by horizontal lines, 
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Figure 3.1: The Cochrane Collaboration logo 
give varying estimates of the efficacy of the treatment, the combined estimate, 
represented by the diamond, strongly indicates that corticosteroids reduce the risk 
of infant mortality caused by complications of prematurity. The updated systematic 
review available on the CDSR contains 14 RCTs conducted between 1972 and 
1994 (Crowley, 1999). This review concludes that antenatal corticosteroid therapy 
reduces mortality, RDS, and intraventricular haemorrhage in preterm infants who 
are subsequently born. Consideration of this example will be restricted to the infant 
mortality data. 
The search strategy used in this review was developed by the Pregnancy and 
Childbirth review group, details of this strategy are available on the CDSR, but 
includes Medline database searches, and hand searching of journals and conference 
proceedings. The search did not uncover any unpublished reports, and the review 
does not report testing for publication bias. Eighteen trials including data on 3,700 
babies born to randomised women were identified although many of these trials 
had duplicate publications. Fourteen trials met the inclusion criteria, table 3.1 and 
figure 3.2 provide summary data of neonatal mortality. 
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Table 3.1: Review: Prophylactic corticosteroids for preterm delivery 
Study Treatment 
Group 
Control 
Group 
OR (95% CI) p-value 
Amsterdam 1980 3/64 12/58 0.19(0.05,0.71) 0.007 
Auckland 1972 36/532 60/538 0.58(0.38,0.89) 0.006 
Block 1977 1/69 5/61 0.16(0.02,1.45) 0.052 
Doran 1980 4/81 11/63 0.25(0.07,0.81) 0.011 
Gamsu 1989 14/131 20/137 0.70(0.34,1.45) 0.169 
Garite 1992 9/40 11/42 0.82(0.30,2.25) 0.349 
Kafir 1994 6/95 9/94 0.64(0.22,1.87) 0.205 
Morales 1986 7/121 13/124 0.52(0.20,1.36) 0.093 
Morrison 1978 3/67 7/59 0.35(0.09,1.41) 0.070 
Papageorgiou 1979 1/71 7/75 0.14(0.02,1.16) 0.034 
Parsons 1988 0/23 1/22 0.30(0.01,7.89) 0.237 
Schmidt 1984 5/49 4/31 0.77(0.19,3.11) 0.355 
Tauesch 1979 8/56 10/71 1.02(0.37,2.77) 0.513 
US Steroid Trial 32/371 34/372 0.94(0.57,1.56) 0.403 
Totals 129/1770 204/1747 0.60(0.47,0.75) «0.001 
° The combined OR and Cl calculated using the Mantel Haens el method 
Figure 3.2: Corticosteroids forest plot 
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3.1.2 Albumin administration in critically ill patients 
The aim of this systematic review was to quantify the effect on mortality of 
administering human albumin of plasma protein fraction (PPF) to critically ill 
patients (Alderson et al., 1999). The review aimed to identify and include all trials 
that compared the administration of albumin or PPF with no administration or with 
administration of crystalloid solution in critically ill patients with hypovolaemia, 
burns, or hypoalbuminaemia. The search strategy consisted of computerised 
searches of the Cochrane Controlled Trials Register, Medline, Embase, and BIDS 
Index to Scientific and Technical Proceedings. Twenty-nine international journals 
and the proceedings of several international meetings on fluid therapy were hand 
searched. Reference lists of trials and review articles were checked, and authors of 
all identified trials were contacted and asked about any other trials that may have 
been conducted, whether published or not. 
The search identified 42 trials of which 30 fulfilled the inclusion criteria. The 
30 trials included one unpublished trial that was contained in the Medical Editors 
Trial Amnesty (see chapter two). No deaths occurred in six of the trials. This 
information was not reported in four of these trials and was obtained by contacting 
the authors. Although these trials fulfilled the inclusion criteria, they were not 
included in the combined odds ratio estimate. The data has been re-analysed here 
to incorporate these trials in the meta-analytic result by adding 0.5 to each cell count 
as suggested by Gart and Zweifel (1967). The choice of adding 0.5 is arbitrary and 
it can be seen by the width of the confidence intervals that these trials contain 
no information. Consequently these trials are given very little weight in the meta- 
analyses. Subgroup analyses for hypovolaemia, burns and hypoalbuminaemia were 
included in the Cochrane review but the results will be analysed here collectively 
only. The review used a simple linear regression to identify publication bias through 
funnel plot asymmetry (see section 5.1.4). The results of this test gave no statistical 
evidence of publication bias. The authors acknowledged publication bias as a threat 
to the validity of meta-analyses but concluded that it was unlikely to have had an 
impact on this study. The data of the 30 trials included in the review are contained 
in table 3.2 and displayed in figure 3.3. 
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Table 3.2: Review: Albumin administered in critically ill patients 
Study Treatment 
Group 
Control 
Group 
OR (95% CI) p-value 
Boldt 1993 0/15 0/15 1.00(0.02,53.66) 0.500 
Boutros 1979 0/7 2/17 0.41(0.02,9.73) 0.292 
Gallagher 1985 0/5 0/5 1.00(0.02,59.99) 0.500 
Grundmann 1982 1/14 0/6 1.44(0.05,40.54) 0.586 
Lowe 1977 3/57 3/84 1.50 (0.29,7.7) 0.686 
Lucas 1978 7/27 0/25 18.66(1.00,346.37) 0.975 
Nielsen 1985 0/13 0/13 1.00(0.02,54.15) 0.500 
Pockaj 1994 0/54 0/53 0.98(0.02,50.38) 0.496 
Prien 1990 0/6 0/6 1.00(0.02,58.44) 0.500 
Rackow 1983 6/9 6/8 0.67(0.08,5.54) 0.354 
Shah 1977 2/9 3/11 0.76(0.10,5.96) 0.398 
So 1997 7/32 5/31 1.46(0.41,5.20) 0.719 
Tollofsrud 1995 0/10 1/10 0.30(0.01,8.33) 0.239 
Virgillo 1979 1/15 1/14 0.93(0.053,16.42) 0.480 
Woittiez 1998 8/15 4/16 3.43(0.75,15.67) 0.944 
Woods 1993 1/37 0/32 2.67(0.11,67.89) 0.724 
Zetterstrom 1981a 0/15 1/15 0.31(0.01,8.29) 0.243 
Zetterstrom 1981b 2/9 0/9 6.33(0.26,152.87) 0.872 
Goodwin 1983 11/40 3/39 4.55(1.16,17.86) 0.985 
Greenhalgh 1995 7/34 3/36 2.85(0.67,12.10) 0.922 
Jelenko 1978 1/7 2/7 0.42(0.03,6.06) 0.261 
Bland 1976 4/14 1/13 4.80(0.46,50.16) 0.905 
Brown 1988 6/34 4/33 1.55 (0.40,6.10) 0.736 
Foley 1990 7/18 6/22 1.70(0.45,6.44) 0.781 
Golub 1994 12/116 6/103 1.87(0.67,5.16) 0.885 
Greenough 1993 6/20 4/20 1.71(0.40,7.34) 0.766 
Kanarek 1992 3/12 2/12 1.67(0.22,12.35) 0.691 
Nilsson 1980 1/29 0/30 3.21(0.13,82.07) 0.760 
Rubin 1997 2/16 1/15 2.00(0.16,24.66) 0.706 
Wojtysiak 1992 0/15 0/15 1.00(0.02,53.66) 0.500 
Totala 98/704 58/715 1.87(1.32,2.64) <0.001 
- combined Vii end UL c&ICuIated using Mantel Haens el method 
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Figure 3.3: Albumin forest plot 
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This systematic review with meta-analysis found no evidence that albumin 
reduces mortality. Contrary to previous beliefs they found that it might increase 
the risk of death. 
3.2 Simulation studies 
Applying methods which investigate publication bias to meta-analyses taken from 
the CDSR will only allow a comparison of the results of different methods. A 
limitation of using real examples is that it is not possible to know how closely the 
methods approximate the truth. In this thesis, three simulation studies are used to 
allow identification of methods that provide closer estimation of the true parameter 
values. 
Simulation studies used to evaluate publication bias methods in previous papers 
have used suppression criteria based on p-values only (Hedges and Vevea, 1996; 
Dear and Begg, 1992; Duval and Tweedie, 2000b; Duval and Tweedie, 2000a; 
Givens et al., 1997; Smith et al., 1997). The simulation studies conducted here allow 
the probability of publication to vary according to a study's p-value and sample size. 
The strongest suppression criteria has been applied to small studies with large p- 
values with the probability of suppression decreasing as p-value decreases and/or 
sample size increases. 
3.2.1 Simulating trial data 
Binary data for a single trial, contained in a2 by 2 table, is a two sample problem 
where each of the populations (treatment and control groups) follow independent 
binomial distributions (see section 4.1). Three sets of 50 trials have been simulated, 
such that each trial within a set forms a2 by 2 table, with the event probabilities 
chosen to be similar to those observed in the CDSR examples. The first simulation 
(sim 1) is designed to have a strong beneficial treatment effect. That is the event 
rate, assumed to be mortality, is much lower in the treatment group than in the 
control. The second simulation (sim 2) has a moderate treatment effect, while the 
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third simulation (sim 3) has no true difference between event rates. The probability 
of an event in all control groups is 0.2 and in the treatment groups is 0.12,0.18, 
and 0.2 resulting in odds ratios of 0.54,0.88 and 1 respectively for siml, sim2, and 
sim3. The purpose of including simulations with true treatment benefit will ensure 
that the methods will not down-weight true treatment effects and will adjust for 
the effects of publication bias only. The purpose of including sim 3 that has a true 
underlying odds ratio of 1 is that many methods which investigate publication bias 
assume that the null hypothesis of no true treatment effect is true, and that the 
effects of publication bias will be stronger where the true effect is small or null. 
Full specification of the binomial distribution requires sample size to be specified 
with the event rates. Trial sample size has been simulated using a normal 
distribution. To allow probability of publication to increase as sample size increased, 
sample size has been split into three groups: small, medium, and large. Classification 
of a trial into one of these three categories was determined by power calculations 
based on siml. Table 3.3 shows the number of patients per group required to detect 
the difference between 0.12 and 0.2 at a given power level (1- Type 2 error) for a 
two-tailed 0.05 level of significance (Type 1 error). 
Table 3.3: Power calculations based on Simulation 1 
Power % N 
per group 
50 157.7 
70 257.3 
80 327.9 
90 435.8 
95 630.8 
99 763.6 
A small trial is defined as having less than 50% power, a medium trial as having 
between 50% and 80% power, and a large trial as having power greater than 80%. 
These cut points are arbitrary, but allow the size of the simulated trials to cover 
the full range of statistical power. Although definitions of trial size are based on 
statistical power in many settings few trials would have more than 157 patients per 
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group (Cheng et al., 1998). This is reflected in the number of trials simulated in each 
range (see table 3.4). The number of patients per group has been simulated from a 
normal distribution for each category where the mean and standard deviation used 
were chosen to agree with the respective definitions. Table 3.4 shows the number of 
trials simulated for each category, and the parameters of the normal distribution. 
Table 3.4: Parameters used to simulate trial sample size 
Normal Distribution 
Number of trials Mean Standard Deviation 
Sample Size of Sample Size 
Small 41 100 30 
Medium 7 242 42 
Large 2 546 109 
The simulated normal data were combined with the event probabilities described 
above and used to simulate data for trials. 
3.2.2 Simulating a selection process 
Three populations of 50 trials were generated as described above. Simulation of 
publication bias requires a mechanism that will suppress some of the data according 
to p-values and sample size. To do this the p-value range has been split in to 3 
intervals, p<0.055,0.055 <p<0.15, and p>0.15. Givens, Smith and Tweedie 
(1997) have also used similar partitioning of the p-value range based on Stern and 
Simes (1997) (see page 45). Once the data are split in to the three p-value intervals 
a bernoulli random variable is applied to each segment to suppress some of the 
data with probability (1 - p; ) where i=1,2,3. The choice of values, representing 
probability of publication, given in table 3.5, are arbitrary but the general pattern 
of suppression follows Stern and Simes (1997). 
The number of simulated trials observed after suppression are given in table 3.6. 
Tables 3.7,3.8 and 3.9 contain the trial data for simulations one, two, and three. 
The data are displayed in figures 3.4 - 3.9. The meta-analyses of the data before 
suppression match the odds ratios used for the simulations. 
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Table 3.5: Publication probabilities used in simulations 
p<0.055 0.055<p<0.15 p>0.15 
Small 0.65 0.2 0.3 
Medium 0.8 0.4 0.55 
Large 0.99 0.85 0.8 
Weighted Mean 0.68 0.252 0.357 
Table 3.6: Results of suppression 
Number trials 
Before suppression After suppression 
siml sim2 sim3 
small 41 19 11 13 
medium 7 4 4 5 
large 2 2 1 1 
total 50 25 16 19 
In chapter four popular methods of meta-analysis for binary data will be reviewed 
with application to the examples contained here. 
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Table 3.7: Simulation 1 
Study Treatment Control OR(95%CI) 
Group Group 
1* 8/94 17/94 0.421 (0.172,1.031) 
2* 7/33 4/33 1.952 (0.512,7.437) 
3 11/73 11/73 1.000 (0.404,2.477) 
4* 8/67 15/67 0.470 (0.184,1.198) 
5* 7/35 8/35 0.844 (0.269,2.648) 
6 5/66 11/66 0.410 (0.134,1.254) 
7 6/73 12/73 0.455 (0.161,1.287) 
8 11/76 14/76 0.749 (0.316,1.776) 
9 13/93 20/93 0.593 (0.275,1.277) 
10 5/55 9/55 0.511 (0.160,1.637) 
11 7/44 10/44 0.643 (0.220,1.880) 
12 * 11/91 18/91 0.558 (0.247,1.259) 
13 * 11/104 26/104 0.355 (0.165,0.764) 
14 9/91 15/91 0.556 (0.230,1.345) 
15 * 7/64 16/64 0.368 (0.140,0.970) 
16 * 19/112 29/112 0.585 (0.305,1.120) 
17 * 3/51 12/51 0.203 (0.054,0.771) 
18 9/66 14/66 0.586 (0.234,1.469) 
19 9/90 25/90 0.289 (0.126,0.662) 
20 14/92 17/92 0.792 (0.365,1.719) 
21 * 6/62 19/62 0.242 (0.089,0.659) 
22 * 8/58 17/58 0.386 (0.151,0.984) 
23 * 6/60 14/60 0.365 (0.130,1.027) 
24   15/83 24/83 0.542 (0.260,1.129) 
25 5/63 9/63 0.517 (0.163,1.641) 
26 8/57 6/57 1.388 (0.449,4.291) 
27 19/91 19/91 1.000 (0.489,2.044) 
28 * 16/160 33/160 0.428 (0.225,0.813) 
29   11/100 16/100 0.649 (0.285,1.479) 
30 8/62 11/62 0.687 (0.256,1.845) 
31 * 5/48 12/48 0.349 (0.112,1.084) 
32 13/92 11/92 1.212 (0.512,2.866) 
33 * 7/62 14/62 0.436 (0.163,1.170) 
34 * 10/84 17/84 0.533 (0.228,1.244) 
35 13/108 18/108 0.684 (0.317,1.477) 
36 1/39 5/39 0.179 (0.020,1.609) 
37 3/56 14/56 0.170 (0.046,0.630) 
38 8/66 15/66 0.469 (0.184,1.197) 
39 * 16/109 21/109 0.721 (0.353,1.470) 
40 6/68 9/68 0.634 (0.213,1.892) 
41 7/96 17/96 0.365 (0.144,0.927) 
42 * 31/286 66/286 0.405 (0.255,0.644) 
43 * 20/190 31/190 0.603 (0.330,1.102) 
44 * 33/245 55/245 0.538 (0.335,0.864) 
45 29/176 31/176 0.923 (0.529,1.609) 
46 36/251 47/251 0.727 (0.452,1.168) 
47 * 32/262 48/262 0.620 (0.382,1.007) 
48 42/279 55/279 0.722 (0.464,1.122) 
49 * 51/428 83/428 0.562 (0.385,0.821) 
50 * 59/504 109/504 0.480 (0.340,0.678) 
subtotal before° 704/5715 1149/5715 0.56(0.50,0.62) 
suppression 
subtotal after" 407/3392 724/3392 0.50(0.44,0.57) 
suppression 
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3.2. SIMULATION STUDIES 
Table 3.8: Simulation 2 
" Thal co. 
Study Treatment Control OR(95%CI) 
Group Group 
1 8/76 13/76 0.570 (0.222,1.467) 
2 19/88 12/88 1.744 (0.789,3.853) 
3 7/45 2/45 3.961 (0.775,20.233) 
4s 28/132 32/132 0.841 (0.473,1.498) 
5 8/55 11/55 0.681 (0.251,1.849) 
6* 13/51 10/51 1.403 (0.551,3.573) 
7 16/82 18/82 0.862 (0.405,1.836) 
8* 27/129 31/129 0.837 (0.466,1.503) 
9s 12/46 11/46 1.123 (0.437,2.888) 
10 s 13/81 20/81 0.583 (0.268,1.271) 
11 24/108 28/108 0.816 (0.437,1.526) 
12 12/83 16/83 0.708 (0.312,1.606) 
13 23/33 26/33 0.860 (0.462,1.601) 
14 16/106 24/106 0.607 (0.302,1.223) 
15 17/77 16/77 1.080 (0.500,2.333) 
16 11/73 16/73 0.632 (0.271,1.475) 
17 20/78 24/78 0.776 (0.385,1.562) 
18 29/137 26/137 1.146 (0.634,2.072) 
19 10/54 13/54 0.717 (0.283,1.813) 
20 s 13/84 17/84 0.722 (0.326,1.599) 
21 17/69 15/69 1.177 (0.533,2.598) 
22* 13/59 13/59 1.000 (0.419,2.388) 
23 12/66 15/66 0.756 (0.323,1.768) 
24 29/138 28/138 1.045 (0.583,1.872) 
25 17/83 19/83 0.868 (0.414,1.817) 
26 15/76 16/76 0.922 (0.419,2.031) 
27 16/85 15/85 1.082 (0.497,2.358) 
28 * 8/64 12/64 0.619 (0.234,1.635) 
29 16/74 19/74 0.799 (0.373,1.708) 
30 18/75 14/75 1.376 (0.627,3.020) 
31 s 11/57 17/57 0.563 (0.236,1.341) 
32 17/111 18/111 0.934 (0.454,1.924) 
33 19/61 12/61 1.847 (0.804,4.245) 
34 s 14/92 25/92 0.481 (0.232,0.999) 
35 14/89 14/89 1.000 (0.446,2.241) 
36 * 9/63 20/63 0.358 (0.148,0.866) 
37 21/98 15/98 1.509 (0.726,3.136) 
38 18/73 16/73 1.166 (0.541,2.515) 
39 16/87 23/87 0.627 (0.305,1.291) 
40 21/87 14/87 1.659 (0.781,3.526) 
41 28/118 22/118 1.358 (0.724,2.544) 
42 s 55/251 55/251 1.000 (0.655,1.526) 
43 s 41/221 47/221 0.843 (0.528,1.346) 
44 36/195 42/195 0.825 (0.502,1.356) 
45 60/276 66/276 0.884 (0.594,1.316) 
46 30/189 39/189 0.726 (0.429,1.228) 
47 s 35/175 43/175 0.767 (0.463,1.272) 
48 * 36/217 53/217 0.615 (0.383,0.988) 
49 * 146/760 167/760 0.844 (0.658,1.083) 
50 105/495 107/495 0.976 (0.721,1.323) 
subtotal before" 1219/6222 1347/6222 0.88(0.81,0.96) 
suppression 
subtotalafter° 474/2482 573/2482 0.79(0.68,0.9) 
suppression 
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3.2. SIMULATION STUDIES 
Table 3.9: Simulation 3 
" The .. 
Study Treatment Control OR(95%CI) 
Group Group 
1+ 12/77 16/77 0.704 (0.308,1.608) 
2 17/103 23/103 0.688 (0.342,1.380) 
3 19/94 22/94 0.829 (0.414,1.659) 
4 20/102 15/102 1.415 (0.679,2.948) 
5" 20/89 25/89 0.742 (0.376,1.464) 
6s 27/127 35/127 0.710 (0.399,1.263) 
7 13/102 13/102 1.000 (0.439,2.277) 
8 12/56 8/56 1.636 (0.612,4.376) 
9w 26/139 29/139 0.873 (0.483,1.576) 
10 23/101 17/101 1.457 (0.725,2.930) 
11 22/111 19/111 1.197 (0.607,2.361) 
12 21/103 21/103 1.000 (0.508,1.970) 
13 20/90 13/90 1.692 (0.784,3.654) 
14 23/99 20/99 1.195 (0.607,2.352) 
15 21/109 22/109 0.944 (0.484,1.839) 
16 25/121 19/121 1.398 (0.724,2.701) 
17 * 13/60 11/60 1.232 (0.502,3.022) 
18 24/114 21/114 1.181 (0.614,2.270) 
19 14/98 19/98 0.693 (0.326,1.475) 
20 * 17/104 27/104 0.557 (0.282,1.100) 
21 12/55 12/55 1.000 (0.405,2.472) 
22 14/79 20/79 0.635 (0.295,1.370) 
23 18/68 9/68 2.360 (0.975,5.715) 
24 11/73 17/73 0.584 (0.252,1.354) 
25 18/79 18/79 1.000 (0.475,2.103) 
26 * 19/82 17/82 1.153 (0.550,2.418) 
27 9/88 10/88 0.889 (0.343,2.305) 
28 * 23/118 29/118 0.743 (0.400,1.380) 
29 * 12/77 16/77 0.704 (0.308,1.608) 
30 27/117 20/117 1.455 (0.763,2.775) 
31 18/87 15/87 1.252 (0.585,2.679) 
32 * 21/112 28/112 0.692 (0.365,1.311) 
33 21/94 19/94 1.136 (0.564,2.285) 
34 18/84 10/84 2.018 (0.870,4.681) 
35 20/71 10/71 2.392 (1.027,5.571) 
36 * 13/75 16/75 0.773 (0.343,1.745) 
37 17/76 15/76 1.172 (0.537,2.559) 
38 * 16/99 21/99 0.716 (0.348,1.471) 
39 16/65 13/65 1.306 (0.570,2.994) 
40 s 17/70 16/70 1.083 (0.496,2.364) 
41 21/94 15/94 1.515 (0.726,3.160) 
42 37/180 35/180 1.072 (0.639,1.797) 
43 43/204 43/204 1.000 (0.621,1.609) 
44 * 25/187 30/187 0.808 (0.455,1.434) 
45 * 43/219 56/219 0.711 (0.453,1.116) 
46 + 23/102 23/102 1.000 (0.519,1.928) 
47 * 39/223 50/223 0.733 (0.460,1.170) 
48 " 40/167 43/167 0.908 (0.553,1.492) 
49 * 91/499 93/499 0.974 (0.707,1.341) 
50 115/583 114/583 1.011 (0.757,1.350) 
subtotal before 1206/6126 1228/6126 0.98(0.89,1.07) 
suppression 
subtotal after' 497/2626 581/2626 0.82(0.72,0.94) 
suppression 
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Chapter 4 
Methods of meta-analysis 
In chapter one, the concept of evidence-based medicine and the rationale behind 
systematic reviews were introduced. In this chapter, odds ratios will be presented 
as a method of summarising data of a single binary trial and methods of meta- 
analysis that combine odds ratios across trials will be introduced. Although the 
methods contained in this thesis focus on binary data the ideas generalise to other 
types of outcomes. In section 4.7 the data sets contained in chapter three will be 
used to illustrate these methods. 
4.1 Single trial: binary data 
A binary variable is a particular form of categorical or qualitative data, in which 
the response of interest is one of two alternatives eg. male or female, dead or alive. 
The results of a randomised controlled trial (RCT), in which binary outcome data 
has been collected are frequently presented in the form of a2 by 2 table (see table 
4.1). 
This table is equivalent to a pair of independent binomial observations A 
(treatment group) and B (control group) with parameters n1, irl and n2, ir2 
respectively, where 7rl is the probability of an event in the treatment group, and 
similarly for 7r2. 
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Table 4.1: Presentation of results in a2 by 2 table 
AB 
Treatment Control Total 
Event abm 
No Event cd N-m 
Total n1 nZ N 
where nj and n2 are fixed by design, and a and b are the observed number of events which 
are subject to sampling variation. 
AN Bin(nl, ir1) 
BN Bin(n2, ire) 
In evaluating the efficacy of one intervention compared to the other it is the 
relationship between irl and ire that is of interest. 
4.1.1 Odds ratios 
For each population the odds of success against failure is defined by 
7r 
1-ir 
An odds ratio, 0, is the ratio of two odds. If 1 is the odds of the outcome in 7rl 
the first group and 1 is the odds of the outcome in the second group then 
_ 7ri 
(I -T2 l- 
W2(1-7i) 
The conditional distribution of A given A+ B=m, where m is the total number 
of events observed, is defined by the noncentral hypergeometric distribution and 
depends only on 0 (see appendix A). 
The maximum likelihood estimators (MLEs) of 7r1 and 1r2 from their respective 
binomial distributions are given by - and , giving an MLE of ni n2 
ad 
- be 
An odds ratio of unity means that events are no more likely to occur in either 
group. Assuming the treatment group relative to control, '<1 occurs when the 
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event occurs less frequently in the treatment group, while an 0>1 occurs when 
the event is observed more often in the treatment group. If the event of interest is 
mortality then '<1 suggests that the treatment has a protective effect while an 
>1 indicates that the treatment maybe harmful. 
Woolf (1955) originally proposed an approximation for large samples to the 
asymptotic variance of loge(ip) as 
_1 
111 
v+ 
ab+c+d 
but this expression is undefined if any count is zero. Gart and Zweifel (1967) 
suggested adding 2 to each count giving 
(a+2)(d+1' 
(b+ 
2)(c+ 
2) 
with variance 
_1111 vaT 2+ 2+ d -F- 2 
This has the advantage of providing a finite variance even when some counts 
equal zero. This is the method used in the human albumin example where zero cell 
counts are frequently encountered. 
The Peto method (Yusuf, 1985) gives an alternative approach to obtaining ýi. 
This is obtained by exp(°V-E), where E and V are the mean and variance of the 
central hypergeometric distribution, (ie, 1 = 1), and 0 is the observed number of 
events. This method extends to combining results from several studies to obtain a 
common odds ratio (see section 4.4.3). 
Although the odds ratio is not as intuitive as other measures of association, a 
key advantage is that it is estimable from data collected according to different study 
designs. When the event is rare the odds ratio provides an approximation to the 
relative risk (RR). The RR is the ratio of the probability of the event occurring in 
one group compared to the other and is a more intuitive measure of association that 
is not estimable from retrospective studies. The odds ratio can assume any value 
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between 0 and oo, and hence its log is approximately normally distributed between 
-oo and oo. The log odds ratio is the main parameter in a logistic regression model 
which is widely used for describing the effects of predictors on a binary response 
variable. 
4.2 Models for combining data 
In combining effect sizes from independent trials there are essentially two distinct 
statistical models that may be used: models based on the assumption of fixed effects 
and those based on random effects. A fixed effects method makes the assumption 
that there is one underlying true treatment effect of which each study provides an 
estimate. 
H: ti; =0 for all i where i indexes studies 
This is based on an assumption of homogeneity. A fixed effects method assumes 
that all variation between observed estimates is caused by sampling variation. This 
means that if variability between observed estimates exceeds that which could be 
expected by random variation then a fixed effects approach is not suitable. 
A random effects model does not rely on the assumption of homogeneity. It 
assumes that the observed estimates are dispersed around a global central parameter 
with variance T2. Therefore the variation of an observed trial consists of two 
components 
i ^ý N(, a) 
V's ' 
N(b, r2) 
The inclusion of a between trial variation component (T2) allows for the impact 
that differences in trial design and populations can have on 0;. The overall estimate 
obtained from random effects is very similar to a fixed effects but in the presence 
of heterogeneity (T2 > 0) the associated confidence intervals will be substantially 
wider due to the between trials variation. 
4.3. HETEROGENEITY 
Tests of heterogeneity exist to help determine the suitability of each model. 
4.3 Heterogeneity 
Tests for the presence of heterogeneity test the null hypothesis 
Ho . V) 1= 2=....... =pik 
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where the O; 's are the underlying true treatment effect of the ith study. The 
alternative hypothesis is that at least one of the effect sizes differs from the 
remainder. The general form of the test is given by 
k 
Q= Wi(loge (00 - log (0)), 
i=1 
where w; is the inverse of the variance and 
log(O) _ ds 
ý 
Dw09e(J 
) 
k Ei=1 Wi 
Q approximately follows a X2 distribution on k-1 degrees of freedom. Due to the 
low power associated with this test, and the small number of trials that are usually 
available the critical level of significance recommended for this test is 0.1 (Fleiss, 
1986). Homogeneity of results can never be confirmed and so lack of statistical 
significance should not be mistaken for evidence of homogeneity. 
Graphical methods exist to explore and identify heterogeneity, and these are 
summarised by Sutton et al. (1998) and described and illustrated by Thompson 
(1993). One approach in dealing with heterogeneity is to include the cause such 
as age, sex, or dosage levels as a covariate in the analysis. Inclusion of covariate 
information may reduce or even remove the heterogeneity and allow for more specific 
therapeutic recommendations. It is possible that heterogeneity, which is present in 
trials for a meta-analysis, cannot be explained, and while investigating sources of 
heterogeneity can increase the relevance of the results, the dangers of speculative 
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conclusions from overzealous inspections of the data should also be considered 
(Chalmers and Altman, 1995). Methods of meta-regression are summarised in 
Sutton et al. (1998) 
4.4 Fixed effects 
Before a fixed effects approach is used the amount of heterogeneity present in the 
data set needs to be considered (see section 4.3). 
4.4.1 Woolf's method 
Woolf's method (1955) estimates a common value of the log odds ratio by weighting 
each study by the inverse of its asymptotic variance 
1111 
_1 
The combined estimate and variance is given by 
n 
109eý ý_ 
ýs _12Usloge 'ýi 
En i_1 Wi 
V(1096)) = Ei 1 wi 
with approximate 95% confidence interval for log odds 
lo9eýý f 1.96 
1 
n EsE- wi 
Exponentiating gives a confidence interval for the odds ratio. 
Fleiss (Fleiss, 1981) recommends that this method should only be used when 
there are few studies to combine, each with large samples. Other work has found 
that Woolf's estimate is not competitive with the Mantel Haenszel estimator when 
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there are more than two studies to combine (Throne et al., 1983; Breslow, 1981; 
McKinlay, 1978). 
4.4.2 Mantel-Haenszel 
Unlike Woolf's and Peto's methods (see section 4.4.3) the Mantel-Haenszel estimate 
(Mantel and Haenszel, 1959) combines estimates on the odds ratio scale and not the 
log odds ratio scale. The pooled odds ratio is defined as 
n 
n ýi-1 
ald 
Ni 
6icj 
Ni 
or equivalently 
wio 
n Ei-1 Wi 
where z%; =6 and wi =N 
From these formulas it can be seen that the Mantel-Haenszel estimate is a 
weighted average of the 
i; obtained from the individual studies. 
A lot of attention has focused on obtaining an asymptotic variance for this 
estimator. The method that has been adopted was developed by Robins et al. 
(1986). It is consistent under both large strata and sparse data limiting models, and 
by using variance of log, (i) has been shown to perform well in providing confidence 
intervals for many situations having modest counts (Emerson, 1994). 
n 
VMg(lO9e(O)) =( sn 
l4+ 
nýs n+ 
ýs Hs 
1 
1 2 Ei=1 R, 2 Fi-1 ý. 
i=1'Ss 2 F. in=1 
21 
"Si 
where 
ai + di Fi = a=d= 
Gri = 
[aidi(bi + c1)] + (biG(ai + di)] 
N; 
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H" - 
bsc1 (b+ c; ) 
R= aid1 
Ni 
S, 
b`ci 
Ni 
The approximate 95% confidence interval is obtained initially for log, (t)) and 
then exponentiated 
exp(lOge(ý)-'1.96se(log, (t)) 
Use of Mantel-Haenszel estimator can be recommended in a wide range of 
circumstances. It provides an asymptotically unbiased estimator of the underlying 
true common odds ratio (0), and although it is not fully asymptotically efficient 
when the true odds ratio differs from one (Tarone et at., 1983; Hauck and Donner, 
1988) has been shown to have high asymptotic efficiency in both fixed and increasing 
strata situations (Hauck and Donner, 1988; Breslow, 1981; Donner and Hauck, 
1986). The Mantel-Haenszel estimator has been shown to remain consistent and 
asymptotically normal even when the assumption of independent trials is violated 
(Liang, 1985; Donald and Donner, 1990). It has also been found to provide a good 
estimate, for large cell counts, when there is some heterogeneity (McKinlay, 1978). 
4.4.3 Peto method 
Yusuf et al. (1985) describe their method for combining 2 by 2 tables as a 
modification of the method given by Mantel and Haenszel (1959) (see section 4.4.2). 
This method considers the difference between the numbers of observed events in the 
treatment group (O=a)and the number of events that would be expected if there 
was no difference between groups (E=(N )rn). If the null hypothesis of no difference 
is true then this value would only differ randomly from zero with variance V, where 
V= nin2m(N - M) 
N2(N -1) 
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and E and V, under the null hypothesis, are the mean and variance of a central 
hypergeometric distribution, conditional on the marginal totals, n1, n21 and m being 
fixed (see appendix A). 
If there were n such studies, then for study i, under the null hypothesis O; - Es 
would be approximately normally distributed with variance V 
O; -E; N 
E(Oi - Ei) N 
i=1 
N(0, V) i=1... n 
n 
Vi) 
i=1 
The test of the null hypothesis Ho where Ho = log,, (V; i) =0 for i=1..... n is given 
by comparing the test statistic below to the critical value on the standard normal 
tables. 
E, n 
n ýi=1 V 
In using this method to obtain an estimate for 'i it is assumed that there is a 
common treatment effect between trials, and that 0 is close to unity. The combined 
odds ratio is given by 
ýEi l(Oi - 
E_) 
= exp n ýi=1 V 
and is approximately normally distributed with variance 
VE 
n- 
l 
ý0i - Ei)) 
=1 Ei=1 V si=1 V 
and 95% confidence interval 
exp( 
E'n-1(Oi - Ei) ± 
1.96 
n ýi=1 V ýi=1 V 
It can be shown that the Peto estimate of loge() is the first iterative step of 
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the Newton Raphson procedure to maximise the conditional log-likelihood when 
the starting value for the combined log odds ratio is zero (see appendix B). This 
explains why this method gives a poor estimate if the underlying odds ratio is far 
from one. 
This method has been heavily criticised. Greenland and Salvan (1990) showed 
that this method may yield biased results when there is imbalance between the 
margins and that the results may still be biased even when there is balance if the 
odds ratio is far from unity. Fleiss (1993) suggested that the marginal values ni and 
n2 should differ by no more than a factor of 3, and gave the interval from 0.2 to 5.0 
as an acceptable range for use of this method. However Fleiss also stated that: 
"Given the simplicity and broad validity of competing methods, and 
the possibility of bias in Peto's method, there are no compelling reasons 
for the (0 - E)/V procedure to be used. " 
4.5 Random effects 
The following random effects models allow for unexplained variation between trial 
estimates. 
4.5.1 DerSimonian-Laird 
DerSimonian and Laird's method (1986) is a random effects approach to obtain a 
combined odds ratio. Fleiss and Gross (1991) illustrate this method on a meta- 
analysis of randomised trials of the effectiveness of aspirin in preventing death after 
a myocardial infarction. Using this example they show how a more conservative 
approach, in some cases, can cast doubt on conclusions of meta-analyses based on 
the assumption of fixed effects. 
In the absence of any heterogeneity DerSimonian and Laird's method is equivalent 
to Woolf's (1955) (see section 4.4.1) , where loge(=) is weighted by wi = 
I. If there 
is heterogeneity between the studies then DerSimonian-Laird weighting factor for 
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study i is given by 
WDLi = (D+V)-' 
where D= max(O, D*) is the between study variance estimate, and 
D* _ 
(Q - (n -1)) E 'i-, wi 
n2n2 (EI 
i wi) - Es_1 wi 
where Q is the test for heterogeneity given in section 4.3. 
The random effects point estimate of the overall odds ratio is given by 
n "/' 
= 62p ýýt=1WDLilO 
e(7bi)) 
nJ ýi=1 W DLi 
with 95% confidence interval 
ex lo 
1.96 
Pý 9e( 
n 
)) 
E=_i WDLi 
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In the absence of heterogeneity (D = 0) use of an alternative fixed effects model 
may be preferable. When heterogeneity is minor, ie. between trials variance is very 
small, then they will give similar results. Berlin (1989) compared the results of 
DerSimonian-Laird with those obtained from the Peto method (Yusuf, 1985) and 
found the results to be comparable when no heterogeneity was present. 
Bayesian methods 
The DerSimonian-Laird method gives a classical approach to a random effects 
meta-analysis. Bayesian methodology has also been developed to combine effect 
sizes allowing for heterogeneity, however the classical and Bayesian methods have 
different justifications for the random effects approach. The rationale for the classical 
approach is that r2 comes from sampling variability from a hypothetical population 
of studies. The Bayesian approach visualises the randomness of the true effect size to 
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represent the investigators subjective uncertainty about the process that produces 
them. The basic paradigm of Bayesian statistics is that initial beliefs about a 
parameter of interest are expressed as a prior distribution. The data collected is 
summarised in the likelihood function and normalising the product of the prior 
and the likelihood forms the posterior distribution. Inference is then drawn from 
the posterior distribution, which can be visualised as an updated version of prior 
beliefs. 
4.5.2 Normal-normal hierarchical model 
Carlin (1992) describes a Bayesian method which uses the normal-normal 
hierarchical structure of the random effects model. Carlin describes his method as 
being closely related to the random effects methodology of DerSimonian and Laird 
but is based on Bayesian principles which emphasize the assessment of uncertainty 
in meta-analytic conclusions. 
A graphical model of the hierarchical structure is given in figure 4.1. Graphical 
models express the conditional independence of the parameters and show how the 
joint distributions are factorised. For detailed references on graphical models see 
Thomas, Spiegelhalter and Gilks (1992). 
If x= is the point estimate of the effect 0; in the ith study then the first stage of 
the hierarchical normal model assumes that 
xi I Di, Qi '" N(Ai, a 
where o is the corresponding estimated standard error. The second stage of the 
model assumes that 
Di 10, T2 - N(Q, T2) 
where 0 and r are hyperparameters for which prior distributions are specified. In 
this analysis the estimated o from each trial are assumed known. This assumption is 
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Figure 4.1: Graphical model for normal-normal meta-analysis 
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caused by the data having an underlying binomial sampling distribution. Due to the 
relationship between the mean and variance of the binomial distribution attaching 
a prior distribution to the o independently of the i; is not appropriate. However 
DuMouchel (1990) has developed a more complex model in which the uncertainty 
in o is also included. 
Alternatively, following Carlin's normal-normal model for the meta-analysis of 
2 by 2 tables an analogous model that utilises the underlying binomial sampling 
distribution is described below. 
From table 4.1 let a; denote the number of events in the treatment group, and b; 
the number of events in the control group for trial i, then the model is given by 
A; N Bin(nil, P; 1) 
B; N Bin(ni2, pi2) 
logit(pi2) = Fis 
logit(Pii) = µs -I- Di 
Di N Normal (0, r2) 
Uninformative prior distributions are then specified for pi, 0, and r. Figure 4.2 
gives the structure of this method in a graphical model. 
4.5. RANDOM EFFECTS 
Figure 4.2: Graphical model for meta analysis using Binomial distribution 
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4.6 Discussion 
The choice of random and fixed effects has caused much discussion about the 
suitability of each model. The aim of each method is to provide a combined effect 
size estimate, yet the assumptions that each model make about the homogeneity of 
the observed studies result in differences between the questions answered by each 
model. Baily (1987) gives two questions: Will the treatment produce benefit `on 
average'?, and Did the treatment produce benefit on average (in the studies at 
hand)?. He surmises that the second question is a limited form of the first and that 
for extrapolation of results to future trials and patients it is the random effects model 
that is appropriate while the fixed effects model answers the second question. Fleiss 
and Gross (1991) also believe that the question addressed by the random effects 
model is more important. Peto (1987) states that analysis using the random effects 
model is "wrong" because it answers a question that is "abstruse and uninteresting". 
Thompson and Pocock (1991) describe as "peculiar" the idea of the random effects 
model that studies are representative of some hypothetical population of studies. 
The appropriateness of combining estimates in the presence of heterogeneity 
needs to be considered, and also how to interpret such a single estimate. The 
interpretation of a random effects model relies on the idea that trials are sampled 
from a hypothetical population of trials and on the unrealistic assumption that 
the heterogeneity between studies can be represented by a single variance, which is 
usually imprecise being estimated from relatively few trials. 
The question of the appropriateness of each model has important consequences 
for conclusions based on the meta-analysis. Discrepancies between these methods 
can alter the conclusions of a meta-analysis. Thompson (1993) suggests reporting 
the results of both methods as a sensitivity analysis that will strengthen both the 
qualitative and quantitative conclusions. 
In the absence of heterogeneity these methods are equivalent. However if there 
is a lack of homogeneity these methods diverge. Use of a random effects method 
gives increased weight to smaller studies than the corresponding fixed effects model. 
This prevents a single large trial dominating the analysis, for an example see 
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Thompson (1993). However, the redistribution of weights in this way maybe 
undesirable making random effects models more sensitive to publication bias. As 
small studies with null or negative results are more likely to be censored, too 
much weight will be given to small spurious studies with strong effects, hence 
emphasising poor evidence at the expense of good (Thompson and Pocock, 1991; 
Greenland, 1994). The detection of publication bias and its influence on meta- 
analytic results will form the basis of following chapters. Methods of meta-analysis 
contained in this chapter and subsequent publication bias methods will be illustrated 
using the examples given in the following section. 
4.7 Application to examples 
Figures 4.3-4.10 give the combined estimates and 95% confidence intervals for each 
method of meta-analysis discussed in previous sections. The simulation data sets 
before suppression, denoted all sim, and after suppression, denoted sim, have 
been included. For the simulations there is little or no difference between the 
combined estimates and their confidence intervals. Use of the Bayesian random 
effects models in the corticosteroid and albumin examples have resulted in wider 
confidence intervals and larger discrepancies between the combined estimates. This 
maybe due in part to the assumptions of these models but also the magnitude of the 
estimates of T from these models. As discussed above this redistribution of weight 
gives more weight in the analysis to smaller studies. 
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Figure 4.3: All Sim 1: comparison of meta-analysis methods 
All Sim 1 
Estimates with 95% confidence intervals 
Method OR 95% Cl 
Peto 0.56 (0.51 , 0.62 
Mantel- 0.56 (0.50 , 0.62 
Haenszel 
Woolf 0.56 (0.51 , 0.62 
DerSimonlan- 0.56 (0.51 , 0.62 
Laird 
Carlin 0.55 (0.50 , 0.62 
DuMouchel 0.55 (0.49 , 0.62 
0.3 0.5 1.0 1.5 
Odds Ratio 
Treatment better 4-- -º Treatment wor 
Figure 4.4: Sim 1: comparison of meta-analysis methods 
Sim 1 
Estimates with 95% confidence intervals 
Method OR 95% Cl 
Peto 0.51 (0.45,0.58) 
Mantel- 0.50 (0.44,0.57) 
Haenszel 
Woolf 0.50 (0.44,0.58) 
DerSimonian- 0.50 (0.44 , 0.58) 
Laird 
Carlin 0.50 (0.43,0.56) 
DuMouchel 0.49 (0.42,0.58) --ý- 
0.3 0.5 1.5 
Odds Ratio 
Treatment better 4-- ---> Treatment wor 
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Figure 4.5: All Sim 2: comparison of meta-analysis methods 
AllSim2 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Peto 0.88 (0.81 , 0.96 
Mantel- 0.88 (0.81 , 0.96 
Haenszel 
Woolf 0.88 (0.81 , 0.96 
DerSimonian- 0.88 (0.81 , 0.96 
Laird 
Carlin 0.88 (0.80,0.98 
DuMouchel 0.89 (0.80 , 0.99 
Figure 4.6: Sim 2: comparison of meta-analysis methods 
Sim 2 
Estimates with 95% confidence intervals 
Method OR 95% Cl 
Peto 0.79 (0.69,0.90) 
Mantel- 0.79 (0.69,0.90) 
Haenszel 
Woolf 0.79 (0.69,0.90) --ý- 
DerSimonian- 0.79 (0.69,0.90) 
Laird 
Carlin 0.79 (0.66,0.90) 
DuMouchel 0.75 (0.63,0.89) -ý- 
89 
0.5 1.0 2.0 
Odds Ratio 
Treatment better 4 -º Treatment worse 
0.5 1.0 2.0 
Odds Ratio 
Treatment better i-- ---+ Treatment worse 
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Figure 4.7: All Sim 3: comparison of meta analysis methods 
AllSim3 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Peto 0.98 (0.89,1.07) 
Mantel- 0.98 (0.89,1.07) 
Haenszel 
Woolf 0.98 (0.89,1.07) 
DerSimonian- 0.98 (0.89,1.07) 
Laird 
Carlin 0.97 (0.89,1.10) 
DuMouchel 1.00 (0.91 , 1.10) 
0.5 1.0 2.0 
Odds Ratio 
Treatment better +- --º Treatment worse 
Figure 4.8: Sim 3: comparison of meta-analysis methods 
Sim 3 
Estimates with 95% confidence intervals 
Method OR 95% Cl 
Peto 0.82 (0.72,0.94) 
Mantel- 0.82 (0.72,0.94) 
Haenszel 
Woolf 0.82 (0.72,0.94) 
DerSimonian- 0.82 (0.72,0.94) 
Laird 
Carlin 0.80 (0.72,0.93) 
DuMouchel 0.81 (0.72,0.93) 
0.5 1.0 2.0 
Odds Ratio 
Treatment better i-- -i Treatment worse 
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Figure 4.9: Corticosteroids: comparison of meta-analysis methods 
Corticosterolds 
Estimates with 95% confidence Intervals 
Method OR 95% CI 
Peto 0.60 (0.49,0.75) 
Mantel- 0.60 (0.47,0.75) 
Haenszel 
Woolf 0.62 (0.49 , 0.78) 
DerSimonian- 0.61 (0.47,0.78) 
Laird 
Carlin 0.57 (0.39,0.74) 
DuMouchel 0.52 (0.37,0.76) 
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0.3 1.0 3.0 
Odds Ratio 
Treatment better E- -4 Treatment worse 
Figure 4.10: Albumin: comparison of meta-analysis methods 
Albumin 
Estimates with 95% confidence intervals 
Method OR 95% Cl 
Peto 1.83 (1.31 , 2.56) 
Mantel 1.87 (1.32,2.64) 
Haenszel 
Woolf 1.79 (1.24,2.58) 
DerSimonian 1.79 (1.24,2.58) 
Laird 
Carlin 2.08 (1.39,3.42) 
DuMouchel 1.63 (1.20,2.19) 
u. s 1.0 s. u 
Odds Ratio 
Treatment better i--- --' Treatment worse 
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4.8 Summary 
4.8.1 Clinical 
Corticosteroids 
The meta-analysis estimates indicate that the use of corticosteroids is beneficial in 
reducing perinatal mortality when administered to pregnant women with high risk 
of preterm delivery. Although there is some variation between point estimates and 
confidence interval widths, each method gives a statistically significant result at the 
p<0.05 level indicating that corticosteroids reduce the risk of perinatal mortality 
by approximately 40%. This example indicated slight heterogeneity with X2 = 13.87 
and 13 degrees of freedom with the DerSimonian Laird estimate of r2 = 0.015. 
Albumin 
Contrary to prior beliefs the meta-analysis estimates for the use of human albumin 
solution suggest that this treatment is harmful. There is some variation in combined 
estimates and confidence interval widths, but the use of this treatment appears to 
increase the risk of mortality by approximately 80%. There was no evidence of 
heterogeneity in this example with X2 = 13.47 and 29 degrees of freedom. The 
DerSimonian Laird estimate of 7-2=0. 
4.8.2 Statistical 
Fixed effects 
As described in section 4.4 the Mantel Haenszel estimator can be recommended in 
the majority of situations in preference to Peto's and Woolf's methods. However, 
in application to the examples this has resulted in little or no difference. 
4.8. SUMMARY 
Random effects 
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DerSimonian and Laird's estimate for r2 was zero in each example except for 
corticosteroids. Where the estimate was zero the results obtained using DerSimonian 
and Laird's method corresponded to Woolf's method. In the corticosteroids example 
the small non-zero estimate of T2 resulted in minor change to the point estimate 
and confidence interval width. The Bayesian methods were implemented in BUGS 
(Spiegelhalter et al., 1999)and convergence checked in CODA (Best et al., 1997). In 
the simulations the Bayesian methods resulted in little difference to the combined 
estimates with slightly increased widths for the confidence intervals. The increase in 
width is caused by the Bayesian methods incorporating the uncertainty in estimating 
i2. 
In the following chapters the robustness of these combined estimates to 
publication bias will be considered. 
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Chapter 5 
Tests for publication bias 
Many people have developed statistical methodology that aims to identify when 
the results of a meta-analysis may have been influenced by publication bias. These 
methods either test for the existence of publication bias or attempt to provide an 
estimate of the number of unpublished studies. In this chapter these methods will 
be reviewed and implemented using the systematic reviews and simulation studies 
given in chapter three. 
5.1 Funnel plot approaches 
5.1.1 The funnel plot 
The funnel plot was first described by Light and Pillemer (1984) . They described 
it as a simple graphical method to provide answers to two questions: 
" Do all studies come from a single population? 
. Is there any evidence of publication bias in this set of studies? 
This method has gained its popularity for its use in answering the second of these 
questions, but can only be used for this purpose if the answer to the first question 
is yes. 
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The funnel plot is a visual display of the statistical principle that as sample size 
increases, variation due to sampling error decreases. If the quantitative outcome 
for each study is plotted on the horizontal axis and sample size or precision on the 
vertical, assuming that the set of studies are homogeneous, then a characteristic 
funnel shape will be evident. 
Figure 5.1: Funnel plot All Sim 1 Figure 5.2: Funnel plot All Sim 2 
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Variation between the studies will be at its greatest at the bottom of the graph 
where statistical power is low, with the spread narrowing at the top of the graph 
where studies estimate the true effect more precisely. Typically, there will be a larger 
number of small studies conducted, and so the number of studies will also decrease 
as sample size increases. This funnel shape is clearly evident in the funnel plots of 
simulations 1 and 2 (see figures 5.1 and 5.2), before suppression was applied. 
If publication bias exists, and studies with non-significant results have been 
censored, then the symmetrical shape of the funnel plot will become distorted. Light 
and Pillemer (1984) describe two distinct patterns of publication bias. 
Hollow funnel plot 
When there is no or little difference between treatment and control groups the centre 
of the funnel should appear `hollow' (see figure 5.3). That is, estimates around the 
null effect will be missing. The studies that will reach publication will be those 
that have reached statistical significance by chance, and have very large positive or 
negative effects, or those that have smaller effects but with very large sample sizes. 
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Asymmetrical funnel plot 
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When there is a treatment effect and small studies around the null effect are censored 
then the plot should become asymmetrical (see figure 5.4). This is the shape that is 
commonly attributed to publication bias. This shape can also occur when the true 
treatment difference is small or null but there is a differential incentive to publish 
studies that favour the experimental group, or suggest that there is no difference 
between the two groups. 
Figure 5.3: Hollow funnel plot 
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Figure 5.4: Asymmetrical funnel plot 
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The hollow and asymmetrical funnel plots in figures 5.3 and 5.4 were produced 
from simulations 1 and 2. To obtain the hollow plot all studies in simulation 2 with 
0.15 <p<0.85 were suppressed. To obtain the asymmetrical funnel plot all studies 
in simulation 1 with p>0.055 were suppressed. 
Variations in presentation 
Light and Pillemer described the funnel plot as having the quantitative outcome 
on the horizontal axis and sample size for each study on the vertical axis. Since 
this original description there have been many variations in presentation. Vevea 
and Hedges (1995) stated that it is often more informative to plot effect magnitude 
against standard error or precision rather than sample size. This has the effect of 
expanding the axis in the lower region of the plot providing a clearer picture of the 
region where publication bias is likely to occur. This also provides a better marker 
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for statistical power for effect sizes such as odds ratios or relative risks where the 
variance is determined by the number of events as well as sample size. For examples 
where sample size or the number of events have been used, see Begg and Berlin 
(1988), Begg and Louis (1989). See Callaham (1998) and Copas (1999) for examples 
of the benefits of plotting effect size against the logarithm of sample size. 
Whatever is plotted as a marker of statistical power, the effect size distribution 
must be symmetrical. This means, for example, in the case of binary data the log 
odds ratio, or alternatively the odds ratio with the x-axis on a log scale (see figures 
5.1-5.11 should be plotted against standard error or precision. 
Guidelines have been used to visually aid the interpretation of funnel plots. 
In many examples, lines through the combined estimate and/or corresponding 
90% or 95% confidence interval lines have been added to help define the funnel 
shape, see references (Vandenbrouke, 1988; Copas, 1999; Callaham et al., 1998; 
Vevea et al., 1993; Vevea and Hedges, 1995) and figures 5.5 and 5.6 for examples. 
The use of guidelines has drawn a distinction between plotting against precision and 
standard error. When guidelines are drawn using standard error the funnel shape 
is clear while precision causes the guidelines to curve. Use of standard error, in 
comparison to precision, also further expands the lower region of the funnel plot 
and reduces the distance between the larger studies, for a comparison see figure 5.6 
and 5.7. 
The problem with these lines are that the line of symmetry through the combined 
estimate will be biased if publication bias exists, and hence the confidence interval 
lines around this estimate will also be biased. See Tang and Liu (2000) for 
examples of where the choice of the method used to construct the funnel plot can 
be misleading. 
5.1.2 Application to examples 
Funnel plots of the examples described in chapter two are given below. See figures 
5.1,5.2, and 5.5 for funnel plots of All Sim 1, All Sim 2, and the albumin review. 
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Figure 5.5: Albumin funnel plot with guideline through combined estimate 
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Figure 5.6: Albumin funnel plotted against precision with 90% confidence interval 
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Figure 5.7: Albumin funnel plotted against standard error with 90% confidence 
interval guidelines 
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Figure 5.8: Funnel Plot of Sim 1 
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Figure 5.10: Funnel plot of Sim 3 
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The corticosteroids review is the only funnel plot that appears to be asymmetrical 
suggesting the presence of publication bias. The albumin review has a symmetrical 
shape, as do simulations 1,2 and 3. For sims 1 and 2, in comparison with the 
funnel plots before suppression (see figures 5.1 and 5.2) it is clear that a number of 
studies have been censored, but this has not resulted in hollow or asymmetric shapes. 
Iyengar and Greenhouse (1994) also found similar results with their simulations. 
They simulated 100 studies and considered two sampling mechanisms. The first 
mechanism suppressed all studies with p-values greater than 0.05, the second gave 
studies with statistically significant results an 80% chance of being reported and 
insignificant results a 10% chance of being reported. Asymmetry was only visible 
in the funnel plot of the first mechanism when a distinct cut off point censoring all 
insignificant results was used. As previously described the hollow and asymmetrical 
funnel plots in figures 5.3 and 5.4 were produced from simulations 1 and 2 by 
applying similar simplistic and extreme suppression criteria. 
Limitations 
It has been demonstrated that funnel plot asymmetry is only likely to be evident 
under obvious and extreme sampling mechanisms, but publication bias is not as 
simple as the presence or absence of a corner of a funnel plot. It is better 
characterised by a pattern of decreasing variability across the whole p-value range, 
which will often not be visually detectable. 
Light and Pillemer described the funnel plot as a good first step to identify 
systematic omission of well - done studies which come from a single underlying 
population to suggest whether an obvious publication bias exists. Funnel plot 
symmetry does not reliably infer that publication bias does not exist, but asymmetry 
does not reliably infer that publication bias is present. The studies in the outlying 
part of the funnel may have exaggerated effects due to poor quality, or heterogeneity. 
See Copas (1999) for an example of the effects of variations of study quality on a 
funnel plot, and Stuck et al. (1998) for an example of asymmetry and heterogeneity 
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Further to these limitations, a funnel plot requires a number of studies to be 
included in the meta-analysis for a funnel shape to be evident, and as typical meta- 
analyses in the Cochrane library contain five or less studies, funnel plots are of 
limited use. Despite these problems, due to its simplicity, the funnel plot has become 
the most frequently used method to consider publication bias. Methods have been 
developed to overcome the subjectiveness of visually assessing possible asymmetry 
and these methods are described below. 
5.1.3 Rank correlation test 
The rank correlation test statistic is a direct analogue of the funnel plot. It is based 
on the assumption that the existence of publication bias will cause an asymmetrical 
shape that will induce a negative correlation between effect size estimates and their 
conditional variances. Similar to the funnel plot this method is both conceptually 
and computationally simplistic. It uses a non-parametric rank correlation test 
based on standardised effect size estimates and their variance estimates. Begg and 
Mazumdar (1994) advocate the use of Kendall's tau, but Begg (1994) also discusses 
the use of other equivalent non-parametric tests. 
Kendall's tau is based on evaluating the number of pairs of studies that are ranked 
in the same order with respect to two factors. If the number of concordant pairs is 
n,, and the number of discordant pairs nd then the normalised test statistic is 
z= 
((ne - fld) 
k(k-1)(2k+5) 
18 
where k is the number of studies and a p-value can be obtained from tables of 
the normal distribution. 
In constructing a valid rank correlation test Begg and Mazumdar (1994) state 
that it is necessary to stabilise the variances. They correlate V with v; finding 
simulations in which the variance stabilising adjustments were omitted to be anti 
conservative, where 
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v; 
v'1v)' 
Evil 
and vi* = v= - (E v; l)-1. 
103 
The standardisation used is based on the estimated pooled effect, which in the 
presence of publication bias will be biased, and so this will produce small correlation. 
Begg (1994) claims that this will not be of great concern since the test will generally 
have low power. 
Concerns over lack of power of this test to detect asymmetry provoked Begg 
and Mazumdar (1994) to evaluate its performance using simulations. They found 
the power of the test to be influenced by the number of component studies in the 
meta-analysis, the strength of selection bias, the range of variances of the effect size 
estimates, and the true underlying effect size. They reported that although the test 
is fairly powerful for very large meta-analyses with 75 component studies it only has 
moderate power for meta-analyses with 25 studies. 
Because of low power, this method should only be used as an exploratory tool 
to complement the funnel graph. It should be remembered that non-significance 
of the test does not imply there is no bias. Begg (1994) discusses the need to use 
this test with a liberal significance level and recommends relying on the informal 
visual assessment of the funnel plot for meta-analyses with relatively small numbers 
of studies. 
5.1.4 Linear regression 
This method provides an alternative method to the rank correlation test. 
Allison et al. (1996) first used a linear regression to examine publication bias in 
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the obesity treatment literature. To assess publication bias they regressed effect size 
estimates on to their standard error. They hypothesised that if publication bias was 
present, and a relationship between effect size and sample size was apparent, then 
this would be reflected in the gradient term of the regression. 
log(o)=a+ß*SE 
Using this method with a 5% significance level they investigated publication bias 
within meta-analyses of obesity treatments. Their results suggested that publication 
bias was evident in two out of the four meta-analyses considered. 
This paper was published in the International Journal of Obesity, but this 
methodology did not receive attention until Egger et al. (1997) published a similar 
paper in the BMJ a year later. This highlights problems of dissemination of research 
published in low circulation or low citation impact factor journals. 
The approach Egger et al. use to measure funnel plot asymmetry also utilises 
simple linear regression, but they regress the standard normal deviate (SND) against 
estimates of precision. Although Allisons and Egger's regression methods are 
essentially equivalent it should be noted that in Egger's method the estimated 
standardised log odds ratio is correlated with the estimated precision. 
SND =a+ß* precision 
or equivalently 
SE = CX 'i- iý * SE 
This regression is closely related to Galbraith's radial plot (Galbraith, 1988) in 
which SND is also plotted against precision (see figure 5.12). 
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Figure 5.12: Galbraith radial plot 
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Galbraith radial plot, Galbraith (1988). For any point, the odds ratio is obtained 
by extrapolating a line from the origin through that point to the circular scale. 
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The purpose of a Galbraith plot is to give more visual weight to studies with 
precise estimates. Individual non-standardised effect estimates are obtained by 
drawing a line through the point and the origin, with the gradient indicating the size 
of the effect. In Egger's method the regression line is not constrained to run through 
the origin. The idea is that small studies will fall near the origin, but a systematic 
deviance of the points to fall above or below the origin will cause the intercept of 
the regression line to move away from the origin. The existence of publication bias 
is determined by a test of the null hypothesis that the intercept is zero. Egger's 
method also implies that a null hypothesis of no true treatment effect is true, while 
the same assumption is not required to use Allison et al. method. See Irwig et 
al. (1998) for an example of an unbiased simulation with a strong treatment effect 
which wrongly indicated the existence of publication bias when this method was 
utilised . 
Egger et al. use their method to detect publication bias in meta-analyses that 
were later contradicted by large trials. They identified eight meta-analyses with 
subsequent large trials. Four of the meta-analyses had results that were concordant 
with the results of the corresponding large trial, and four discordant. Concordant 
results were defined as effects in the same direction with the meta-analytic estimate 
being within 30% of the trial estimate. Where the results were classed as discordant 
the discordance was due to the meta-analyses showing larger effects. Using their 
method, with p=0.1 as the significance level of the test to compensate for low 
power, they detected funnel plot asymmetry in three out of the four discordant sets. 
When the rank correlation test proposed by Begg and Mazumbar was applied to the 
four meta-analyses with discordant results they found that it indicated significant 
asymmetry (p < 0.1) for only one meta-analysis. On the basis of these results Egger 
et al. conclude that the linear regression test offers more statistical power than the 
rank correlation test. 
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A major advantage of the regression method over a rank correlation test is 
demonstrated by Allison et al. (1996) who use the regression method to control 
for cluster-effects while identifying publication bias. Thompson and Sharp (1999) 
also highlight the benefits of a regression by extending the regression analysis to 
allow for the plausibility of residual heterogeneity. In an example using a meta- 
analysis of the effectiveness of endoscopic sclerotherapy Thompson and Sharp show 
how inclusion of residual heterogeneity in the regression altered conclusions about 
the existence of publication bias. 
Egger et al. briefly discuss the problem of the linear regression method suffering 
from lack of power and suggest using a more liberal p-value. The problem with this 
approach is that this will increase the false positive rate. Allison et al. illustrate a 
further problem with this method. In the application of their method to a published 
meta-analysis of educational intervention among diabetic adults they obtained a 
statistically significant result for the presence of publication bias. However, when 
they looked at the data they found that there was one high leverage point and that 
removal of this point altered their conclusions. 
5.1.5 Hedges test 
The disadvantage of the above methods is that they rely on publication bias 
producing an asymmetrical funnel plot, and can not detect less extreme situations. 
Hedges method (1992) works by splitting the p-value range into k segments and then 
comparing the observed distribution of p-values with the distribution that would be 
expected given no publication bias. 
The probability function of the p-value from study i is given by 
. 
fi(ý I ori, A, T) - 
of b{[sign(Xi)ai(D-1(p) +A ]/77i} 
iic{[sign(Xs)ai(D-1(p)]/ai} 
where sign(Xi) is +1 if Xi is positive and -1 otherwise, and i=Q; + T2 
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If there is no publication bias then the expected pdf of the observed p-values is 
given by 
1n 
f(pI all.... oi Ei T) =-> fi(NIaii&&r) 
ni=1 
This distribution depends on the combined estimate 0, and T the between trial 
variation. Estimates of these parameters are given by 
T2 _E 
Xi - Xý2 
.En 
Qi 2 
i=1 n-1 _i n 
and 
Q_ 
ýs=1X /(f2+Q) 
i1/(T2 + a2) 
where X is the unweighted mean of Xi, ..... X.. 
Given k intervals defined by the cutpoints 0- ao < al < ... < ak = 1, the 
expected number, E of p-values in the jth interval [as-1, aa] is given by 
f 
E, = nj- f(l a1,.... a ,, 
)dp 
aj_1 
n 
= LýBiiýýýT) 
i=1 
where B, 1(0, T) is given by 
Bij =1- 41)[(bi, 1 - A)/77i] 
Bsj = (D[(bsj-1- 0)/77i] - , I)[(b;,; - 0)/i ]1<j<k 
Bi, k = 'ýP[(bi, k-1 - 
0)/? 7i] 
and bij = -Q; lb-1(ai). 
A chi-squared test of goodness of fit of the observed p-values to the expected 
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p-value distribution under the null hypothesis of no publication bias is given by 
X2 =k 
ýOj E'ýZ 
. i=1 
E. 7 
which should be compared to a chi-squared distribution on k -1 degrees of freedom. 
The equations above relate to a one-tailed selection process but are easily modified 
to give a two-tailed selection process. 
Limitations 
This method uses a random effects model, and assumes that the effects are normally 
distributed with mean 0 and variance a +, r 2. The distribution of the p-values 
depend on 0, and r which are estimated using the observed data and will be biased 
if publication bias is operating. The test statistic will only have an approximate 
chi-squared distribution if the number of studies n is large compared to the number 
of intervals k, and this fit will be improved if each p-value range contains at least 
five expected counts. This approach is not applicable to small numbers of studies. 
The cut points of the p-value range are arbitrary, but it is suggested that they relate 
to values known to influence publication. 
The idea of splitting the p-value range in to k segments is expanded upon by 
Hedges (1992) and Dear and Begg (1992) and is utilised in modelling the selection 
process to provide adjusted effect size estimates. These methods are discussed in 
chapter six. 
5.1.6 Application to examples 
Table 5.1 contains the results of applying Allisons, Egger's and the rank correlation 
test to the examples contained in chapter three. Table 5.2 gives the results of 
applying Hedges test. 
Each of the methods in table 5.1 obtains a statistically significant result for the 
corticosteroids example. The asymmetry in this example was clearly detectable 
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Table 5.1: Measuring funnel plot asvmmetrv 
Method Rank 
Correlation 
Ho: T=O 
Allison et at. 
log(OR) =a+, Bse 
Ho: 0 B=O 
Egger et at. 
SND = a+ f 
HO: a=O 
Example T p-value a ß p-value a 0 p-value 
Corticosteroids -0.38 0.050 -0.08 -1.10 0.042 -1.17 -0.02 0.034 
Albumin -0.18 0.153 1.05 -0.49 0.136 -0.44 0.99 0.148 
Siml -0.21 0.148 -0.65 -0.15 0.816 -0.27 -0.60 0.535 
Sim2 -0.12 0.529 -0.18 -0.33 0.685 -0.60 -0.09 0.274 
Sim3 0.08 0.624 -0.319 0.346 0.600 -0.327 -0.102 0.538 
All siml -0.17 0.090 -0.19 -0.96 0.023 -0.35 -0.45 0.340 
All sim2 0.02 0.86 -0.49 1.03 0.043 0.17 -0.18 0.639 
visually. The other examples did not display any clear signs of asymmetry and 
these methods have not been able to contradict the visual findings even though we 
know publication bias to be present in Sim 1,2 and 3. Application of Allison's 
method in All Sim 1 and 2 gave statistically significant results. No publication bias 
or asymmetry was present in either of these data sets. All p-values were calculated 
using two-sided level of significance. Figures 5.13-5.19 show the regression lines for 
Allison's and Egger's tests. 
Table 5.2: Annlication of Hedges test 
Corticosteroids Albumin Sim 1 Sim 2 
Cuts Obs Exp chi Obs Exp chi Obs Exp chi Obs Exp chi 
0.05 4 3.66 0.03 2 4.08 1.06 15 13.8 0.10 3 3.25 0.02 
0.10 3 1.57 1.30 3 2.76 0.02 6 2.92 3.26 3 1.74 0.92 
0.30 3 3.71 0.14 9 8.05 0.11 2 4.88 1.70 6 4.44 0.55 
0.50 3 2.23 0.26 8 5.88 0.77 1 1.95 0.46 2 2.84 0.25 
1.00 1 2.83 1.18 8 9.24 0.17 1 1.45 0.14 2 3.73 0.80 
F, 2.91 2.12 5.66 2.53 
p 0.42 0.29 0.77 0.36 
Sim 3 All Sim 1 All Sim 2 
Cuts Obs Exp chi Obs Exp chi Obs Exp chi 
0.05 1 3.02 1.35 18 20.82 0.38 3 5.51 1.14 
0.10 2 1.93 0.003 14 6.36 9.17 4 3.98 0.00 
0.30 9 5.33 2.53 11 12.16 0.11 19 12.52 3.36 
0.50 4 3.63 0.04 4 5.65 0.48 9 9.95 0.09 
1.00 3 5.08 0.85 3 5.01 0.81 15 18.04 0.51 
4.77 10.95 5.10 
0.31 0.97 0.72 
5.1. FUNNEL PLOT APPROACHES 
Figure 5.13: Sim 1: linear regression plots 
Iog(OR)=-0.65-0.15*SE SND=-0.27-0.60*precision 
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Despite the preference for the use of Hedge's test in being able to detect non 
asymmetrical patterns of publication bias in practice its performance is poor. This 
may be due to the relatively small numbers of studies in each example and hence 
p-value interval which may have resulted in a poor approximation to the chi-square 
distribution. 
The S-Plus program written to implement this method is given in appendix D. 
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Figure 5.14: Sim 2: linear regression plots 
Iog(OR)=-0.18-0.33*SE SND=-0.60-0.09*precision 
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Figure 5.15: Sim 3: linear regression plots 
Iog(OR)=-0.32+0.35*SE SND=-0.33-0.10*precision 
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Figure 5.16: All Sim 1: linear regression plots 
Iog(OR)=-0.32+0.35*SE SND=-0.33-0.10*precision 
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Figure 5.17: All Sim 2: linear regression plots 
Iog(OR)=-0.49+1.03*SE SND=0.17-0.18*precision 
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Figure 5.18: Corticosteroids: linear regression plots 
Iog(OR)=-0.08-1.1 0*SE SND=-1.17-0.02*precision 
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Figure 5.19: Albumin: linear regression plots 
Iog(OR)=1.05-0.49*SE SND=-0.44-0.99*precision 
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5.2 Robustness measures: estimating file drawer 
N 
The methods contained in this section are all based on two approaches. Those 
based on Rosenthal's method attempt to assess the extent of publication bias by 
calculating the minimum number of unpublished studies with non-significant results 
that would need to exist to overturn the conclusion reached from a meta-analysis. 
The approach described by Gleser and 01kin (1996), and those based on it, attempt 
to estimate the actual number of unpublished studies that exist. 
5.2.1 Rosenthal's file drawer problem 
Rosenthal (1979) coined the term "file drawer problem" as a description of the 
problem of publication bias. The term relates to studies whose results have been 
put into a file drawer without publication. An extreme view of the problem of 
publication bias, given by Rosenthal, is that journals are filled with the 5% of study's 
that show false-positive results while the file drawers are filled with the 95% of the 
studies that show non-significant results. 
Rosenthal's method is taken from Stouffer's et at. (1949) combined test of 
significance. This method derives the overall p-value of a set of research studies 
by converting each study's p-value to a standard normal deviate. The efficacy of the 
intervention is then determined by whether the combined z value, Z., is significant. 
k 
Zi-1 
Z' 
c -- S 
where Z; = (D-1(1 - pi) for i=1....... k, (D is the standard normal cumulative 
distribution function, and k is the number of studies observed. 
If the null hypothesis of no overall treatment effect is rejected, then Rosenthal's 
file drawer method calculates N, the number of unpublished studies with a mean z 
value of zero, which would be required to overturn the significant result. 
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Za _ 
Es 
1Zs+E 1zi 
V. N- 
or equivalently 
Za - 
kZk - NZN 
N +k 
where Z. is the value from the standard normal distribution for the critical level of 
significance. Under the assumption that the mean Z value (2N) of the unpublished 
studies is zero and rearranging the formula 
N=(ý= 1 i)2-k 
Za 
The calculated hypothetical number of unpublished studies is then judged 
subjectively by considering how probable such a quantity of studies is likely to be. If 
N is large then it may be argued that it is unlikely that so many unpublished studies 
exist and so the significant result obtained would not be overturned. If N is small 
then the results of the combined significance test may be due to the biased selection 
of studies. Rosenthal does not describe this method as the definitive solution but 
suggests that it is used to `establish reasonable boundaries on the problem and 
estimate the degree of damage to any research conclusion that could be done by the 
file drawer problem'. 
Rosenthal's method is subject to many criticisms. The most obvious criticism is 
that this method assumes that the unpublished studies taken together are null, ie 
they have an average effect size of zero. 
Two methods of overcoming this criticism are considered. 
5.2.2 Oakes 1993 
Oakes (1993) expresses difficulty with Rosenthal's assumption that the mean Z of 
the unpublished studies ( ZN) is equal to zero, claiming that it `contradicts its 
premises'. He reasons that if the published research is a biased sample then the 
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results in the file drawers must also be biased. Assuming that the null hypothesis 
of no treatment effect is true, the mean Z of the unpublished studies would not be 
zero but a negative quantity, as few such filed experiments would attain significance 
and most of those would be in the wrong direction. He suggests ZN = -0.5 as a 
more reasonable alternative. This could be used as a sensitivity analysis, although 
Rosenthal's method is extremely sensitive to even small changes of ZN. 
Oakes modification 
Za_ 
k2k-0.5N 
N+k 
5.2.3 Iyengar & Greenhouse (1988) 
Iyengar and Greenhouse (1988) also use an alternative value of the mean z-score 
than that proposed by Rosenthal. Oakes' choice of ZN = -0.5 was still arbitrary 
while Iyengar and Greenhouse use a truncated normal distribution to provide a 
basis for their estimate. This approach works on the theory that if publication 
bias in favour of statistically significant findings was operating then the Z values of 
the unpublished studies would not be a sample from the normal distribution, as in 
Rosenthal's method; they would be from the part of the population of studies whose 
Z values were less than Z. If 0 denotes the standard normal density and the 
standard normal cumulative distribution function, then 
'(ZQ) 
for x< Za 
0 otherwise 
The mean value of the unpublished studies under the density g (x; Z. ) is given by 
M(a) zý = ý(za) 
5.2.4 Klein et al. (1986) 
Klein et at. (1986) have adapted Rosenthal's method to provide an alternative to 
implementation on the p-value scale. Their method applies to odds ratios, but more 
importantly incorporates a weighting scheme for the observed studies. Klein et aLs 
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adaptation is based on Woolf's method (1955) (see chapter two) where the observed 
log odds ratios are weighted by the inverse variance estimate. 
Similar to Rosenthal it is assumed that the null hypothesis of no true treatment 
effect is true, and that N 
log (617, ) 
i=1 
Having combined the observed studies using Woolf's method and obtaining a 
statistically significant result at a 5% level then 
R)k )2 - N> (klo1g. 
(6Ö4 
A 
where w= average weight of the k published studies, OR is Woolf's combined 
estimate, and N is the number of unpublished null trials of similar weight required 
to overturn the observed significant result. 
Klein et al. discuss various weighting schemes in application of this method to 
allow the observed studies to be weighted according to their precision and quality. 
Limitations 
The methodology described above attempts to estimate how many unpublished 
studies would need to exist to overturn the observed result. It assumes that the null 
hypothesis of no true treatment benefit is true and also assumes that all statistically 
significant studies reach publication. This method is extremely sensitive to changes 
in the mean of unpublished studies, and this sensitivity is illustrated in the examples 
below. 
Rosenthal's method and its modifications are based on the normal distribution, 
and rely heavily on the z-statistic. The z-score is an inadequate summary of a 
studies evidence; it does not take into account the sample size or precision of an 
individual study, and this method gives all studies, observed and hypothetically 
unpublished, equal weighting. Klein's modification attempts to overcome these 
limitations, however it is assumed that the unpublished studies collectively receive 
5.2. ROBUSTNESS MEASURES: ESTIMATING FILE DRAWER N 119 
equivalent weight to those published. 
5.2.5 Application to examples 
Table 5.3: Estimating the file drawer N 
Z, Rosenthal 
ZN =0 
Iyengar & Greenhouse 
ZN = -0.1085 _ 
Oakes 
ZN = -0.5 
Klein et at. 
EN log(OR) =O 
Corticosteroids -1.213 93 43 16 70 
Albumin 0.44 35 18 7 77 
Simi -1.91 816 208 64 914 
Sim2 -0.87 56 28 11 53 
Sim3 -0.66 39 20 8 39 
Allsiml -1.48 1985 372 107 2151 
Allsim2 -0.35 69 30 10 99 
Rosenthal's, Iyengar and Greenhouse, and Oake's method essentially involve the 
solution of the equation below 
0= (k2Zk - kZä) - 
(2k2k2N + ZZ)N + 2NN2 
Where solution of this equation has given more than one root the root with the 
lowest real part has been given. Comparison of all the results show the extreme 
sensitivity of this method to the choice of ZN. As expected the simulations show 
that the number of studies required to overturn the significant results increases with 
the strength of treatment effect. The corticosteroids example requires between 16 
and 93 studies to make the efficacy of the treatment and control groups equivalent. 
The albumin example requires between 7 and 35. In each case the plausibility of this 
number of studies is related to the specific area of research and the actual number of 
studies observed. Considering that 30 studies have already been observed, it does not 
seem implausible that a further 7 unpublished studies evaluating human albumin 
exist. However it is not clear whether their inclusion in a meta-analysis would 
remove the apparent treatment effect. Methods of meta-analysis weight studies by 
their precision, and in the methods in this section it is implicitly assumed that all 
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studies receive the same weight. If the premise of bias against small statistically 
insignificant studies is true, then collectively, in a meta-analysis where the weight of 
each study is determined by its precision, these studies may be given little weight 
and hence have a lower impact on the overall combined estimate than the methods 
described above expect. 
5.3 Robustness measures: estimating N 
The estimate, N, obtained using these models will be very different to the value 
obtained by Rosenthal's method (Rosenthal, 1979). The `file-drawer' N given by 
Rosenthal relates to the number of unpublished studies that would be required to 
overturn the observed result assuming the null hypothesis is true while methods in 
this section try to estimate the true number of unpublished studies. 
5.3.1 Gleser and O1kin 
Gleser and Olkin (1996) propose two models to estimate the number of unpublished 
studies. Both models are based on the p-values reported in the observed studies and 
assume that: 
. the N+k studies reported and unreported, are mutually statistically 
independent; 
9 the N+k p-values are a random sample from the uniform distribution on the 
interval [0,1] 
9 the null hypothesis of no treatment effect is true; 
Simple model for p-values 
This model also assumes that the k observed studies have the smallest p-values 
0< p(l) < ....... < p(k) < p(k+l) < .......... < p(k+N) <1 
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where p(; ) denotes the ith largest p-value from among all N+k studies. 
Under the above assumptions the joint distribution of the observed p-values is 
given by 
f (p(i)...... p(k)\N) _ 
(NNik)! 
(1- p(k))N 
Gleser and 01kin propose two estimates for N, a maximum likelihood estimate, 
NMLE which they show to be upwardly biased, and an unbiased estimate 1V. 
NMLE = 
k(1- P(k)) 
P(k) 
N_ k(1-p(k))-1 
P(k) 
with the lower bound on the confidence interval given by 
n -}-1 NL = minn>o{n : F2k, 2(n+i); a < k(1 - 
P(k) } 
P(k) 
where F2k, 2(n+l); a is the 100ath percentile of the F distribution with 2k and 2(n-ß-1) 
degrees of freedom. 
Generalization of the simple model 
It is unrealistic to believe that we only observe the k smallest p-values among all 
N+k studies, reported and unreported. The generalization of the simple model 
assumes that we have observed the m, 1<m<k, smallest p-values and that the 
remaining k-m observed p-values have been sampled at random from the N+k-m 
largest p-values. 
Replacing k by m and N by N+k-m the joint density of the observed p-values 
is 
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f ý(1) s ... p(m), p(m+l) i ..... p(k)) =N +N k+-k! m! 
(1- P(m)N+k-m 
with 
NMLE _mI -k 
P(m) 
= 
m-1 
-k p(m) 
NL = minq>o{9 : F2m, 2(v+i); a < 
(Q + 1)p() } 
m(1 - p(mm) 
where q=n+k-m 
The formula for NMLE can give negative values and it is suggested in this case 
that NMLE = 0, although the occurrence of this may cast doubt on the applicability 
of the model to the data at hand. A problem with this model is deciding which of the 
observed p-values constitute the smallest and which of the remaining observed values 
are from a random sample of the uniform distribution. Gleser and Olkin suggest that 
if m is unknown, which it invariably will be, to plot the graph of (i, p(; )), i=1..... k 
and that if the generalized model holds then the graph will approximately fit two 
straight lines, one passing through the points (i, p(; )) for i=1..... m and the other 
line through the remaining k-m points. In applying this method to the examples 
this is the approach followed. 
5.3.2 Bayesian analysis of Gleser and Olkins model 
Begum (1997) developed a Bayesian approach to Gleser and Olkins simple model, 
which can be extended to the generalised model. 
Following Gleser and 01kin the joint distribution of the observed p-values or 
likelihood of N, is given by 
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_ 
(N + k)! 
- L(N I p(k)) N! (k -1)! 
Pýkýl(1 p(k) )N 
where p(k) is the largest observed p-value and N is a positive integer. 
Begum uses a vague prior for N such that 
P(N=n)an1 
The choice of this prior allows a conjugate posterior distribution given by 
P(N\p(k), k) a L(N\p(k))P(N = n) 
(N + 
a 
(N + 1)! (k) 
p(, )1(1 - p(k)) 
N 
The posterior distribution of N is a negative binomial distribution with 
parameters k and p(k) 
P(N I P(k), k) _ (k 1 )P(k) (1 - P(k))m 
where m=N+1. The mean and variance of N are given by 
E(N) _ 
k(1- P(k)) 
-1 P(k) 
Var (N) = 
k(1 P(k)) 
P(k) 
Depending on the parameter values the negative binomial distribution may be 
skewed, and so in the examples to follow we will also report the median and 2.5% 
and 97.5% quantiles. 
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5.3.3 Application to examples 
The graphs in figures 5.20-5.26 are suggested by Gleser and Olkin to determine 
the suitability of applying their simple and general models. If the simple model is 
appropriate and the null hypothesis is true then a straight line should approximately 
fit the data. If the generalised model is appropriate then two straight lines should 
describe the data, with the location of the change in gradient determining the value 
of m. The simple and general models have been applied to all examples, the choice 
of m for the general model has been based on visually examining these plots. 
Application of all of these methods assumes that the null hypothesis of no 
treatment effect is true. Simulations 1 and 2 do not meet this criterion. This 
may explain the extreme values obtained for simulation 1 with the general model. 
The estimate of the NMLE in the simple and general models is known to be biased, 
however, for the simple model this bias has little impact. The bias of NMLE has 
greater influence in the general model. This is reflected by the substantial variation 
between NMLE and 9, although the extent of this bias decreases as m increases. 
The estimates using Begums model were, as expected, directly comparable to 
Gleser and Olkins simple model. The Bayesian model also offers the advantage of 
obtaining an upper bound on the confidence interval. 
Considering Sims 1,2 and 3 only it is clear that the simple model, and 
hence Begums Bayesian approach greatly underestimate the number of unpublished 
studies, yet in All Sim 1 and 2 this number is over estimated. 
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Figure 5.20: Sim 1: rank based p-value 
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Figure 5.26: Albumin: rank based p-value plot 
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Table 5.4: Estimating N 
P(k) 
Simple Model 
NMLE N NL m 
General Model 
m 
NMLE N NL 
Corticosteroids 0.513 13 11.35 6 3 0.011 264 171.9 63 
7 0.093 61 50.7 23 
Albumin 0.761 9 8.13 4 3 0.056 23 5.7 0 
6 0.115 22 13.5 0 
Sim 1 0.836 4 3.69 1 8 0.010 809 705.2 392 
21 0.08 237 225.2 155 
Sim 2 0.76 5 3.71 1 3 0.025 104 64.3 18 
6 0.097 45 35.42 13 
12 0.27 27 23.5 12 
Sim 3 0.68 9 7.63 4 5 0.13 19 11.9 0 
9 0.20 25 21 7 
All Sim 1 0.84 9 8.58 5 32 0.1 281 271.4 196 
40 0.21 140 135.7 99 
All Sim 2 0.95 2 1.53 0 13 0.167 28 22 0 
26 0.28 42 39 19 
Begum's Bayesian Method 
E(N) Var(N) 2.5% median 97.5% 
Corticosteroids 12.3 13.3 4.48 13 24 
Albumin 8.45 9.45 3 9 16 
Sim 1 3.9 4.9 1 5 10 
Sim 2 4.03 5.03 1 5 11 
Sim 3 8.11 9.11 3 9 17 
All Sim 1 8.78 9.78 3 9 16 
All Sim 2 1.58 2.58 0 2 6 
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5.4 Summary 
5.4.1 Clinical 
Corticosteroids 
The corticosteroids review funnel plot (see figure 5.11) was visually asymmetrical. 
Application of each of the methods to detect asymmetry resulted in statistically 
significant results. This suggests that publication bias may be affecting the 
results of the meta analysis although the funnel plot asymmetry may be caused by 
heterogeneity. Estimates of the file drawer N were highly variable ranging between 16 
and 93 studies (see table 5.3) required to overturn the statistically significant result 
of the meta-analysis. The plausibility of the existence of this number of unpublished 
studies needs to be considered against the extent of the search strategy, the number 
of studies observed and background knowledge of this area of research. Estimates 
of the lower bound of the actual number of unpublished studies ranged between 6 
and 63 (see table 5.4). If such a number of unpublished studies exist their impact 
on the meta-analytic estimate cannot be quantified using this methodology. 
Albumin 
The funnel plot of the albumin review appeared to be symmetrical (see figure 5.5). 
None of the methods to detect asymmetry conflicted with the visual appearance of 
the plot. Estimates of the file drawer N (see table 5.3) ranged between 7 and 77 
studies required to overturn the statistically significant result of the meta-analysis. 
Lower bounds on the number of actual unpublished studies in existence ranged 
between 0 and 4 (see table 5.4). Without knowing the point estimate and weight 
of each of these studies it is not possible to quantify their impact on the combined 
estimate of the meta-analysis. 
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5.4.2 Statistical 
The issue of publication bias has received much attention and has frequently 
been cited as a major possible cause of discrepancies between meta-analyses and 
subsequent large trials. Empirical research into publication bias has focused on 
quantifying its existence and the identification of risk factors. Statistical methods 
which have been developed to detect when publication bias is present are typically 
flawed by low power and commonly assume that a selection mechanism will result 
in funnel plot asymmetry (see table 5.5). 
Other approaches to publication bias have estimated the number of unpublished 
studies. This estimate has two possible forms: the number of unpublished studies 
required to overturn a statistically significant result, and the actual number of 
unpublished studies in existence. All of these methods assume that the null 
hypothesis of no true treatment effect is true (see tables 5.6 and 5.7). 
The major problem with the methods summarised in tables 5.5-5.7 is that once 
a combined effect estimate is obtained the direct impact of unpublished studies on 
that estimate cannot be quantified. 
Methods have been developed to adjust the combined effect estimate for 
publication bias, and in the process some of these methods have estimated the 
number of unpublished studies. However this estimate has been shown to be highly 
variable and yet its impact on the adjusted effect size estimate is not of the same 
magnitude. These methods are discussed in chapter six. 
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Table 5.5: Summary: testing for publication bias 
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Information Required Detects Problems and 
Effect Precision P-value Asymmetry Comments 
Size Only 
Funnel Plots "" " visual assessment 
Rank Correlation "" " low power 
Linear Regression "" " low power 
Hedges Test " low power and more 
complex to apply 
Table 5.6: Summary: file drawer N 
Information Required Assumptions 
Effect Precision P-value Ho ZN = All Stat Weight=1 Problems and 
Size True Sig Studies for all Comments 
Published Studies 
Rosenthal " " 0 " " 
Oakes " " -0.5 " " modified 
version of 
Rosenthal 
Iyengar & " " 41 ä) " " unpublished 
Greenhouse from truncated 
normal distn 
Orwin "" " 0 " " based on 
Cohens d 
Klein et al "" " 0 " collectively 
gives 
unpublished 
and published 
equal weight 
-OR only 
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Table 5.7: Summary: estimating N 
Information Required Assumptions 
Effect Precision P-value Ho All Stat Decision to Problems & 
Size True Sig Studies Publish Comments 
Published based on 
P-value 
only 
Gleser & " "" Assumes k 
Olkins smallest 
Simple p-values 
Model observed 
Gleser & " "" Modified 
Olkins version of 
Generalised simple 
Model model. 
Assumes 
observed m 
smallest 
P-values 
m<k 
Begum " "" Bayesian 
approach to 
Gleser& 
Olkins. 
Analytically 
tractible 
Chapter 6 
Adjusting effect estimates 
In this chapter the primary focus will be the use of selection functions in the form of 
weighted distributions to model the publication process and derive effect estimates 
adjusted for publication bias. Methods that have used techniques other than 
weighted distributions to obtain adjusted effect estimates will also be considered. 
Adjusting effect estimates for publication bias is important because given the 
evidence outlined in chapter two and the limitations of methods of detection and 
robustness in chapter five the methods described in this chapter offer the only way 
to directly assess the impact of publication bias on the combined effect estimate. 
6.1 Introduction 
Fisher (1934) stated: 
"It is a statistical commonplace that the interpretation of a body of 
data requires a knowledge of how it was obtained..... 
... statistical methods are sometimes put 
forward, and their 
respective claims advocated with entire disregard of the conditions of 
ascertainment. " 
This quote highlights the importance of understanding the sampling mechanism 
used to obtain data. Rao (1965) stated that when an investigator collects a sample 
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of observations generated by a certain model, the original distribution may not be 
reproduced due to various reasons. He advocated the use of weighted distributions 
in three situations: non-observability of events, partial destruction of observations, 
and sampling with unequal chances of observations. Publication bias as described by 
Rosenthal (1979) is an extreme situation where non-observability of events reduces 
the observed distribution to a truncated form. However, in its more general form 
it is a situation where an event may be observable with a probability that depends 
on characteristics of the event. This situation is an example of sampling with 
unequal chances of observation. Section 6.2 describes truncated sampling, section 6.3 
details weighted distribution methods which relax the censoring criteria of truncated 
methods with applications to the examples and simulations in chapter three given in 
section 6.3.5. Section 6.4 gives an alternative method to weighted distributions with 
applications in section 6.4.1 while section 6.5 details a more restrictive alternative 
method with application to examples in section 6.5.2. 
6.2 Truncated sampling 
Lane and Dunlap (1978) were the first to investigate the implications of truncated 
sampling, followed by the work of Champney (1983), Dawes et al. (1984), and 
Hedges (1984). These studies have considered the estimated standardised effect size 
of a continuous outcome with normally distributed errors with censoring based on 
two-sided levels of significance. 
Lane and Dunlap simulated a large number of two group experiments and selected 
for further study those where the results were statistically significant. As expected 
they found that the mean difference estimated using the statistically significant 
results only, consistently overestimated the true population mean difference. Their 
results also suggested that the sample variance of the statistically significant studies 
underestimated the population variance. They concluded that effect size estimation 
was impractical unless scientific journals dropped the consideration of statistical 
significance as a criterion for publication. 
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Hedges (1984) considered the probability distribution function (pdf) of the 
truncated sampling model using a noncentral t distribution to model the unbiased 
distribution of effect estimates. His results confirmed those of Lane and Dunlap. 
He showed that although the degree of bias for an individual study depended on 
the sample size of the study and on the effect size parameter, in situations where 
the sample size or the true effect size was small, the amount of bias could be very 
substantial, in some cases exceeding 200%. 
The results of these investigations highlight the important implications for 
interpreting research results from a single study when statistical significance is a 
requirement for publication and provides support for Rao's statement that `Failure 
to make adjustments for methods of ascertainment can lead to wrong conclusions' 
(Rao, 1985). 
6.3 Weighted distributions 
The weighted distributions that will be considered in this section relate to the case 
where an event may be observable with a certain probability dependent upon its 
characteristics. 
Consider a random variable X with pdf f (x; 0) where 0 is the effect size 
parameter of interest. If a random sample of observations on X is drawn then 
unbiased estimates of the moments of X can be obtained. If the sampling mechanism 
used does not produce a random sample then inference drawn from that sample will 
be biased. 
If the chance of inclusion of an observation x is w (x) then the recorded X, denoted 
X, , has the pdf 
fw (x; A) _-w 
(X) f (x; A) 
A 
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where 
A= E[w(x)] 
= 
Jw(x)f(x; 0)dx x continuous 
= Ew(x) f (x; 0) x discrete 
fw(x; 0) is the distribution of the observed data and is a weighted distribution 
with weight function w(x). If w(x) =1 for all x then this defines a random sample. 
The distribution of a random variable truncated to a set 11 as discussed in the 
previous section can also be described using this notation: 
W (X) _1 
for XESZ 
0 elsewhere 
The appeal of weighted distributions for publication bias is that they allow the 
selection process to be modelled explicitly. Weight functions can be used in a variety 
of situations where a non random sample has been drawn such as sample surveys, 
family studies and geology. See Patil & Rao (1977) for other examples of weight 
functions. 
6.3.1 Parametric approach 
Use of a weighted distribution requires specification of two separate models: a model 
for effect size in the absence of selection, and a separate model for the selection 
process. Parametric methods specify known distributions for the models of effect 
estimates and weight functions. This means that although the true shape of the 
weight function is unknown it is pre-defined by the model. 
Model for effect size 
In modelling the distribution of standardised mean effect sizes, Hedges (1984) used 
the non-central t-distribution. Following Hedges specification, the non central t- 
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distribution has commonly been used to specify the distribution of effect sizes for 
use in combination with a parametric weighted distribution. This model assumes 
that the individual trials are independent, each estimating the same effect size (fixed 
effects approach), that the sample size in the experimental and control groups are 
equal, and that the selection mechanism can be modelled by the test statistic. 
Throughout the development of the parametric weighted distribution 
methodology a meta-analysis of ten studies given in Hedges and Olkin (1985) has 
commonly been used. This meta-analysis compares the effects of experimental open 
classroom education with traditional education on student creativity. Despite this 
meta-analysis being used to demonstrate the various weight function methods in 
each paper the results have not been directly compared. In this section the various 
approaches and the results of application on this data set will be discussed. 
Choice of weight function 
Iyengar and Greenhouse (1988) were the first to use a parametric weight function 
to adjust the results of a meta-analysis for the possibility of publication bias. To 
allow for the fact that the exact shape of the weighted distribution is not known and 
the possibility of different selection schemes, Iyengar and Greenhouse advocated the 
use of two selection functions to examine the choice of weighted distribution on the 
inferences drawn about A. 
w1 (x; ß, q) = 
L1 if ýx 1< t(q,. 05) t(q,. 05) 
1 otherwise 
and 
W2 (x; N, q) = 
e-0 if Ix 1< t (q, . 05) 
1 otherwise 
where P(I To 1> t(q,. 05)) = . 05 and To has a central t distribution with q dof. 
Both models assume a two-tailed selection process is operating and that all 
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statistically significant studies reach publication. These two weight functions differ 
in the selection process they model for results that are not statistically significant. 
The selection process modelled by Al increases the probability of publication as 
the study results approach statistical significance, whereas the process modelled by 
W2 states that the probability that a non-significant study is reported is the same for 
all non-significant studies. Both models exhibit the properties that if the parameter 
ß is zero then no selection bias is present but if they are infinite then they describe 
the extreme form of selection described by the truncated model of Hedges (1984). 
Iyengar and Greenhouse's paper provoked much discussion, and in the comments 
following were criticised for implementation of their method using a fixed effects 
approach. 
Patil and Taillie (1989) extended the work of Iyengar and Greenhouse. Using 
the same data set of ten studies they consider modelling selection based on p-values 
instead of the test-statistic, the use of a normal distribution as an approximation 
to the non-central t distribution for the model of effect size, and incorporation of a 
parameter for between trials variation. 
Patil and Taillie also apply half-normal and negative exponential distributions as 
alternative weight functions 
W3 (x; ß) _ exp(-ß * p(x)2) 
and 
w4 (x; ß) = exp(-ß * p(x)) 
where p(x) is a two sided p-value. 
These functions have similar properties to those of Iyengar and Greenhouse in 
that when 0=0 both functions give the model when selection bias is absent, 
however the functions wl and W2 assume that all statistically significant studies are 
published, this assumption is not inherent in w3 and w4. 
Patil and Taillie found the normal distribution to be a good approximation to the 
non-central t distribution. The most interesting feature of Patil and Taillie's method 
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comes from the results of fixed and random effects models and the importance 
of publication bias in the education data set. Using a fixed effects method to 
adjust for publication bias the method of Iyengar and Greenhouse suggested the 
presence of publication bias with confidence intervals for ß excluding zero. When 
the random effects model was used, confidence intervals for ß included zero, and 
likelihood ratio tests showed that once heterogeneity had been incorporated into the 
models, publication bias was relatively unimportant for this data set. This example 
illustrates the necessity of including a term to model between trial variability to 
avoid mistaking lack of homogeneity for existence of publication bias. However, a 
problem in estimating # is that there is little information contained in the data set. 
Iyengar and Greenhouse (1988) comment on this and demonstrate it by showing the 
flatness of the likelihood function. 
Larose and Dey (1998) analysed this data set fitting the weighted distributions 
within a Bayesian hierarchical model with uninformative priors. A comparison of 
the estimates of Larose and Dey's Bayesian analogue to Patil and Taillie's random 
effects model shows that the Bayesian estimates of A and ß are consistently larger 
across all models. This may be caused by the Bayesian estimates for r2 in this 
example being approximately double those estimated using classical analysis. 
Discussion 
In the comments following Iyengar and Greenhouse, Hedges commented that the 
weight functions chosen to model publication bias were unrealistic and that it may 
be more realistic to: 
"... model the weight function relating effect size to probability of 
observation by an s-shaped curve like a logistic function rather than a 
power function or an exponential. For example: + e°+ßl°I), 
where 0 is the effect magnitude, a is a parameter that sets the 
probability that a result is observed even when A=0 and ß is a constant 
effectively determining the slope of the curve near its inflection point. " 
This weight function has never been applied. 
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In the re-analyses of this meta-analysis adjusting for publication bias neither 
Iyengar and Greenhouse (1988), Patil and Taillie (1989) nor Larose and Dey (1998), 
considered the effects of selection based on one-tailed instead of two-tailed p-values. 
In the discussion of the paper by Begg and Berlin (1988) McPherson stated that: 
"... I wanted to impose an asymmetry on the publication bias criteria. 
Significant results in the expected direction will have a different impact 
than significant results in the opposite direction. In particular significant 
beneficial effects of new therapies are more likely to see the light of day 
than are deleterious effects, if, as is usually the case, beneficial effects 
are more plausible. " 
If this is true, then modelling selection based on two-tailed p-values will not 
capture the expectation, or prior believes of the investigators for rejection of the 
null hypothesis in favour of an alternative in which the anticipated direction of true 
effect is specified. Application of weighted distributions to the examples in chapter 
three will base selection on one tailed p-values. 
6.3.2 Semi-parametric approach 
The shape of the weight function in semi-parametric methods is not predefined as in 
the parametric approaches. This allows the shape to be determined by the observed 
data, with out enforcing the characteristics of a specific distribution. 
Model for effect size 
All of the methods that have used a semi-parametric approach have adopted a 
random effects model for effect size based on assumptions of normality. 
Xi ^' N(D, a +T2) 
where X; are the individual effect estimates, 0 is the global effect parameter, with 
T2 representing between trial variation, and Q; within trial variance, both 0 and r- 2 
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are unknown. 
Equivalently 
77-'0( 
xi -o 
lJj 
where rjf =a+ r2 and q5(z) is the standard normal density. 
Model for selection process 
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Consider the unit interval of the p-value split in to k segments, with the left and 
right endpoints of the jth step denoted by aß_1 and a3 respectively for j=1..... k 
where ao =0 and ak = 1. If we assume that the decision to publish is based solely 
on a study's p-value and that this probability, denoted w(p; ), is the same for all 
studies with a p-value contained in a given range, then 
wl ifO<p; <al 
W (p: ) = w1 if a3_1 < pi < a5 
Wk ifak_1<p; 
_<1 
The test statistic used to test the null hypothesis H0: 6 =0 is given by z, =M 
with two-tailed p-value 
p; = 1- (D(Z; ) + 41)(-Z; ) = 2(b(-Z=) 
As the p-value p; is a function of the estimate of X; and its variance a i', the weight 
function can be rewritten as 
Wl if -Q; (b-1(2) < Xi <- oo 
W(XqýQs) = Wj -1( 62 ) if -Q; ý2) < Xi < -ai 
Wk if 0<X; < -Q; ýp-1(a' -1) 2 
for X; >0 and similarly for X; < 0. 
The number of missing studies is unknown, so in the absence of information other 
than the observed effect size and variance estimates it is necessary to set wl equal 
to 1. This implies that the weights w2 to wk are relative weights. That is, w; values 
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represent the chance that an estimate with a given p-value is observed relative to the 
chance that studies with p< ai are observed. Alternatively, if it can be assumed 
that studies with p< al are always observed, ie. wl = 1, then the following wj 
values can be interpreted as the probability that estimates with a given p-value are 
observed. 
Likelihood 
The weighted probability density of X; given the weight function w(X{, o) and 
parameters 0, a, and w= (wl, .... ) Wk) is 
f(XAO, Q, w) = 
(Xi, ai) 
? iiAi(A, Qi, 'w) 
where 
00 X; -0 )dX; Ai (A, a1, w) =f 77s 1w(Xi, ai)«( 77i 00 
giving the joint likelihood 
LOsQw X) - 
11 17i (I 
i=l 7]i is 
) As(OQ w 
Alternatively, as A; is the sum of normal integrals over the regions where w(Xi, a j) 
is a constant, A; can be rewritten in the form 
k 
Ai (A, a, w) _E wjB+j (A, a) 
j=1 
where B33 (0, a) is the probability that a normally distributed random variable 
with mean A and variance rf; is assigned weight value w that is 
Bill =1- ýP[(bij - A)/71i] + c[(-bi, l - 0)/17i] 
Bi, j = 4D[(biJ-1 - 
D)/r%il 
- ID[(-bi, 9 - 
A)/77i] 
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+4)[(-bs, j - A)1? 7f] - 4D[(-bsä-1- 0)/77ß] 1<j<k 
Bi, k = (D[(bi, k-1 - 
0)/%i] - D[(-bi, k-1 - O)/r%i] 
where the b1 = -a'-1(2) are the left endpoints of the intervals of positive X 
values assigned weight ww in the ith study. Writing the log-likelihood as 
log(L) =c +Elogwi(Xi, oi)- 2E(Xý-ý), ->log(rli) 
i=1 i=1 11i i=1 
nk 
-Flog[ wjBij(L, a)] 
i=1 j=1 
first and second order derivatives can be obtained and solved using iterative 
methods for the MLEs of A, r2, w= (col, ...... , wk) and their variances. 
Location of discontinuities 
Two methods for specifying the location of the discontinuities along the unit p- 
value range have been used. The first and most frequently used is to specify the 
locations a priori. The rationale behind this comes from investigations into the 
perceived conclusiveness of research results that were found to be strongly related 
to the p-value. This relationship was found not to be smooth but to display "cliff 
effects" near conventionally used levels of significance (Rosenthal and Gaito, 1963; 
Rosenthal and Gaito, 1964; Nelson et at., 1986). An example of this is given by the 
commonly used significance level a=0.05. A result with a p-value of 0.045 was 
found to be perceived much more conclusively than a result with a p-value of 0.055, 
but that a pair of results with p-values of 0.045 and 0.035, or 0.055 and 0.065 were 
thought to be equally conclusive. All of the semi-parametric methods specify the 
location of the discontinuities in this way apart from Dear and Begg (1992). Dear 
and Begg use the observed data or studies to obtain the MLE of the weights but 
also to obtain the location of the breaks in the p-value range. Their approach is to 
order the p-values so they are ranked from the largest observed p-value, pl, to the 
smallest pn, and then to specify the discontinuities at alternate individual observed 
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p-values. The weight function is then given by 
wl if1>p>P2 
W(P) = 
WI if P2j-2 P>P2f 
Wk if p_1 >p>0 (n odd) 
if p >p>0 (n even) 
with the number of weights, k, equal to 1+ int(n/2). 
Dear and Begg's approach introduces more "steps" in to the weight function 
than the a priori method, increasing flexibility of the weight function but also the 
amount of uncertainty in the model. A problem with the a priori method is that a 
specified interval may not contain any observations. This will not occur with Dear 
and Beggs approach, although it is easily dealt with by collapsing two adjacent 
intervals. However, this further reduces flexibility of the selection function. 
The use of non-parametric weight functions allows the feature of the "cliff effect" 
found by psychological researchers to be easily incorporated in to the model for 
selection bias. However, since the results of this research, researchers have been 
encouraged to use confidence intervals in conjunction with a p-value. As a result of 
this the "cliff-effect" phenomenon may not be so apparent. 
Hedges (1992) was the first to describe the weight function non-parametrically 
with the location of the discontinuities specified a priori. Later methods are all 
modifications of this approach. 
6.3.3 Modifications of Hedges step function 
One-tailed versus two-tailed selection 
The most simplistic change was to alter the assumption of selection based on two- 
tailed p-values to one-tailed (Hedges and Vevea, 1996). A one tailed preference is 
more realistic, in many cases, as it is conceivable that there may be an incentive to 
publish significant results favouring the experimental treatment over the standard 
treatment, causing small trials exhibiting results in favour of the standard treatment 
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to be censored. This is also the pattern commonly displayed in an asymmetric funnel 
plot that maybe associated with publication bias. Hedges (1992) applied the model 
assuming two-tailed selection process to data from a meta-analysis of 755 studies of 
the validity of the General Aptitude Tests Battery (GATB) using the results of the 
general ability scale only. This data set has also been considered using the one-tailed 
adaption (Vevea et at., 1993). 
Under two-tailed selection the estimated effect (Ö = 0.25) was approximately 
the same as that assuming no selection process is operating (Ö = 0.26). This is 
consistent with the values for the estimated weights: weights of 1 for each interval 
would indicate that no selection process was operating. The one-tailed model 
gave conflicting results. The weights tended to decrease as the p-value increased 
suggesting that a selection process was operating. This shifts the effect estimate ,& 
to 0.20. Vevea et at. (1993) consider one tailed selection to be more appropriate 
for the GATB data set, this view being supported by the funnel plot. This example 
highlights how mis-specification of the selection model can result in non-detection 
of publication bias. See Hedges and Vevea (1996) for evaluation of the performance 
of the one-tailed p-value selection model using simulations. 
The other two changes to Hedges method are more substantial: one incorporating 
a general linear model for estimating effect size (Vevea and Hedges, 1995), and the 
other adopting a Bayesian approach (Givens et at., 1997). 
General linear model for effect size 
Heterogeneity may be confused with publication bias if funnel plot asymmetry exists. 
If a group of studies with small sample sizes displayed larger effect estimates due to 
an identifiable factor, such as baseline severity or dosage, then this could cause the 
skewed upper tail usually associated with a biased funnel plot. This problem was 
emphasised by Patil and Taillie 
(1989) who found strong variation of the importance 
of publication bias depending on whether a fixed or random effects model had been 
used (see page 136). 
This modification of Hedges step function alters the effect size model by 
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incorporating linear predictors allowing variability caused by heterogeneity to be 
investigated. Details of this method with application can be found in Vevea and 
Hedges (1995), with a further application in Linde et al. (1997) on the effects of 
homeopathy. 
Bayesian method 
Givens et al. (1997) developed a Bayesian analogue of Hedges step method. As 
well as deriving adjusted effect estimates this method also estimates the number 
of missing studies. While the adjusted effect estimates appear to be robust to the 
choice of prior this is not reflected in the estimated number of missing studies. 
This Bayesian approach of Givens et al. has been extended to allow stratification 
on study quality (Smith et al., 1997). A major disadvantage of the Bayesian 
approach is that the programming is extremely complex, being written in four 
programming languages: Splus, csh, Fortran, and lapack. As Dear and Dobson 
commented in the discussion section of their paper, `the culture of meta-analysis 
has traditionally favoured very simple methods...... the value of any new statistical 
methodology depends, in part, on the extent to which it is adopted'. 
6.3.4 Maximum likelihood estimation of model parameters 
Implementation of the parametric, and semi-parametric models within a frequentist 
framework require MLE to be obtained using a numerical iterative procedure. This 
requires first and second order derivatives of the parameters to be obtained from 
the log likelihood functions. Hedges (1992), Dear and Begg (1992), and Vevea and 
Hedges (1995) have discussed the use of a Newton-Raphson algorithm in deriving 
parameter estimates. 
The non-application of these methods in the research literature has been blamed 
upon the lack of available software to implement the methodology (Sutton et al., 
1998). This has rendered these techniques to remain unused and consequently the 
direct impact of publication bias on combined estimates not considered. 
Implementation of these methods in section 6.3.5 has been based on formulating 
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the log likelihood functions within S-plus (MathSoft, 1999). The S-plus function 
nlminb, which is a minimization routine for bounded problems based on a Newton- 
Raphson procedure, is used to obtain the estimates. The use of the nlminb command 
has been used without the specification of gradient information. This means that 
estimates are derived using a quasi-Newton approach in which the gradient is 
approximated by finite differences. 
In the original application of Hedges semi-parametric approach, standard error 
estimates were obtained by relying on the fact that the negative of the Hessian 
converges to the Information matrix for large n, and inverting to obtain the 
covariance matrix. Due to the small number of studies commonly found in a meta- 
analysis this approach is rarely applicable. The weighted distribution standard error 
estimates in this thesis have been obtained by deriving the Information matrix. 
In the application of Hedges step function problems were encountered in deriving 
the estimated parameters. Although the program reported that it had reached 
convergence it indicated that it had encountered singularity. This happened in each 
example. Programmes where re-run from a number of different starting values. 
Convergence was always reported at the same estimate. 
Development of Splus programs, a package commonly available to medical 
statisticians, will make the implementation of these techniques much more accessible. 
Examples of Splus programs written for the implementation of these methods in this 
thesis are contained in appendices F and G. 
6.3.5 Application to examples 
In the previous sections parametric and semi-parametric weighted distributions have 
been reviewed and commonly applied to an education data set with a continuous 
outcome measure on a two-tailed p-value selection basis. In this section the models 
will be applied to the binary data of the medical examples and simulations contained 
in chapter three. 
Following the comments of McPherson, (see page 138), and the results of the 
application of Hedges semi-parametric method on both one and two-tailed p-values 
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modelling of the selection process in this section will be based on one tailed p- 
values. This allows the investigators' prior beliefs of the direction of rejection of the 
null hypothesis to be incorporated in to the weight function. The weight functions 
applied in this section are: Hedges semi-parametric `step' method, Patil and Taillie's 
negative exponential and half-normal models, and a modified version of Hedges 
suggested logistic function. 
Weighted distributions w3i and w4 were chosen as their selection process was 
originally based on p-values, they were easily modified to allow selection on a one- 
tailed basis and were continuously defined over the p-value range. The logistic 
function was selected as although previously suggested it had not been applied. It 
was modified to allow selection based on one-tailed p-values with the probability of 
a study with p-value of zero reaching publication equal to one. This was to allow 
direct comparability with w3, and t4. The model defined by w2 is essentially a 
two step function. Implementation of a semi-parametric method has been based on 
Hedges (1992). This approach allows greater flexibility of weight function than w2, 
but requires estimation of fewer parameters than Dear and Begg's method. The 
weight functions and the log-likelihoods of each model are listed below: 
Hedges semi-parametric method 
Weight function 
w((1 - ID (i») = 
Log-likelihood 
wl if 0< (1 - 4D(ß )) < 0.05 
w2 if 0.05 < (1-ý()) <0.10 ali 
w3 if 0.10 <(1-(D(-')) <0.30 
w2 if 0.30<(1-'()) <0.50 
w5 if 0.50<(1-c(ö))<1 
n1n Xi 2 
nn 
log(L) aE lo9Wi(Xii O'i) -1 
E( 
77i 
-r log (77i) -E 
logt WjBij (A, a)] 
i=1 i=1 iu1 i=1 j=1 
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where Bsj (0, a) is the probability that a normally distributed random variable 
with mean 0 and variance 772 is assigned weight value ww, that is 
B 
,1=1 
-'1[(b1,1 - 
0)/r7s] 
Bi,, = 4)[(bs, j-l - 0)/? 7i] - (D[(b; j - A)/7 7i] 1<i<k 
Bf, k = 0)/77fl 
where the b=j = -a 1(a1) are the left endpoints of the intervals of positive X 
values assigned weight w1 in the ith study. 
Half-normal 
Weight function 
w(xa; ) = exp(-ß(1-, D(xi/ai))') 
Log-likelihood 
log(L) oc ýs))2- (Xtrliý)2 
_ 
- 
log 
f 
o(X )exp(-ß(1 - gD(Xi))2)dxi 
i=1 °° rf i %i 
Negative exponential 
Weight function 
w(xi, a1) = exp(-ß(1- (D(xilai))) 
Log-likelihood 
log(L) oc Qt))- 2Xi-A)2 
i=1 s i=1 i7i 
n- 
-E log 
f X' )exp(-ß(1 
- lb(! 
' )))dxi 
i_1 0° 77j Ili 
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Figure 6.1: One tailed normal distribution 
Logistic function 
Weight function 
2* exp(-Pil - (Di 
w(x" a`) 1-I- exp(-ß(1- (D( ))) 
Log-likelihood 
X' 2 log(L) « )) - log(1 + exp(-ß(1-'D (-»» - 
rri "-o 
{ r%i 1 %i 
2 L. r 
(ti) 
-E logr 
exp(-ß(1 - 41)(z ))) dx 
s_1 
J-oo rji 1+ exp( ß(1 ý n ))) ' 
In applying Hedges `step' function the odds ratios were calculated such that 
the upper region of the normal distribution was the area of interest. This means 
that for the simulations and the corticosteroids example, as the event occurred 
more frequently in the control groups the odds ratios were inverted so 
ÖR = e'°. 
Consequently p<0.05 indicates that the treatment was superior to control, while in 
the albumin example p<0.05 indicates the reverse and 
ÖR = e°. In the application 
of the parametric weight functions, when using one-tailed p-values it is necessary 
to ensure that the p-value region p<0.05 relates to those studies with the highest 
probability of publication. This is caused by p=0 corresponding to a weight of one 
in each weight function. Therefore, in applying the parametric weight functions to 
the examples all odds ratios were calculated such that p<0.05 indicates superiority 
of the treatment and 
ÖR = e-°1. 
'For the albumin example the direction of the gradients of the parametric and semi-parametric 
weight functions in figures 6.14 and 6.15 differ due to calculation of the OR. In the parametric 
models p<0.05 relates to the treatment being beneficial while in the semi-parametric model the 
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Sim 1 
149 
All methods moved point estimates closer to the true value. There was little 
variability between the adjusted estimates with the confidence interval widths 
slightly increased. After adjustment all results remained statistically significant. 
Sim 2 
All methods moved point estimates in the direction of the null value, there was 
some variability between the methods. Confidence interval widths substantially 
increased. The meta-analysis results were no longer statistically significant after 
adjustment. The most extreme adjustment was obtained using Hedges method 
which over compensated for the selection mechanism. 
Sim 3 
Hedges method moved the point estimate slightly further away from the null value 
while application of the non-parametric weight functions moved the point estimates 
past the null value suggesting that the treatment was harmful. The confidence 
interval widths were greatly increased but although the methods over compensated 
for publication bias all confidence intervals included the null effect. 
All Sim 1 and All Sim 2 
Application of these methods to the full simulations was to observe the effects of 
the weighted distributions when it was known that no selection mechanism was 
operating. In each case there was a minor adjustment to the point estimate and 
some increase in the confidence interval widths. In the case of All Sim 2 this changed 
the results from being statistically significant. 
converse is true 
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Corticosteroids 
All methods moved the point estimates closer to the null value. The corticosteroids 
example was the only example with between trial variation greater than zero. This 
has lead to substantially increased confidence interval widths and a large variability 
between point estimates. Given the pathophysiological reasons behind the efficacy of 
the use of this treatment the adjustment for publication bias in the non-parametric 
methods seems overly extreme with the adjusted estimate obtained using Hedges 
step function appearing more reasonable. 
Albumin 
Generally the existence of publication bias causes the results of meta-analyses to 
be overly extreme. That is the combined estimate is moved further away from the 
true underlying treatment value in the opposite direction to the null hypothesis. 
Consequently methods that adjust for publication bias move the point estimate 
back in the direction towards the null hypothesis value. This can be observed in 
the other examples. Application of these methods to the albumin example found 
the existence of publication bias to support the null hypothesis. Publication bias, in 
contrast to expectations, moved the combined estimate towards the null hypothesis 
while methods to adjust for publication bias move the estimate away from the null 
hypothesis. Until the results of the albumin systematic review, albumin had been 
thought to be an effective treatment that reduced mortality. Application of this 
method suggests that statistically significant results that went against the prior 
belief of the benefit of this treatment could have been suppressed and less likely to 
be published than non-significant results. Consequently the adjusted odds ratio is 
moved further away from the null value suggesting that albumin could be even more 
harmful than originally suggested by the unadjusted meta-analysis estimate. 
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Figure 6.2: Sim 1: parametric weight functions 
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Figure 6.4: Sim 2: parametric weight functions 
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Figure 6.6: Sim 3: parametric weight functions 
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Figure 6.8: All Sim 1: parametric weight functions 
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Figure 6.9: All Sim 1: non-parametric weight function 
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Figure 6.10: All Sim 2: parametric weight functions 
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Figure 6.12: Corticosteroids: parametric weight functions 
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Figure 6.13: Corticosteroids: non-parametric weight function 
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Figure 6.14: Albumin: parametric weight functions 
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Figure 6.15: Albumin: non-parametric weight function 
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Table 6.1: Step function parameter estimates 
Example Parameter Obs Exp est so 
Sim 1 w1 15 13.8 1 - 
w2 6 2.92 1.4375 0.8039 
w3 2 4.88 0.2593 0.2202 
w4 1 1.95 0.29 0.3369 
w5 1 1.45 0.344 0.4335 
0 0.6008 0.1020 
-r2 0 0.0300 
Sim 2 w1 3 3.25 1 
w2 3 1.74 1.0414 1.9974 
w3 6 4.44 0.5408 1.6694 
w4 2 2.84 0.1874 0.7817 
w5 2 3.73 0.0801 0.4202 
A 0.0199 0.4483 
72 0 0.0566 
Sim3 w1 1 3.02 1 
w2 2 1.93 3.2421 4.4062 
w3 9 5.33 5.4009 7.7134 
w4 4 3.63 3.6049 6.3894 
w5 3 5.08 1.9933 4.6010 
0 0.2083 0.2215 
r2 0 0.0328 
All Sim 1 w1 18 20.82 1 - 
w2 14 6.36 2.3316 1.0098 
w3 11 12.16 0.9203 0.4767 
w4 4 5.65 0.6875 0.4984 
w5 3 5.01 0.5503 0.4874 
0 0.5392 0.0906 
72 0 0.0245 
All Sim 2 w1 3 5.51 1 - 
w2 4 3.98 1.5409 1.2376 
w3 19 12.52 2.0835 1.5574 
w4 9 9.95 1.1273 0.9943 
w5 15 18.04 0.9338 0.9892 
A 0.0737 0.1068 
T' 0 0.0173 
Corticosteroids wl 4 3.66 1 - 
w2 3 1.57 1.0390 0.9355 
w3 3 3.71 0.3325 0.3501 
w4 3 2.23 0.4216 0.5146 
w5 1 2.83 0.0791 0.1334 
A 0.2168 0.2555 
7' 0.0053 0.0624 
Albumin w1 2 4.08 1 - 
w2 3 2.76 3.4517 3.8295 
w3 9 8.05 4.5694 5.3403 
w4 8 5.88 7.1030 9.5353 
w5 8 9.24 5.9841 9.1473 
0 1.0171 0.4643 
r2 0 0.25 
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Table 6.2: Step function correlation tables 
A T w2 w3 w4 w5 
Sim 1 
A 1 -0.327 -0.443 -0.423 -0.425 -0.529 
T2 1 0.079 0.121 0.168 0.227 
w2 1 0.372 0.325 0.358 
w3 1 0.278 0.317 
w4 1 0.305 
w5 1 
Sim 2 
A 1 0.938 -0.893 -0.963 -0.968 -0.982 
Ta 1 -0.888 -0.951 -0.949 -0.946 
w2 1 0.937 0.924 0.920 
w3 1 0.976 0.977 
w4 1 0.975 
w5 1 
Sim 3 
A 1 -0.356 -0.357 -0.615 -0.748 -0.863 
T2 1 -0.100 -0.036 0.0815 0.267 
w2 1 0.803 0.732 0.639 
w3 1 0.912 0.849 
w4 1 0.902 
w5 1 
All Sim 1 
A 1 -0.271 -0.521 -0.637 -0.620 -0.675 
r2 1 0.032 0.120 0.180 0.293 
w2 1 0.627 0.545 0.517 
w3 1 0.581 0.582 
w4 1 0.541 
w5 1 
All Sim 2 
0 1 -0.379 -0.182 -0.407 -0.551 -0.775 
T2 1 -0.173 -0.208 -0.128 0.105 
w2 1 0.724 0.659 0.584 
w3 1 0.864 0.813 
w4 1 0.856 
w5 1 
Corticosteroids 
A 1 -0.094 -0.407 -0.593 -0.719 -0.733 
r2 1 -0.290 -0.279 -0.212 -0.048 
w2 1 0.624 0.621 0.507 
w3 1 0.726 0.623 
w4 1 0.692 
w5 1 
Albumin 
A 1 0.389 -0.549 -0.731 -0.797 -0.837 
T2 1 -0.327 -0.349 -0.303 -0.232 
w2 1 0.805 0.783 0.753 
w3 1 0.916 0.901 
w4 1 0.931 
w5 1 
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Table 6.3: Half-normal parameter estimates 
example 
ß 
est se 
A 
est se 
T 
est se 
Sim 1 1.010 2.405 0.669 0.078 0 0.026 
Sim 2 2.587 2.573 0.136 0.157 0 0.029 
Sim 3 5.522 4.114 -0.109 0.434 0 0.039 
All Sim 1 1.234 1.459 0.541 0.068 0 0.024 
All Sim 2 0.512 1.157 0.091 0.096 0 0.017 
Corticosteroids 6.652 5.603 0.113 0.768 0.054 0.242 
Albumin 1.598 1.154 -1.011 0.346 0 0.184 
Table 6.4: Negative exponential parameter estimates 
example 
ß 
est se 
O 
est se 
T 
est se 
Sim 1 2.369 2.040 0.614 0.096 0 0.029 
Sim 2 2.553 2.495 0.087 0.210 0 0.027 
Sim 3 4.640 3.103 -0.150 0.310 0 0.028 
All Sim 1 1.461 1.237 0.501 0.088 0 0.025 
All Sim 2 0.457 1.219 0.090 0.109 0 0.015 
Corticosteroids 5.344 4.368 -0.068 0.910 0.043 0.171 
Albumin 0.484 1.291 -0.693 0.346 0 0.203 
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Table 6.5: Logistic function parameter estimates 
example 
ß 
est se 
A 
est se 
T 
est se 
Sim 1 2.680 2.318 0.632 0.089 0 0.028 
Sim 2 3.205 2.557 0.100 0.199 0 0.028 
Sim 3 5.591 3.106 -0.160 0.335 0 0.031 
All Sim 1 1.970 1.481 0.513 0.081 0 0.025 
All Sim 2 0.860 1.750 0.086 0.108 0 0.016 
Corticosteroids 5.727 4.115 0.029 0.841 0.042 0.191 
Albumin 1.366 1.540 -0.798 0.342 0 0.194 
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Table 6.6: Parametric correlation estimates 
Example Corr #, O Corr ß, T Corr(, T 
Half-normal 
Sim 1 -0.445 0.242 -0.154 
Sim 2 -0.799 0.545 -0.679 
Sim 3 -0.935 0.687 -0.854 
All Sim 1 -0.572 0.330 -0.280 
All Sim 2 -0.873 0.504 -0.495 
Corticosteroids -0.847 0.731 -0.925 
Albumin -0.825 -0.113 -0.130 
Negative exponential 
Sim 1 -0.618 0.276 -0.345 
Sim 2 -0.890 0.553 -0.702 
Sim 3 -0.917 0.480 -0.709 
All Sim 1 -0.752 0.389 -0.438 
All Sim 2 -0.909 0.285 -0.308 
Corticosteroids -0.922 0.143 -0.907 
Albumin -0.845 -0.290 0.182 
Logistic 
Sim 1 0.564 -0.260 -0.282 
Sim 2 0.874 -0.580 -0.721 
Sim 3 0.911 -0.534 -0.761 
All Sim 1 0.705 -0.375 -0.395 
All Sim 2 0.905 -0.367 -0.387 
Corticosteroids 0.911 -0.770 -0.916 
Albumin 0.840 0.221 0.067 
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Figure 6.16: Sim 1: comparison of adjusted effect estimates 
Sim 1 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Truth 0.56 (0.50,0.62) 
Unadjusted 0.50 (0.44,0.57) 
Hedges 0.55 (0.45,0.67) 
Half-Normal 0.51 (0.44,0.60) 
Negative- 0.54 (0.45,0.65) 
Exponential 
Logistic 0.53 (0.45,0.63) 
Function 
0.3 
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Figure 6.17: Sim 2: comparison of adjusted effect estimates 
Sim 2 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Truth 0.88 (0.81 , 0.96) 
Unadjusted 0.79 (0.69,0.90) 
Hedges 0.98 (0.41 , 2.36) 
Half-Normal 0.87 (0.64,1.19) 
Negative- 0.92 (0.61 , 1.38) 
Exponential 
Logistic 0.91 (0.61 , 1.34) 
Function 
0.5 1.0 2.0 
Odds Ratio 
Treatment better i-- -º Treatment worse 
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Figure 6.18: Sim 3: comparison of adjusted effect estimates 
Sim 3 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Truth 0.98 (0.89,1.07 
Unadjusted 0.82 (0.72 , 0.94 
Hedges 0.81 (0.53,1.25 
Half-Normal 1.12 (0.64 , 2.10 
Negative- 1.16 (0.63,2.14 
Exponential 
Logistic 1.17 (0.61 , 2.26 
Function 
Figure 6.19: All Sim 1: comparison of adjusted effect estimates 
All Sim I 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Unadjusted 0.56 (0.50,0.62 
Hedges 0.58 (0.49 , 0.70 
Half-Normal 0.58 (0.51 , 0.67 
Negative- 0.61 (0.51 , 0.72 
Exponential 
Logistic 0.60 (0.51 , 0.70 
Function 
0.3 0.5 1.0 2.0 
Odds Ratio 
Treatment better . -- -. Treatment worse 
0.3 0.5 1.0 2.0 3.0 
Odds Ratio 
Treatment better *- -º Treatment worse 
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Figure 6.20: All Sim 2: comparison of adjusted effect estimates 
All Sim 2 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Unadjusted 0.88 (0.81 , 0.96 
Hedges 0.93 (0.75,1.15 
Half-Normal 0.91 (0.76,1.10 
Negative- 0.91 (0.74,1.13 
Exponential 
Logistic 0.92 (0.74 , 1.13 
Function 
Figure 6.21: Corticosteroids: comparison of adjusted effect estimates 
Corticosteroids 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Unadjusted 0.62 (0.49,0.78 
Hedges 0.81 (0.49,1.33 
Half-Normal 0.89 (0.20,4.02 
Negative- 1.07 (0.18 , 6.36 
Exponential 
Logistic 0.97 (0.19 , 5.08 
Function 
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Figure 6.22: Albumin: comparison of adjusted effect estimates 
Albumin 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Unadjusted 1.78 (1.24,2.58) 
Hedges 2.77 (1.11 , 6.87) 
Half-Normal 2.75 (1.40,5.41) 
Negative- 2.00 (1.02 , 3.94) 
Exponential 
Logistic 2.22 (1.14,4.34) 
Function 
0.3 1.0 3.0 10.0 
Odds Ratio 
Treatment better +- -º Treatment worse 
6.4 Copas (1999) :a sensitivity analysis 
Previous methods in this chapter modelled the selection process using weighted 
distributions which related the probability of publication to a study's p-value. The 
selection process that Copas (1999) models is based on a study's sample size or 
precision such that as a study's sample size increases so should its probability of 
reaching publication. Copas' method, based on an earlier method by Copas and Li 
(1997), utilises the relationship between sample size and probability of publication 
by linking the random errors of two models: one for effect size, and one for the 
selection process, by a standard bivariate normal distribution. 
Model for effect size 
The model for effect size describes the population of studies that have, or could be 
carried out to estimate 0 the global parameter of interest. Defining individual study 
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effect size y such that y fVýx-/n), with asymptotic within study variance 
n-1, and between study variance component 72, the model for effect size is given by 
y=O+ (T2 + n-1)1/2e 
where c is a random error from a standard normal distribution 
Model for selection 
The model for selection describes the relationship between observation of a study 
and study sample size or precision 
z=7o+ yin1/2+6 
where yo is the underlying rate of publication, ryl describes the relationship 
between publication and sample size, and the error, ö, follows a standard normal 
distribution. 
If sample size does not influence observation of a study then 5 and e will both 
follow independent standard normal distributions, but if it does, then these two 
random errors will follow a standard bivariate normal distribution with correlation 
p. It is assumed that the nature of publication bias will lead to a positive correlation 
between the two errors such that a large value of 5 will lead to a large value of c. 
The degree of non-randomness in the selection process is represented by p. 
Copas (1999) states that the crucial assumption is that n enters the selection 
equation but not into the mean term of the equation for effect size, so the association 
between y and n is explained by selection bias, and not by any genuine tendency for 
smaller studies to produce more positive results. 
The majority of large studies will be published and hence be available for inclusion 
in a meta-analysis, but for small studies, the effects of publication bias means that 
those with positive findings are more likely to reach publication than those with 
negative or null results. The mechanism between the two errors of the models can 
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be viewed in two equivalent ways. If a study has been observed but only has a 
small sample size then the error in the selection model will be large. The positive 
correlation between the two models will inflate the error in the effect size model and 
correspond to an extreme observed effect estimate. Alternatively, if the observed 
effect estimate is extreme then the error in the effect size model will be large, this 
will in turn cause the error in the selection equation to become inflated such that 
this study will have a high probability of publication irregardless of its sample size. 
The log likelihood function is given by 
m11 (yi -A)2 log(L) a 
[_1o(r2 
+ ni 2(T2 + n. - 
log{h(ui)} + log{ý(v{)} 
i. l :) 
where 
Ui ='Yo+ryins's 
and 
= 
ns+P(ys-0)VýT2-I-n; 1) 
Vi (1-p2)"2 
Copas remarks that the way n enters the selection equation is arbitrary, but 
that his choice of n1/2 reflects that it seems sensible that z increases with n less 
quickly than a linear term. Also as y is the standardized effect estimate n'1/2 
governs precision and hence accuracy of a study, which is what is important for the 
likelihood of selection. Due to the arbitrary specified relationship between y and 
na sensitivity approach is adopted. The parameters yo and ryl are fixed and the 
rest of the model is estimated. By varying the values of the fixed parameters over 
plausible ranges it is possible to see how sensitively the estimate of A depends on 
'yo and 7,. For given values of 'yo and yi, MLES of the remaining parameters are 
found by using the nlminb command of Splus as described in section 6.3.4. 
6.4.1 Application to examples 
Figures 6.23-6.29 illustrate the results of applying Copas' method to each of the 
examples contained in chapter three. Each figure represents a contour plot, with 
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the contours labelled with the estimated adjusted odds ratios for given fixed values 
of yo and y'. The top right hand corners of each graph depict areas where there is no 
selection mechanism present and all trials, small and large, have a high probability 
of reaching publication. The odds ratio estimates in this region are approximately 
equivalent to the unadjusted estimates. The bottom left hand comers of the contour 
plots depict areas where selection is strong. 
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Figure 6.23: Copas model: Sim 1 contours 
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Figure 6.24: Copas model: Sim 2 contours 
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Figure 6.25: Copal model: Sim 3 contours 
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Figure 6.26: Copas model: All Sim 1 contours 
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Figure 6.27: Copal model: All Sim 2 contours 
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Figure 6.28: Copas model: Corticosteroid contours 
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Figure 6.29: Copas model: Albumin contours 
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This method offers a convincing alternative to the weighted distribution methods. 
Copas (1999) applies this method to a meta-analysis of rehabilitative treatments, 
a meta-analysis evaluating the use of intravenous magnesium for patients with 
suspected acute myocardial infarction, and considers the effects of publication bias 
in a meta-analysis evaluating the effects of passive smoking on lung cancer (Copas 
and Shi, 2000). Evaluation by simulations would allow the applicability of this 
method to be determined when the number of studies is small and the effect size is 
null to moderate, and in the existence of strong funnel plot asymmetry. 
In contrast to estimates derived from weighted distributions, confidence intervals 
around the point estimates for the odds ratios are not considered, with the emphasis 
placed on how the point estimates are affected by varying the strength of suppression. 
Considering the imprecision of the selection parameters in the weighted distributions 
this approach seems preferable. However, given the region of the contour plots, 
there is no device, other than intuition and knowledge of the area to indicate which 
adjusted estimates are most likely. For this reason a Bayesian analogue of this 
approach may be beneficial. However, similarly to estimating /. 3 in the weighted 
distribution methods, there is little information contained in the data sets about 
yo and yl. This means that if a Bayesian approach was adopted the posterior 
distributions for yo and yl would be heavily influenced by the choice of prior. 
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The effect size model of this approach could easily be extended to incorporate 
linear predictors to explain heterogeneity. Displaying the results of the extended 
model could be problematic with multiple contour plots required as the number of 
predictors increases. 
6.5 Trim and fill 
This is a simple data-augmentation method based on funnel plot asymmetry. It is 
closely related to the rank correlation test of Begg and Mazumdar (1994) used to 
detect the presence of publication bias (see chapter five). The key to Duval and 
Tweedie's method (1998) lies in estimating the number of missing studies which is 
based on the assumption that suppression has taken place in such a way that the 
set of unpublished studies is comprised of the most extreme negative or null effect 
estimates. The methods used to estimate the number of unpublished studies are 
based on the ranks of the absolute values of the observed effect sizes, and the signs 
of those effect sizes around 0, where A is the global effect size. 
6.5.1 Estimating the number of missing studies 
Let X; = X; - 0, and denote the ranks of the observed values of I X; I as r; 
which run from 1 to n, and 0 is estimated using the observed studies. Let ry* >0 
denote the length of the rightmost run of ranks associated with positive values of 
the observed Xs ; and denote the Wilcoxon rank test statistic for these observed n 
values as 
T =>T; 
x >0 
Based on these values Duval and Tweedie (1998) define estimators of the number 
of missing studies given by 
Ro =y*-1 
4Tn -n n+1 Lo = 2n-1 
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Qo=n-2- J2n2-4Tn-+ -4 
The properties and performance of these estimators are formally discussed in 
Duval and Tweedie (1998). However in Duval and Tweedie (1999) they describe 11 
and Lo as the simplest and most useful stating that both of these estimators have 
good properties, ie. that both have low bias, but as n gets larger the estimator f) 
becomes preferable to Lo in terms of having a relatively smaller variance. 
R0, Lo, and Qo provide estimates of the number of missing studies, or equivalently, 
how many studies comprise the asymmetric outlying part of the funnel plot. This 
number of studies is then trimmed off the asymmetric part of the funnel plot and 
i is re-calculated using the symmetric remainder to provide an estimate of the true 
centre of the funnel. The trimmed studies are then replaced and the missing studies 
imputed by symmetrically reflecting the values of the trimmed studies around the 
centre of the funnel. The imputed studies are given the same estimate of standard 
error as their trimmed counterparts. The adjusted mean and its variance are then 
estimated based on the `filled' funnel plot. 
Duval and Tweedie describe two algorithms, one in which 0 is assumed known, 
as described above, and an iterative procedure in which 0 is assumed unknown. 
They found little difference between these methods but where a difference existed 
the iterative method was found to be generally more conservative. Moreover for both 
methods they found that the `filled' versions of the funnel plot whether assuming A 
known or unknown improved coverage and provided closer estimates of the values 
used in simulations than traditional methods which ignore the problem of publication 
bias. See Sutton et at. (2000) for an empirical assessment of publication bias using 
this method. 
6.5.2 Application to examples 
Table 6.7 contains the results of applying the `trim and fill' method. By considering 
the funnel plots in chapter five, the only example in which funnel plot asymmetry 
was clearly evident was the corticosteroid example. This is reflected in the estimates 
of the number of missing studies and on the adjusted effect estimate. However, the 
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Table 6.7: Trim and fill results 
175 
R L 
N OR 95% CI T N OR 95% CI T 
Sim 1 Unadjusted 0.49 (0.42 , 0.58) T=0 
Trimmed 
Filled 
0 0 
Sim 2 Unadjusted 0.79 (0.69 , 0.90) 7=0 
Trimmed 
Filled 
0 
- 
1 0.80 (0.70 , 0.92) 
0.80 0.70 , 0.92) 
0 
0 
Sim 3 Unadjusted 0.82 (0.72 , 0.94) I r: 4 0 
Trimmed 
Filled 
0 
- -_ 
1 0.83 (0.73 , 0.96) 
0.82 (0.72 , 0.94) 
0 
0- 
i ll Sim 1 Unadjusted 0.56 (0.50 , 0.62) T=0 
Trimmed 
Filled 
2 0.57 (0.51 , 0.63) 0 
0.70 (0.51 , 0.95) 0.119 
3 0.57 0.52 , 0.63) 
0.57 (0.52 , 0.63) 
0 
0.086 
All Sim 2 Unadjusted 0.88 (0.81 , 0.96) 0 
Trimmed 
Filled 
0 
- 
1 0.90 0.86 , 0.95) 
0.90 (0.86 , 0.94) 
0 
0 
Corticosteroids Unadjusted 0.61 0.47 , 0.78 T=0.014 
Trimmed 
Filled 
5 0.70 0.54 , 0.90) 0 
0.70 (0.51 , 0.95) 0.119 
3 0.66 (0.52 , 0.85 
0.65 (0.48 , 0.88) 
0 
0.086 
Albumin Unadjusted 1.79 (1.24 , 2.58) T=0 
Trimmed 
Filled 
0 0 
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adjusted effect estimate of the corticosteroid example is not markedly different from 
its original unadjusted estimate. This is because the most extreme positive effect 
estimates also tend to have the smallest variance, and so when these points are 
reflected around A they are given little weight and hence little influence in the 
meta-analysis. 
ý`4:. 
»aý: '. 
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Figure 6.30: Sim 2: trimmed and filled funnel plots 
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Figure 6.31: Corticosteroids L: trimmed and filled funnel plots 
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Figure 6.32: Corticosteroids R: trimmed and filled funnel plots 
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6.5.3 Discussion 
The model of publication bias that the trim and fill method reflects is that 
suppression has taken place in such a way that it is the values of the effect estimates 
with the most extreme left values that have been suppressed. In terms of a weighting 
function this would be equivalent to 
W(xi) 
1 ifx, >9 
0 otherwise 
That is it assumes that all studies are published if their effect size is greater 
than 0 and do not reach publication otherwise. It also assumes that the missing 
data points can be obtained by reflecting the points in the outlying asymmetrical 
part of the funnel around the combined estimate, imputing values of precision for 
the missing studies based on the reflected counterparts. This method of imputing 
studies assumes that the left and right hand corners of the funnel plot are mirror 
images. This is a large and unrealistic assumption. 
The trim and fill method differs from the assumptions of the selection process 
in the weight functions of section 6.3 as it assumes that it is based on the effect 
estimates and not the p-value associated with each study. In the majority of 
situations the two processes should be equivalent. However, the p-value is also a 
function of o and as the results of Lane and Dunlap (1978) indicated via truncated 
simulations a significant p-value may be caused by the sample variance of the 
statistically significant studies under estimating the population variance 
(see section 
6.2). 
Overall, publication bias is not as simple as the presence or absence of a group of 
points in the lower left hand corner of a funnel plot but is a decreasing pattern of 
variability in the density of points across the whole of the p-value or effect estimate 
range. This is a simplistic method which basically assumes that the observed values 
form a truncated distribution and it can not adjust for studies that may be missing 
due to publication bias in any other region of the funnel plot. This explains the 
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discrepancy between the results of the trim and fill method and the weight functions 
of section 6.3. It is also difficult to see how this model could be extended to allow 
heterogeneity to be investigated. 
6.6 Summary 
6.6.1 Clinical 
Corticosteroids 
The corticosteroids review was the only example to display strong funnel plot 
asymmetry, which was also detectable by the publication bias tests of chapter five. 
The trim and fill method which relies on funnel plot asymmetry estimated that 
there were approximately five studies in the outlying asymmetrical part of the plot. 
Five missing studies were then imputed to balance the plot. In comparison with the 
weighted distribution methods the adjusted estimate of the trim and fill method was 
hardly changed. This is caused by the inability of trim and fill method to adjust 
for missing values in all regions of the plot. The imputed values also correspond to 
the observed most extreme positive values, and as these results are often the most 
imprecise little weight is given to the imputed values in the adjusted meta-analysis. 
In the weighted distribution methods the adjusted estimates ranged from 0.8 to 
1.1, with each confidence interval around these point estimates including the null 
value. However, there was great increase in the width of each confidence interval. 
This may be explained by the strength of the correlation between the estimated 
parameters, the fit of each model to the 
data, or possibly the heterogeneity present 
in this example. In applying Copas' method to this data the strong correlation 
already present in this example between precision and the effect estimates resulted 
in problems with convergence in the region of the contour plot corresponding to 
no publication bias. The regions of the plot where estimation was possible found 
estimates for the odds ratio to vary 
between 0.71 for moderate publication bias to 
1.28 for extreme bias. 
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Albumin 
Lack of funnel plot asymmetry in the albumin example resulted in the number of 
missing studies for the trim and fill method to be zero, and hence the conclusion 
of no publication bias in this review. This does not correspond with the adjusted 
estimates derived via the weighted distribution methods. The unadjusted combined 
estimate of the albumin review is 1.8, but the adjusted estimates of the weighted 
distributions ranged from 2.0 to 2.8. Each method has consistently moved the 
adjusted effect estimate further away from the null value. This was also supported 
by the results of Copas' method. The region of the contour plot where publication 
bias was minimal gave the estimated adjusted odds ratio to equal the unadjusted 
estimate of 1.8. In the region of the plot corresponding to extreme publication bias 
the odds ratio estimate was 4.0. 
Application of the methods to adjust for publication bias suggests the existence 
of selection bias. The extent of the bias varies between methods and the belief as 
to which estimate is perceived to be correct among those estimated is subjective. 
6.6.2 Statistical 
In adjusting effect estimates for publication bias the main area of methodological 
development is weighted distributions. Essentially there are two approaches to 
weighted distributions, those defined using a parametric weight function, and those 
which use a non-parametric approach. The main benefit of using parametric 
methodology is the need to estimate fewer parameters making it more amenable 
to meta-analyses with fewer studies. The problem is that the shape of the weight 
function needs to be predefined. By using a variety of weight functions it is possible 
to consider the robustness of the combined estimate in a sensitivity analysis. Where 
there is variability of adjusted effect estimates graphs of the weight functions will 
illustrate regions of the p-value range where functions differ in severity of suppression 
(see figures 6.2-6.15). 
Selection process models need to be able to distinguish between the effects of 
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selective publication and the effect of a strong underlying treatment effect. If there 
is a strong treatment effect most of the resulting p-values from individual studies will 
be small, resulting in few unpublished studies. Methods adjusting for publication 
bias need to be able to distinguish between publication bias and a high number of 
statistically significant results caused by a strong treatment effect. Where treatment 
effects were strong the weight functions did not over adjust for selection. As the true 
treatment effect became weaker use of the weight functions appeared to over adjust 
for the selection mechanism. This is apparent in the results of Sim 3. Application to 
All Sim 1 and 2 illustrates that when no selection mechanism is operating the weight 
functions have little effect on the estimated parameter values. These full simulations 
contain 50 studies and these results may be more strongly influenced when there are 
fewer component studies. The corticosteroids example was much more sensitive to 
the choice of weight function with extensive variability in the point estimates. The 
studies in this example contained greater than expected between trial variation and 
despite the models incorporating a random effects term more needs to be done to 
determine sensitivity of weight functions in the presence of heterogeneity. 
Systematic reviewers have not implemented the weighted distribution 
methodology. Dear and Dobson (1997) note that `the culture of meta-analysis has 
traditionally favoured very simple methods'. The weighted distribution methodology 
is computer intensive and is therefore not likely to be implemented until the advent 
of user friendly software. However, the trim and fill approach of Duval and Tweedie 
(1998) is a conceptually and computationally simplistic method, and as such is 
likely to become a popular method for considering the effects of publication bias on 
combined effect estimates. In Sims 1 and 2 this method was shown to be ineffective 
in correcting for publication bias. This method relies upon the concept of publication 
bias producing strong asymmetry in the funnel plots and is susceptible to one or 
two results in the negative region balancing the plot. 
Copas' model provides a complementary approach to the weighted distributions. 
Figures 6.23-6.29 give the contour plots for each example with selection extremes 
illustrated in the top right and bottom left corners of the plots. In each example 
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the weighted distribution adjusted estimates are contained approximately mid way 
between the two extremes. The plot for the Corticosteroids example is not complete, 
with the top right hand region that gives estimates assuming no publication bias 
missing. It was not possible to obtain convergence for estimates in this region using 
the nlminb program. In this region of the plot estimates of p, which represent 
the degree of non randomness in the observed data should be approximately zero 
to reflect no selection mechanism or equivalently a random sample. However, the 
corticosteroids review displayed strong funnel plot asymmetry. Therefore there is 
a strong correlation between effect estimates and precision in this data set which 
would naturally force MLEs of p away from zero. A possible explanation for the 
convergence difficulties in this region of the plot is the poor fit of the model to the 
assumption of no publication bias or no asymmetry. 
Publication bias causes a decrease in power, and modelling the selection process 
causes a further decrease in precision, predictably increasing confidence interval 
coverage. These methods cannot reliably be used to detect the presence of statistical 
significance after adjustment unless the effect size is large, but their use would be 
more beneficial if collectively they were used more as means of a sensitivity analysis 
on the point estimates in comparison with each other and the unadjusted value. 
Chapter 7 
Selection functions 
The selection functions in chapter six are limited by modelling the selection process 
on p-values only. In this chapter the selection functions will be extended to examine 
the effects of selection based on sample size alone, and sample size and p-values 
combined. 
7.1 Selection mechanisms 
In chapter two, review of the empirical evidence of publication bias highlighted the 
potential for factors other than p-values to influence publication such as sample 
size and quality. Begg (1994) described sample size as `the most important 
leverage for identifying publication bias'. While many authors and discussants of 
the methodology reviewed in chapter six have commented on the desirability of 
extending weighting functions beyond p-values this has not been developed. If the 
role of sample size in determining the existence of publication bias is so influential 
then its role in modelling the selection process should also be explored. 
7.1.1 Selection based on sample size 
Assuming that a study's probability of publication is affected only by its sample 
size or precision, then using the notation of the weighted distribution functions in 
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chapter six, the selection mechanism becomes a function of a only. 
The weighted distribution of the observed studies is given by 
w(Q1)f (x; ui) 
f w(Qi)f (x; i, ui)! x 
If the standard deviations are assumed known, then this equation simplifies to 
f" (x; O, Qi) =f (x; A, ui) 
This suggests that a selection mechanism based on study sample size alone will 
not bias the results of a meta-analysis. Tables 7.1 and 7.2 contain the results of 
25 simulations with suppression criteria based on sample size. For each simulation 
50 trials were generated using the parameters used to generate simulations 1 and 
2 prior to suppression. Suppression criteria were then applied such that the study 
id represents the pattern of suppression. Study id 1 denotes heavy suppression to 
small studies with all large studies reaching publication. As the study id increases 
the probability of publication for a small study increases while the probability of 
publication for a large study decreases. The results of these simulations confirm 
that a selection mechanism based on sample size only will not bias the results of a 
meta-analysis but will result in a loss of precision. This is also illustrated in figure 
7.1. 
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Table 7.1: Results of simulations based on Sim 1 with suppression criteria based on 
sample size 
Before Suppression After Suppression 
ID OR 95% Confidence Interval OR 95% Confidence Interval 
1 0.5850 (0.5339 , 0.6409) 0.5975 
(0.5313 
, 0.6719) 
2 0.5872 (0.5342 , 0.6454) 0.5962 
(0.5278 
, 0.6734) 
3 0.5575 (0.5082 , 0.6115) 0.5764 
(0.5128 
, 0.6478) 
4 0.5384 (0.4891 , 0.5926) 0.5218 
(0.4588 
, 0.5935) 
5 0.5774 (0.5259 , 0.6341) 0.5815 
(0.5145 , 0.6571) 
6 0.5590 (0.5092 , 0.6137) 0.5425 
(0.4803 
, 0.6126) 
7 0.6164 (0.5616 , 0.6765) 0.6288 
(0.5616 
, 0.7039) 
8 0.5090 (0.4625 , 0.5602) 0.4866 
(0.4360 
, 0.5432) 
9 0.5412 (0.4916 , 0.5957) 0.5480 
(0.4866 
, 0.6171) 
10 0.5096 (0.4629 , 0.5609) 0.4905 
(0.4305 
, 0.5587) 
11 0.5354 (0.4857 , 0.5903) 0.5795 
(0.5010 
, 0.6702) 
12 0.4937 (0.4484 , 0.5435) 0.4894 
(0.4299 
, 0.5570) 
13 0.5923 (0.5388 , 0.6510) 0.6005 
(0.5057 
, 0.7132) 
14 0.5141 (0.4679 , 0.5648) 0.4935 
(0.4327 
, 0.5629) 
15 0.5237 (0.4770 , 0.5751) 0.5084 
(0.4532 
, 0.5704) 
16 0.5567 (0.5067 , 0.6117) 0.5139 
(0.4552 
, 0.5801) 
17 0.5266 (0.4794 , 0.5784) 0.5369 
(0.4763 
, 0.6051) 
18 0.5118 (0.4659 , 0.5623) 0.5108 
(0.4490 
, 0.5811) 
19 0.5373 (0.4884 , 0.5912) 0.5329 
(0.4674 
, 0.6075) 
20 0.5725 (0.5211 , 0.6288) 0.5217 
(0.4584 
, 0.5937) 
21 0.5173 (0.4695 , 0.5700) 0.5244 
(0.4526 
, 0.6075) 
22 0.5493 (0.5001 , 0.6033) 0.5696 
(0.5000 
, 0.6488) 
23 0.5380 (0.4888 , 0.5921) 0.5585 
(0.4963 
, 0.6286) 
24 0.5368 (0.4882 , 0.5903) 0.5698 
(0.5036 
, 0.6446) 
25 0.5055 (0.4594 , 0.5563) 0.5106 
(0.4502 
, 0.5791) 
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Table 7.2: Results of simulations based on Sim 2 with suppression criteria based on 
sample size 
Before Suppression After Suppression 
ID OR 95% Confidence Interval OR 95% Confidence Interval 
1 0.9393 (0.8635,1.0217) 0.9332 (0.8390,1.0379) 
2 0.9369 (0-8615,1.0190) 0.9220 (0.8280,1.0267) 
3 1.0499 (0.9645 , 1.1429) 1.0494 
(0.9407 
, 1.1706) 
4 0.9296 (0.8536,1.0125) 0.9638 (0.8646,1.0744) 
5 0.9788 (0.9026,1.0615) 0.9403 (0.8556,1.0335) 
6 1.0508 (0.9669,1.1419) 1.0433 (0.9460,1.1505) 
7 0.9786 (0.9004,1.0635) 1.0126 (0.9221 , 1.1120) 
8 0.9828 (0.9037,1.0687) 0.9366 (0.8464,1.0365) 
9 1.0276 (0.9410 , 1.1223) 
1.0774 (0.9573 , 1.2127) 
10 0.9797 (0.9020,1.0642) 1.0514 (0.9481 , 1.1661) 
11 1.0160 (0.9335 , 1.1057) 0.9949 
(0.8645,1.1449) 
12 0.9926 (0.9125,1.0798) 0.9640 (0.8534,1.0889) 
13 0.9741 (0.8963,1.0588) 0.9733 (0.8684,1.0909) 
14 0.9743 (0.8939,1.0619) 0.9168 (0.8057,1.0433) 
15 0.9561 (0.8806 , 1.0380) 0.9382 
(0.8471 
, 1.0391) 
16 0.9583 (0.8815 , 1.0417) 
1.0594 (0.9451 , 1.1876) 
17 0.9962 (0.9150 , 1.0847) 0.9705 
(0.8741 
, 1.0776) 
18 0.9939 (0.9155,1.0789) 1.0090 (0-9137,1.1143) 
19 1.0497 (0.9653 , 1.1416) 
0.9915 (0.8933 , 1.1005) 
20 0.9723 (0.8933,1.0584) 1.0342 (0.9203,1.1622) 
21 0.9190 (0.8457 , 0.9987) 
0.9673 (0-8639,1.0831) 
22 1.0731 (0.9862 , 1.1678) 
1.0612 (0-9399,1.1981) 
23 0.9110 (0.8356 , 0.9932) 
0.9288 (0.8291 , 1.0405) 
24 1.0405 (0.9565 , 1.1319) 
1.1001 (0.9682,1.2499) 
25 1.0256 (0.9436 , 1.1147) 
1.0350 (0-9199,1.1644) 
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Figure 7.1: Selection based on sample size 
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7.1.2 Selection based on p-values and sample size 
Although a selection mechanism based on sample size alone does not bias the 
conclusions of a meta-analysis it seems intuitively reasonable that studies with 
larger sample sizes have a higher probability of publication. How should sample 
size be incorporated in the weight functions as a predictor of publication? The 
results of the previous section suggest that inclusion of sample size or precision as 
an additive component within the exponential, for example exp(aaj - ßp; ), will not 
alter the weight functions. This is true with the extra term cancelling reducing the 
log likelihood to the equations given in chapter six. Modification of the selection 
model has been based on inclusion of standard error with in the exponential of the 
weight functions as a multiplicative term. This modifies the weight functions such 
that a large standard error or a large p-value decrease the probability of publication. 
The likelihood functions for this selection process are given below 
Half-normal 
Weight function 
w(x vi) = exp(-ßa (1- 41)(xi/ai))2) 
Log-likelihood 
log(L) oc -, BEoi(1-4D(ls)) 
i1ý 
ý)2 
i1i 
- log 
1 
0(Xi )exp(-ßQ, (1 - (D(1 
))2)dxi 
i_1 00 ii r%i 
Negative exponential 
Weight function 
'a(xs, as) = exp(-ßoß(1- 11)(xi/as))) 
Log-likelihood 
log(L) a2 
Xi ý)2 
77i s-i s s-i 
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-A x* 
- log 
f 0(X_ )exp(-ßo; (1 - (D(")))dx+ 
=i 7/i lii 
Logistic function 
Weight function 
2*exp(-, 6ai(1-ý(n ))) 
ý(ýiýQi) =1 +exp(-ßQi(1 -n ))) 
Log-likelihood 
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" X. -0" °° Xi -0 expp(-ßci(1 -n ))) dxi -2 E( Ali 
)2 - log 
f 
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0( 
Ili 
)1 
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7.1.3 Application to examples 
Figures 7.2-7.21 illustrate the weight function contour plots for each example. These 
contour plots show how the estimated weights change as the p-value and standard 
errors vary. Generally there is little difference between the contour plots of each 
parametric weight function. Noticebly in Sim 1 the modified half-normal contour 
plot maintains higher probabilities of publication than in the corresponding negative 
exponential and logistic contour plots but this has caused little influence on the point 
estimates (see figure 7.22). In All Sim 2, contrary to expectations estimation of ß 
has resulted in the regions of the plot with high p-values and large standard errors 
receiving the greatest weight. However in this simulation no publication bias was 
present and results show the estimates of ,B to be imprecise and again this has had 
little impact on the point estimates (see figure 7.26). 
Figures 7.22-7.28 show the results of applying the modified weight functions to 
the examples. Generally, introduction of the standard error term has reduced the 
magnitude of the adjustment to the effect estimates given in chapter six. In Sim 
2 and 3 introduction of the standard error term has greatly reduced the width of 
the confidence intervals, and in Sim 3 has prevented the over adjustment of the 
point estimates. In the corticosteroids example the variability between the point 
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Table 7.3: Modified half-normal parameter estimates 
ß 0 
example est se est se est se 
Sim 1 0.046 3.704 0.685 0.074 0 0.025 
Sim 2 4.309 2.985 0.181 0.088 0 0.018 
Sim 3 9.781 5.913 0.029 0.709 0 0.060 
All Sim 1 2.187 1.552 0.546 0.059 0 0.021 
All Sim 2 -0.494 2.095 0.138 0.066 0 0.015 
Corticosteroids 9.770 2.931 0.247 0.198 0.021 0.058 
Albumin 0.955 0.585 -0.869 0.267 0 0.214 
estimates and the associated confidence intervals have been greatly reduced. In this 
example the estimates adjusted using p-values and standard error are approximately 
equivalent to the adjusted estimate obtained using Hedges semi-parametric method. 
In the albumin example the variability between the adjusted effect estimates has 
also been reduced and the confidence interval widths have decreased. 
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Table 7.4: Modified negative exponential parameter estimates 
fJ A T 
example est se est se est se 
Sim 1 2.671 3.362 0.647 0.083 0 0.026 
Sim 2 3.894 3.991 0.166 0.106 0 0.020 
Sim 3 5.765 5.345 0.065 0.153 0 0.027 
All Sim 1 2.845 2.035 0.511 0.072 0 0.023 
All Sim 2 -0.470 2.059 0.139 0.071 0 0.014 
Corticosteroids 5.134 2.759 0.278 0.181 0.001 0.059 
Albumin 0.498 0.600 -0.716 0.244 0 0.198 
Table 7.5: Modified logistic function parameter estimates 
#Q O T 
example est se est se est se 
Sim 1 9.338 26.037 0.596 0.081 0 0.024 
Sim 2 5.354 4.519 0.196 0.098 0 0.020 
Sim 3 8.278 5.564 0.068 0.145 0 0.028 
All Sim 1 3.841 2.458 0.544 0.067 0 0.022 
All Sim 2 0 4.147 0.126 0.072 0 0.014 
Corticosteroids 5.993 2.872 0.337 0.164 0 0.057 
Albumin 0.748 0.721 -0.716 0.236 0 0.198 
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Table 7.6: Modified parametric correlation estimates 
Example Corr(#, A) Corr(ß, T) Corr(A, T 2) 
Half-normal 
Sim 1 -0.4o6 0.208 -0.083 
Sim 2 -0.625 0.250 -0.296 
Sim 3 -0.837 0.523 -0.705 
All Sim 1 -0.489 0.236 -0.182 
All Sim 2 -0.728 0.269 -0.176 
Corticosteroids -0.625 0.356 -0.645 
Albumin -0.663 -0.050 -0.122 
Negative exponential 
Sim 1 -0.531 0.180 -0.170 
Sim 2 -0.707 0.166 -0.256 
Sim 3 -0.852 0.046 -0.419 
All Sim 1 -0.628 0.218 -0.252 
All Sim 2 -0.780 0.123 -0.077 
Corticosteroids -0.593 0.163 -0.391 
Albumin -0.654 -0.128 0.006 
Logistic 
Sim 1 0.566 -0.031 0.068 
Sim 2 0.637 -0.114 -0.152 
Sim 3 0.823 -0.308 -0.473 
All Sim 1 0.558 -0.202 -0.212 
All Sim 2 0.782 -0.121 -0.094 
Corticosteroids 0.524 -0.136 -0.314 
Albumin 0.618 0.085 -0.020 
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Figure 7.2: Sim 1: modified half-normal contour plot 
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Figure 7.3: Sim 1: modified negative exponential contour plot 
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Figure 7.4: Sim 1: modified logistic contour plot 
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Figure 7.5: Sian 2: modified half-normal contour plot. 
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Figure 7.6: Sim 2: modified negative exponential contour plot 
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Figure 7.7: Sim 2: modified logistic contour plot 
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Figure 7.8: Sim 3: modified half-normal contour plot 
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Figure 7.9: Sim 3: modified negative exponential contour plot 
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Figure 7.10: Sim 3: modified logistic contour plot 
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Figure 7.11: All Sim 1: modified half-normal contour plot 
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Figure 7.13: All Sim 1: modified logistic contour plot 
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Figure 7.12: All Sim 1: modified negative exponential contour plot 
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Figure 7.14: All Sim 2: modified half-normal contour plot 
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Figure 7.15: All Sim 2: modified negative exponential contour plot 
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Figure 7.16: Corticosteroids: modified lialf-normal contour plot 
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Figure 7.17: Corticosteroids: modified negative exponential contour plot 
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Figure 7.19: Albumin: modified lialf-normal contour plot 
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Figure 7.20: Albumin: modified negative exponential contour plot 
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Figure 7.21: Albumin: modified logistic contour plot 
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Figure 7.22: Sim 1: effect estimates adjusted for p-values and precision 
Sim 1 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Truth 0.56 (0.50,0.62 
Unadjusted 0.50 (0.44,0.57 
Half-Normal 0.50 (0.44,0.58 
Negative- 0.52 (0.44,0.62 
Exponential 
Logistic 0.50 (0.43 , 0.59 
Function 
0.3 0.5 1.0 2.0 
Odds Ratio 
Treatment better f--- ---+ Treatment worse 
Figure 7.23: Sim 2: effect estimates adjusted for p-values and precision 
Sim 2 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Truth 0.88 (0.81 , 0.96) 
Unadjusted 0.79 (0.69,0.90) 
Half-Normal 0.83 (0.69,1.01) 
Negative- 0.85 (0.69,1.04) 
Exponential 
Logistic 0.82 (0.68,0.99) 
Function 
0.5 1.0 2.0 
Odds Ratio 
Treatment better E-- --º Treatment worse 
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Figure 7.24: Sim 3: effect estimates adjusted for p-values and precision 
Sim 3 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Truth 0.98 (0.89,1.07 
Unadjusted 0.82 (0.72,0.94 
Half-Normal 0.97 (0.68,1.40 
Negative- 0.94 (0.69,1.26 
Exponential 
Logistic 0.93 (0.70,1.24 
Function 
Figure 7.25: All Sim 1: effect estimates adjusted for p-values and precision 
All Sim 1 
Estimates with 95% confidence intervals 
Method OR 95% Cl 
Unadjusted 0.56 (0.50,0.62 
Half-Normal 0.58 (0.51 , 0.66 
Negative- 0.60 (0.52,0.69 
Exponential 
Logistic 0.58 (0.51 , 0.66 
Function 
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Figure 7.26: All Sim 2: effect estimates adjusted for p-values and precision 
AllSim2 
Estimates with 95% confidence intervals 
Method OR 95% Cl 
Unadjusted 0.88 (0.81 , 0.96 
Half-Normal 0.87 (0.77,0.99 
Negative- 0.87 (0.76,1.00 
Exponential 
Logistic 0.88 (0.77,1.01 
Function 
Figure 7.27: Corticosteroids: effect estimates adjusted for p-values and precision 
Corticosterolds 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Unadjusted 0.62 (0.49,0.78 
Half-Normal 0.78 (0.47,1.31 
Negative- 0.76 (0.53,1.08 
Exponential 
Logistic 0.71 (0.52,0.98 
Function 
0.5 1.0 2.0 
Odds Ratio 
Treatment better i- -º Treatment worse 
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Figure 7.28: Albumin: effect estimates adjusted for p-values and precision 
Albumin 
Estimates with 95% confidence Intervals 
Method 
Unadjusted 
Half-Normal 
Negative- 
Exponential 
Logistic 
Function 
OR 95% Cl 
1.78 (1.24,2.58) 
2.38 (1.41 , 4.02) 
2.05 (1.27 , 3.30) --ý- 
2.05 (1.29,3.25) 1m 
0.3 1.0 3.0 10.0 
Odds Ratio 
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7.2 Conclusions 
7.2.1 Clinical 
Albumin 
203 
In comparison to the adjusted effect estimates obtained in chapter six where 
the selection process was modelled using p-values only, extension of the selection 
mechanism to include standard error has reduced the magnitude of the adjustments 
made by each parametric model. Extending the selection model in this way has 
also reduced the confidence interval widths and has made the adjusted estimates 
obtained under each model more consistent with adjusted estimates now varying 
between 2.1 and 2.4 compared with 2.0 and 2.8 obtained in chapter six. 
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Corticosteroids 
The corticosteroids example displays the most dramatic effects of the benefits of 
modelling the selection process on p-values and standard error. In comparison to 
the results obtained in chapter six extension of the selection mechanism has greatly 
reduced the size of the adjustments, confidence interval widths, and variablity 
between the parametric methods. This may be caused by the inclusion of the 
standard error term in the selection model making an allowance for a small study 
effect. 
7.2.2 Statistical 
Work in this chapter shows that a selection mechanism based on sample size alone 
will not bias the results of a meta-analysis but will result in a loss of precision. 
Extending the selection mechanism to include standard error and p-values appears 
to improve the fit of the weighted distributions. This is reflected in the adjusted 
effect estimates, confidence interval widths, and variability between the parametric 
models. Inclusion of the standard error term in the model generally decreases the 
size of the adjustment for publication bias. This seems intuitively reasonable as 
this allows a large study a higher probability of publication than a small study 
with an equivalent p-value. The models based on p-values alone are not be able to 
differentiate between the two studies giving them equal weight. In the simulations 
where publication bias criteria was applied, the criteria varied with p-values and 
study size and so it may be argued that the extended model would be expected 
to provide improved adjusted estimates. This improvement was also seen in the 
corticosteroids and albumin reviews, and in the simulations in which no selection 
mechanism was operating. Increased probability of publication for large trials seems 
realistic as it may be reflective of journal editors appreciation of the amount of work 
involved, researchers determination to write up and publish their work, or other 
factors such as improved quality. 
Application of the parametric weight function methods suggest that the accuracy 
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of these methods to reflect the true underlying effect size is affected by the number 
of trials in the meta-analysis and by the strength of the treatment effect. 
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Chapter 8 
Publication bias and heterogeneity 
In this chapter the effects of modelling publication bias in the presence of 
heterogeneity will be considered. 
The corticosteroids review is the only example where funnel plot asymmetry is 
clearly evident. One explanation for this is the presence of publication bias another 
competing reason is heterogeneity. This raises the question of what happens to point 
estimates when they are adjusted for publication bias if there is no publication 
bias yet heterogeneity is present. To consider this question in this chapter the 
corticosteroids review will be considered in more detail along with two simulations, 
one based on the corticosteroids review and one based on the simulations contained 
in chapter three. In section 8.3 the model for effect size will be extended to 
allow covariate inclusion allowing publication bias and heterogeneity to be modelled 
simultaneously. Ways of extending the selection model will be discussed. 
8.1 Heterogeneity examples 
5.1.1 Corticosteroids review revisited 
The corticosteroids review on the CDSR presents its results for mortality as a 
subgroup analysis and as a total combined estimate (see figure 8.1). The trials are 
split into two groups according to whether treatment was received before or after 
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1980 based on the reasoning that the treatment effect may not be so apparent in 
trials performed since 1980 as the case-fatality rate for respiratory distress syndrome 
has altered. 
Heterogeneity and publication bias are not mutually exclusive. Although the 
funnel plot asymmetry in the corticosteroids example appears to be explained by 
the subgroups (see figure 8.2) this does not mean that the meta-analysis is free 
of publication bias. To consider the robustness of the corticosteroids review to 
the assumption of publication bias allowing for heterogeneity, the results will be 
compared with those of the simulations detailed below. 
8.1.2 Heterogeneity simulations 
For the corticosteroids simulation the event rates and sample sizes were taken from 
the review. This was done such that eight trials were simulated using probability 
of event of 61/1071 and 130/1062 for treatment and control groups respectively 
matching the size of each study on those in the corticosteroids review. Six trials 
were then generated matching the size of each study on those in the review using 
the post 1980 observed event rates of 65/699 and 81/685 for treatment and control 
groups respectively. The simulated data are given in table 8.1 and displayed in 
figure 8.3. For the heterogeneity simulation trials 1 to 35 were simulated using 
the event rates 0.2 and 0.2 in the treatment and control groups, and trials 36 to 
50 with event rates of 0.12 and 0.2. The sample sizes and suppression criteria for 
the heterogeneity simulation were based on the simulations in chapter three. The 
resulting data are given in table 8.2 and displayed in figures 8.5 - 8.8. 
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Figure 8.1: Corticosteroids forest plot with subgroups 
Meta-analysis of Corticosteroids 
Estimates with 95% confidence intervals 
Study 
Treated before 1980 
Amsterdam 1980 
Auckland 1972 -ý 
Block 1977 
Doran 1980 
Gamsu 1989 
Morrison 1978 
Papageorgiou 1979 
Tauesch 1979 
Subtotal O 0.51 ( 0.38,0.68 ) 
Treated after 1980 
Garite 1992 
Kari 1994 
Morales 1986 
Parsons 1988 
Schmidt 1984 
US Steroid Trial 
Subtotal 0.78 ( 0.54,1.12 ) 
Total O 0.60 (0.47,0.75) 
0.1 0.3 1.0 3.0 10.0 
Odds Ratio 
Treatment better i- -> Treatment worse 
Figure 8.2: Corticosteroids funnel plot with subgroups 
A before 1980 
x after 1980 
X 
X 
e 
ýý X 
1 0.2 0.5 1.0 2.0 5.0 10 
Odds Ratio 
209 
210 CHAPTER 8. PUBLICATION BIAS AND HETEROGENEITY 
Ta. h1P R-1! Cnrticnsternids simulation 
id Treatment 
Group 
Control 
Group 
OR(95% CI) 
1 13/64 12/58 0.98(0.41,2.36) 
2 28/532 59/538 0.45(0.28,0.72) 
3 3/69 9/61 0.26(0.07,1.02) 
4 4/81 10/63 0.28(0.08,0.92) 
5 10/131 15/137 0.67(0.29,1.56) 
6 6/67 9/59 0.55(0.18,1.64) 
7 6/71 8/75 0.77(0.25,2.35) 
8 1/56 8/71 0.14(0.02,1.18) 
subtotal 61/1071 130/1062 0.50(0.31,0.83) 7-2=0 
9 1/40 4/42 0.24(0.03,2.28) 
10 12/95 13/94 0.90(0.39,2.09) 
11 12/121 17/124 0.69 (0.32,1.52) 
12 4/23 2/22 2.11(0.34,12.86) 
13 4/49 0/31 6.23(0.32,119.87) 
14 32/371 45/372 0.69(0.43,1.11) 
subtotal 65/699 81/685 0.76(0.53,1.08) T2=0 
Total 136/1770 211/1747 0.61(0.47,0.78) r'= 0.015 
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Figure 8.3: Cort Sim forest plot with subgroups 
Meta-analysis of Corticosteroids Simulation 
Estimates with 95% confidence intervals 
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Subtotal Cf 0.76 (0.53 , 1.08 
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Figure 8.4: Cort Sim funnel plot with subgroups 
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Table 8.2: Heterogeneity simulation 
2 20/91 26/91 0.70(0.36,1.38) 
3 21/95 14/95 1.64(0.78,3.46) 
4 35/155 28/155 1.32(0.76,2.31) 
5* 16/65 16/65 1.00(0.45,2.22) 
6 26/116 29/116 0.87(0.47,1.59) 
7 12/71 12/71 1.00(0.42,2.41) 
8 19/99 19/99 1.00(0.49,2.03) 
9* 8/67 13/67 0.56(0.22,1.46) 
10 * 20/150 28/150 0.67(0.36,1.25) 
11 * 26/148 34/148 0.71(0.40,1.26) 
12 * 14/93 24/93 0.51(0.24,1.06) 
13 35/152 31/152 1.17(0.68,2.02) 
14 23/110 16/110 1.55(0.77,3.13) 
15 12/72 15/72 0.76(0.33,1.76) 
16 24/117 30/117 0.75(0.41,1.38) 
17 11/52 9/52 1.28(0.48,3.41) 
18 16/72 22/72 0.65(0.31,1.37) 
19 15/86 13/86 1.19(0.53,2.67) 
20 16/74 13/74 1.29(0.57,2.93) 
21 24/129 26/129 0.91(0.49,1.68) 
22 * 13/66 12/66 1.10(0.46,2.64) 
23 9/59 9/59 1.00(0.37,2.73) 
24 * 19/98 24/98 0.74(0.38,1.46) 
25 18/114 21/114 0.83(0.42,1.66) 
26 20/78 13/78 1.72(0.79,3.77) 
27 25/112 28/112 0.86(0.47,1.60) 
28 22/116 26/116 0.81(0.43,1.53) 
29 28/118 17/118 1.85(0.95,3.60) 
30 * 40/234 38/234 1.06(0.65,1.73) 
31 * 35/204 44/204 0.75(0.46,1.23) 
32 * 40/208 44/208 0.89(0.55,1.43) 
33 69/310 61/310 1.17(0.79,1.72) 
34 * 55/246 49/246 1.16(0.75,1.79) 
35 * 81/389 79/389 1.03(0.73,1.46) 
subtotal before suppression 885/4483 910/4483 0.96(0.87,1.07) r2=0 
subtotal after suppression 385/2085 432/2085 0.87(0.74,1.01) r2=0 
36 * 9/104 25/104 0.30(0.13,0.68) 
37 * 5/54 9/54 0.51(0.16,1.64) 
38 * 11/122 17/122 0.61(0.27,1.37) 
39 18/120 27/120 0.61(0.31,1.18) 
40 * 10/93 17/93 0.54(0.23,1.25) 
41 16/83 12/83 1.41(0.62,3.21) 
42 8/45 8/45 1.00(0.34,2.95) 
43 18/122 25/122 0.67(0.34,1.31) 
44 * 17/126 20/126 0.83(0.41,1.66) 
45 * 10/104 22/104 0.40(0.18,0.89) 
46 * 11/97 20/97 0.49(0.22,1.09) 
47 11/111 26/111 0.36(0.17,0.77) 
48 * 29/201 39/201 0.70(0.41,1.19) 
49 * 34/315 63/315 0.48(0.31,0.76) 
50 * 26/253 49/253 0.48(0.29,0.80) 
subtotal before suppression 233/1950 379/1950 0.57(0.47,0.68) r2=0 
subtotal after suppression 162/1469 281/1469 0.53(0.43.0.651 r2=0 
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Figure 8.5: All Het Sim forest plot with subgroups 
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Figure 8.6: All Het Sim funnel plot with subgroups 
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Figure 8.7: Het Sim forest plot with subgroups 
Meta-analysis of Het Sim 
Estimates with 95% confidence intervals 
Study 
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Figure 8.8: Het Sim funnel plot with subgroups 
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8.2 Modelling publication bias in the presence of 
heterogeneity 
Using the corticosteroids review, the simulation based on the corticosteroids review 
(Cort Sim) and the heterogeneity simulation before and after suppression (All Het 
Sim and Het Sim) the effects of modelling publication bias in the presence of 
heterogeneity will be considered. The parametric weighting functions modelled on 
p-values, and p-values and standard errors will be applied to each of these examples. 
8.2.1 Application to heterogeneity examples 
For application to the corticosteroids example see figures 6.21 and 7.27. Figures 8.9- 
8.11 show that there is a tendancy for the modified weight functions which include 
standard error to reduce confidence interval width. This was most apparent in the 
corticosteroids review, Het Sim and All Het Sim. In the corticosteroids review 
inclusion of standard error also reduced the variability in the point estimates, 
however in the simulations there was little difference between the point estimates 
using either selection model. 
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Figure 8.9: Cort Sim: adjusted effect estimates 
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Figure 8.10: Het Sim: adjusted effect estimates 
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Table 8.3: Half normal parameter estimates 
,ß O T 
example est se est se est se 
Cort Sim -0.440 1.614 0.524 0.142 0 0.052 
Het Sim 2.9915 3.712 0.139 0.445 0.070 0.138 
All Het Sim -0.089 1.572 0.189 0.152 0.036 0.042 
Table 8.4: Modified half normal parameter estimates 
,B O T 
example est se est se est se 
Cort Sim -1.114 1.399 0.539 0.126 0 0.051 
Het Sim 12.702 9.459 0.041 0.420 0.089 0.127 
All Het Sim 0.793 2.950 0.156 0.115 0.042 0.036 
Table 8.5: Negative exponential parameter estimates 
ýB O r2 
example est se est se est se 
Cort Sim -0.143 1.633 0.512 0.167 0 0.053 
Het Sim 2.880 3.348 0.076 0.451 0.048 0.082 
All Het Sim -0.058 1.627 0.188 0.183 0.037 0.033 
Fable 8.6: Mod ified ne ative ex onentiaº parameter estimates 
# O T2 
example est se est se est se 
Cort Sim 
Het Sim 
All Het Sim 
-0.536 
10.568 
1.083 
1.483 
6.263 
2.800 
0.525 
0.024 
0.141 
0.134 
0.273 
0.125 
0 
0.051 
0.040 
0.051 
0.059 
0.031 
218 CHAPTER 8. PUBLICATION BIAS AND HETEROGENEITY 
Table 8.7: Logistic parameter estimates 
O T 
example est se est se est se 
Cort Sim 0.223 3.639 0.510 0.170 0 0.054 
Het Sim 3.485 3.429 0.097 0.457 0.055 0.1 
All Het Sim 0.113 3.412 0.187 0.183 0.037 0.033 
Table 8.8: Modified logistic parameter estimates 
10 
1 A I r 2 
example est se est se est se 
Cort Sim 1.938 9.542 0.493 0.159 0 0.051 
Het Sim 11.473 6.121 0.076 0.275 0.071 0.073 
All Het Sim 1.913 4.092 0.176 0.115 0.041 0.032 
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Table 8.9: Parametric correlation estimates 
Example Corr(#, A) Corr(ß, T) Corr(A, T) 
Half-normal 
Cort Sim -0.567 0.286 -0.115 
Het Sim -0.939 0.855 -0.924 
All Het Sim -0.934 0.753 -0.697 
Modified half-normal 
Cort Sim -0.383 0.130 -0.003 
Het Sim -0.881 0.734 -0.893 
All Het Sim -0.866 0.561 -0.516 
Negative exponential 
Cort Sim -0.708 0.290 -0.187 
Het Sim -0.957 0.776 -0.864 
All Het Sim -0.954 0.532 -0.504 
Modifi ed negative exponential 
Cort Sim -0.473 0.109 -0.020 
Het Sim -0.865 0.455 0.699 
All Het Sim -0.891 0.300 -0.311 
Logistic function 
Cort Sim 0.719 -0.289 -0.194 
Het Sim 0.954 -0.819 -0.895 
All Het Sim 0.954 -0.508 -0.480 
Modified logistic function 
Cort Sim 0.674 -0.156 -0.064 
Het Sim 0.857 -0.523 -0.730 
All Het Sim 0.868 -0.380 -0.376 
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Figure 8.11: All Het Sim: adjusted effect estimates 
All Het Sim 
Estimates with 95% confidence Intervals 
Method OR 95% Cl 
Unadjusted 0.83 (0.75,0.93 
Half-normal 0.83 (0.61 , 1.12 
Mod half-norm 0.86 (0.68,1.07 
Neg-exp 0.83 (0.58,1.19 
Mod neg-exp 0.87 (0.68,1.11 
Logistic 0.83 (0.58,1.19 
Mod logistic 0.84 (0.67,1.05 
8.3 Extending models for selection and 
heterogeneity 
The results in the previous sections suggest the importance of including terms for 
both the standard error and p-value in the model for selection. This is particularly 
evident when the true underlying effect size is null or heterogeneity is present. While 
the programs written to estimate the standard errors are lengthy and difficult to 
extend to include extra model parameters the programs that derive the adjusted 
point estimates are more easily modified. Consequently the effects of extending the 
models will be considered on the point estimates only. 
In this section the model for effect size will be extended to include covariates 
to explain heterogeneity with application to the corticosteroids review and the 
simulated data sets in section 8.1.2. 
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Model for effect size 
In the absence of a selection mechanism the model for effect size can be written as 
a linear random effects model. The observations X;, for i=1, ..., n, are assumed to 
follow a normal distribution such that 
X, - N(Js, Qs ) 
where a represents within trial variance which is assumed known, and a; is assumed 
to be distributed such that 
bi ^' N(Di, TZ) 
where r2 is the parameter for between trial variation and 0; is a function of linear 
predictors such that 
Ai = ao+alYil+a2Y2.......... +a,, 1 
where the 4 are study level explanatory variables. 
Model for selection 
In the same way as the effect size model can be extended to include linear predictors 
the model for selection may also be extended. Using the negative exponential weight 
function as an example 
ca(Xi, a2) = exp(ßops + ß'a pi + ß2qiPi) 
where p; =1- (D(! ) and qj is an indicator of study quality. This model could be 
extended to include other predictors of publication such as study type. 
Application of these extended models will be based on the effect size model 
containing one predictor such that 
Ai = ao + a1Y1 
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where Y, "1 is a vector of indicators. The adjusted odds ratio for the main part of 
the funnel plot is obtained by exp(-ao), and exp(-(ao+a'Yi)) gives the adjusted 
odds ratio for the outlying part of the plot. For the weight functions three models 
will be applied such that model one bases selection on p-values only, model two 
bases selection on a combination of p-values and precision, and model three is a 
combination of models one and two. These weight functions are given below for the 
negative exponential model. 
ö ))) Model 1 exp(-ßo * (1 
Model 2 exp(-ßi *o* (1 - 
Model3 exp(-Po *(1-4)(- ))-ßi*Qs*(1D(L)) 
8.3.1 Application to heterogeneity examples 
The results of applying models 1,2 and 3 are given in tables 8.10-8.13. Plots of 
the weight functions are given in figures 8.12-8.15 with the rows giving half-normal, 
negative exponential, and logistic weight functions and the columns models 1,2, and 
3 respectively. In each of these graphs the models display characteristics associated 
with publication bias such that the probability of publication decreases as standard 
error and p-value increase. However, in Cort Sim the weight function contour plots 
are not consistent with this image. This may have been caused by the two extreme 
outliers generated in the simulation, but this has had a minimal effect on the adjusted 
effect estimate. 
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Table 8.10: Corticosteroids: adjusting for heterogeneity and publication bias 
#o #1 ao al T OR main OR asym 
unadjusted 0 0.51 0.78 
Half normal 
modelt 10.731 0.459 -1.121 0 0.632 1.939 
model 2 12.792 0.499 -0.711 0 0.607 1.236 
model 3 5.010 7.455 0.433 -0.937 0 0.649 1.655 
Neg exp 
modelt 5.970 0.360 -0.750 0 0.698 1.477 
model 2 5.858 0.481 -0.537 0 0.618 1.058 
model 3 2.097 4.023 0.395 -0.622 0 0.674 1.255 
Logistic 
modelt 6.872 0.400 -0.810 0 0.670 1.507 
modelt 7.119 0.501 -0.538 0 0.606 1.038 
model 3 3.272 3.991 0.409 -0.675 0 0.664 1.305 
Table 8.11: Cort Sim: adjusting for heterogeneity and publication bias 
, Bo , Bi ao a, T OR main OR asym 
unadjusted 0 0.50 0.76 
Half normal 
modelt -0.267 0.684 -0.387 0 0.505 0.743 
model 2 -0.971 0.698 -0.377 0 0.498 0.725 
model 3 5.582 -5.566 0.608 -0.456 0 0.544 0.860 
Neg exp 
modelt -0.002 0.674 -0.395 0 0.510 0.757 
modelt -0.445 0.690 -0.389 0 0.502 0.740 
model 3 2.704 -2.699 0.605 -0.434 0 0.546 0.843 
Logistic 
modelt -0.004 0.674 -0.395 0 0.510 0.757 
model 2 -0.351 0.680 -0.393 0 0.507 0.751 
model 3 3.604 -2.895 0.601 -0.451 0 0.548 0.861 
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Table 8.12: Het Sim: adjusting for heterogeneity and publication bias 
, Bo ßi ao al T OR main OR asym 
unadjusted 
before suppression 0 0.96 0.57 
after suppression 0.87 0.53 
Half normal 
modelt 5.661 -0.219 0.791 0 1.240 0.564 
model 2 16.283 -0.144 0.710 0 1.155 0.568 
model 3 -1.100 18.932 -0.119 0.687 0 1.126 0.567 
Neg exp 
modelt 5.340 -0.258 0.727 0 1.294 0.626 
modelt 11.030 -0.098 0.604 0 1.103 0.603 
model 3 2.790 5.570 -0.188 0.671 0 1.207 0.617 
Logistic 
modelt 6.230 -0.273 0.772 0 1.314 0.499 
model 2 13.655 -0.096 0.622 0 1.100 0.591 
model 3 2.760 7.950 -0.181 0.691 0 1.200 0.600 
Table 8.13: All Het Sim: adjusting for heterogeneity and publication bias 
, Bo #1 ao al T OR main OR asym 
unadjusted 0 0.96 0.57 
Half normal 
modelt 0.570 -0.012 0.567 0 1.012 0.574 
model 2 0.9947 0.009 0.550 0 0.991 0.572 
model 3 1.446 -1.955 -0.032 0.586 0 1.033 0.575 
Neg exp 
modelt 0.721 -0.027 0.561 0 1.027 0.586 
modelt 0.868 0.011 0.542 0 0.989 0.553 
model 3 3.300 -5.141 -0.104 0.612 0 1.110 0.602 
Logistic 
modelt 1.145 -0.027 0.565 0 1.027 0.584 
modelt 1.416 0.013 0.542 0 0.987 0.574 
model 3 3.343 4.417 -0.081 0.605 0 1.084 0.592 
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Figure 8.12: Corticosteroids: weight function contour plots 
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Figure 8.13: Cort Sim: weight function contour plots 
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Figure 8.14: Het Sim: weight function contour plots 
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Figure 8.15: All Het Sim: weight function contour plots 
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As expected, inclusion of the linear predictor in the effect size model has removed 
the between trial variation in each example. For the simulation results (see 
tables 8.11-8.13) model 2 has given adjusted results closest to the true parameter 
values. For Het Sim each model over adjusted for the effects of publication bias. 
This was particularly apparent for the subgroup generated with an odds ratio of 1. 
However, this over adjustment was minimized by model 2. In All Het Sim, models 
1 and 3 still tended to overadjust when the odds ratio was 1, but this was no longer 
apparent for model 2. The improvements in estimation between Het Sim and All 
Het Sim is likely to be caused by the increase in number of studies and not the 
absence of a selection mechanism. 
In the corticosteroids and Cort Sim examples model 2 again gave the smallest 
adjustments. In comparison to Cort Sim the corticosteroids example displayed large 
changes in its adjusted effect estimates. In Cort Sim, which was generated assuming 
the event rates in the review were true, there was no publication bias, and application 
of the models did not substantially change the estimates. This suggests that the 
corticosteroids example contains heterogeneity and publication bias. 
8.4 Conclusions 
8.4.1 Clinical: Corticosteroids 
Further examination of this example suggests that the funnel plot asymmetry may 
be the result of heterogeneity and not publication bias. Extending the effect size 
model to incorporate a linear predictor for this heterogeneity did not remove the 
impact of publication bias on the two subgroups. Considering the results of model 2 
only, the review gave adjusted odds ratios of approximately 0.61 and 1.06 for before 
and after 1980 compared with the unadjusted estimates of 0.51 and 0.78. In Cort 
Sim where there was no publication bias the estimates were only slightly changed. 
Given that these models appear to over adjust when the true underlying odds ratio 
is close to one it is not suggested that corticosteroids is not effective after 1980 but 
that the treatment may not be as effective as thought with an odds ratio closer to 
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one than that estimated. The decrease in mortality in the control group suggests 
that post 1980, corticosteroids may be no more effective than alternative forms of 
treatment. 
8.4.2 Statistical 
When heterogeneity is present within the data set this does not remove the threat 
of publiation bias to affect the validity of the analysis. If heterogeneity is present 
then the interpretation of one global effect is difficult. Weighted distributions 
provide a flexible way of considering the effects of publication bias and heterogeneity 
simultaneously. A reason for non-application of weighted distributions has been 
given as the methods are too computer intensive to implement. However, while 
this may remain to be true in obtaining standard errors of adjusted estimates the 
adjusted point estimates can be obtained by specifying the log-likelihood and using 
a standard iterative function within a statistical package. While this may not allow 
inference on statistical significance it will provide a way to examine the robustness 
of results to the assumption of publication bias. In considering the three selection 
mechanism models applied in this chapter, model 2 appeared to give preferable 
results. This was expected in comparison to model one given the results in chapter 
seven. Model 2 also appeared to perform better than model 3. This may be 
caused by model 3 requiring estimation of an extra parameter within the weight 
function. Inclusion of the standard error term in the selection model allows contour 
plots of the probability of publication to be produced. These contour plots show 
how the probability of publication changes as the standard error and p-values vary. 
Compared to the graphs of model one they provide a more realistic alternative. 
Chapter 9 
Conclusions and further work 
9.1 Clinical conclusions 
9.1.1 Corticosteroids 
The corticosteroids review demonstrated clear funnel plot asymmetry, which was 
detected by the methods that test for asymmetry. This could be indicative of 
publication bias or alternatively heterogeneity. Estimates of the number of missing 
studies gave highly variable results and when the weighted distribution methods were 
applied the adjusted effect size estimates were also found to be highly variable with 
extremely wide confidence intervals. Applying the extended weight distributions 
developed in chapter seven which model selection on p-values and standard error 
reduced this variation. Using this model the impact of publication bias changed the 
total combined estimate from 0.62 to approximately 0.76. 
This review contained greater than expected between trial variation. As well as 
presenting all trials combined, the original Cochrane review split the trials in to 
two subgroups dependent on whether treatment was received before or after 1980. 
Re-analysing the trials allowing for this source of heterogeneity and publication bias 
changed the estimates from 0.51 and 0.78 to approximately 0.61 and 1.10 for before 
and after 1980 respectively. Given the small number of studies in each subgroup and 
the ability of the model to over adjust when the true odds ratio is close to one it is 
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not suggested that the treatment with corticosteroids after 1980 is not beneficial but 
that true odds ratio may be much closer to one than suggested by the unadjusted 
meta-analysis. A large randomised controlled trial may be helpful in accurately 
determining the treatment benefit of corticosteroids in current medical practice. 
9.1.2 Albumin 
Contrary to prior beliefs the albumin review meta-analysis found this treatment to 
be harmful. The funnel plot appeared to be symmetrical and none of the methods to 
detect asymmetry conflicted with the visual appearance of the plot. Estimates of the 
file drawer N ranged between 7 and 77 studies required to overturn the statistically 
significant result with the lower bound on the number of unpublished studies in 
existence ranging between 0 and 4. Adjusting the effect estimate for publication bias 
modelling the selection process on p-values only moved the point estimate from being 
1.8 to being between 2.0 and 2.8. Extending the selection process to include standard 
error reduced this range to 2.1 to 2.4. Use of the Copas model also confirmed that 
the true treatment effect was likely to be more harmful than estimated by the 
meta-analysis. In considering the albumin review forest plot (see figure 3.3) it has 
been commented that there appears to be a lack of heterogeneity with the estimates 
derived from each trial being in close agreement. While this could be due to chance it 
may also be caused by the effects of publication bias. The heterogeneity simulations 
show that if studies are more likely to be published based on the strength of their 
statistical significance and the direction of their effect estimate then the resulting 
suppression affects the estimate of between trial variation as well as the combined 
estimate. This was also apparent in the corticosteroids example where adjusting for 
publication bias decreased the strength of the combined estimate and increased the 
estimate of r2. 
Since publication of this review evidence exists from the producers of human 
albumin that there has been an approximate 50% decrease in its use over the 
last year (Hyde, 1999). In response to the review the Committee on Safety in 
Medicine set up an expert working party to consider the evidence and advise on 
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the need for regulatory action (Committee on Safety of Medicines, 1999). The 
expert working party decided that due to concern of limitations in the clinical trials 
included in the meta-analysis and their applicability to current medical practice 
there was insufficient evidence to warrant withdrawal of albumin products. They 
concluded that the question of albumin and mortality would only be answered by 
conducting a large, purpose-designed randomised controlled clinical trial. However 
recommendations were made that the summary of product characteristics should be 
amended to clarify indications for use of human albumin and the warnings about 
safety. 
9.2 Statistical 
Publication bias can have a detrimental effect on the results of meta-analyses. Meta- 
analyses that only include published papers will give a poor approximation of the 
truth if there are a number of studies that differ systematically from those published. 
Empirical research has found that studies with statistically significant results are 
more likely to be accepted for presentation at conferences, and more likely to be 
published in full. Research that has looked at the time taken to reach full publication 
has also found that statistically significant studies will reach publication in a shorter 
duration of time. This has strong implications for the results of meta-analyses. 
Methodology to examine the influence of publication bias has fallen in to three 
categories: tests for the existence of publication bias, robustness methods which 
estimate the number of unpublished studies, and methods which model the selection 
process to adjust the combined effect size estimate. 
Methods that test for the existence of publication bias are based on the 
assumption that the suppression of studies will result in an asymmetrical funnel plot. 
These methods are already known to have low power, but funnel plot asymmetry 
may also be caused by heterogeneity. A further limitation to the usefulness of these 
methods is that only extreme and simplistic sampling mechanisms are likely to 
produce funnel plot asymmetry. 
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Robustness measures estimate the number of missing studies. This estimate 
takes two forms: an estimate of the number of missing studies required to over 
turn a statistically significant result, or an estimate of the number of studies in 
existence. Each of these methods assumes that the true underlying treatment effect 
is null. The estimates given are highly variable dependent upon the assumption of 
the value of the combined estimate of the unpublished studies. Once the number 
of unpublished studies has been estimated its impact on the meta-analytic result 
is difficult to assess. The existence of one moderately large study could have the 
potential to strongly influence the combined estimate while a small study could 
barely alter the observed result. 
When considering the possibility of publication bias the ultimate question is the 
size of the impact on the combined estimate. The most common method used to 
adjust combined estimates for publication bias is weighted distributions. Weighted 
distributions use two models: one for effect size and one for the selection process. 
Previously the model for selection has been specified as either non-parametric or 
parametric but has been limited to modelling based on two-tailed p-values only. In 
data sets in which there is heterogeneity or the true treatment effect is null this 
can lead to over adjusted estimates, considerable variability between estimates, and 
very wide confidence intervals. In this thesis it has been shown that extending the 
selection model to include standard error can improve results. Using this extended 
model it is possible to include other covariates, which may influence publication such 
as study quality or type. The effect size model can be extended in a similar way to 
include linear predictors. The combination of these two models allows the influence 
of publication bias and heterogeneity to be considered simultaneously. 
Weighted distributions offer a flexible approach to modelling publication bias 
that allows the direct impact of unpublished studies on the combined estimate to 
be examined. Inclusion of precision in the selection model improves results and 
reduces the problem of over adjusting. No selection model should be used on 
its own but in conjunction with others to allow a sensitivity approach. However, 
applying a set of alternative weight functions to model publication bias will not 
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give an exhaustive set of plausible alternative models. Although the adjusted effect 
estimates appear insensitive to the choice of weight function, particularly when the 
selection mechanism is based on p-values and precision, this maybe due to the lack 
of information contained in the data sets regarding the selection parameters. An 
alternative way to provide a sensitivity analysis may be to adopt an approach similar 
to Copas (1999) by varying the selection parameters over plausible ranges. 
Reasons for non-application of weighted distribution methodology have been 
given, as the methods are too computer intensive and difficult to implement. 
Weighted distributions in this thesis have been implemented by developing 
programmes in S-plus. Although estimation of standard errors of the adjusted 
estimates is complex, standard functions are available in statistical packages that 
allow point estimates to be derived fairly easily. Estimating the adjusted effect size 
estimate will allow the robustness of the combined estimate to the assumption of 
publication bias to be considered. 
9.3 Further statistical work 
The weighted distribution methodology has been found to over adjust for publication 
bias. However, this over-estimation decreases as the number of studies in the meta- 
analysis and the strength of the underlying true treatment effect increase. Simulation 
studies would be beneficial in determining the extent of the over adjustment in 
situations were the number of included studies and the strength of the true treatment 
effect varied. 
While both real and simulated data have been used in this thesis, both offer 
advantages and disadvantages. The problem with real data is that it will not be 
possible to know how closely the adjusted estimates reflect the true values. While 
this is possible with simulations, simulated data is artificial and will never be able 
to reflect the complexities of real trial data. In a similar approach to Egger et al. 
(1997), it may be beneficial to consider publication bias on meta-analysis data sets 
where a subsequent large trial has become available. A comparison could then be 
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drawn between the adjusted effect estimates treating the large trial as the "truth". 
The parametric weight functions are more easily implemented than the semi- 
parametric approach and offer a method of sensitivity analysis not possible with 
the semi-parametric method. Applying various parametric models can point to the 
robustness of the adjusted estimates. In this thesis the choice of models was limited 
to half-normal, negative exponential and logistic function distributions. Possible 
alternative models include the Aranda-Ordaz or weibull distributions. 
It may be possible that with increased awareness of publication bias and the 
move towards the reporting of confidence intervals instead of p-values that the effects 
of publication bias are decreasing over time. The potential for studies conducted 
now to reach publication may not be so heavily influenced by their attainment of 
statistical significance. To examine this, the work of Sterling (1959,1995) could be 
replicated and if the effects of publication bias were found to be decreasing with 
time the parametric selection models could be extended to include a time covariate. 
Copas' sensitivity model offers the leading alternative to weighted distributions. 
Development of a Bayesian analogue of this method would allow the resulting 
contour plot to indicate regions of the plot where the adjusted effect size estimates 
are most likely. 
Publication bias is commonly assumed to be acting upon the primary outcome 
measure of a research paper. Research papers frequently contain multiple secondary 
outcomes which may also influence publication. Cochrane reviews frequently look 
at endpoints which were not the primary focus of the original paper and models of 
the selection process may need to be extended to incorporate two or more possibly 
correlated outcomes. 
Appendix A 
The conditional distribution of a2 
by 2 table 
The conditional distribution of A given A+B=m, where m from table 4.1 is the total 
number of events observed is given by 
P(A=aIA+B=m) = 
P(A=a'A+B=m) 
P(A +B= m) 
where 0<m<N and by independence of A and B 
P(A = alA+ B= m) = 
P(A = a)P(B =m- a) 
EkP(A=k, B=m-k) 
_ 
P(A = a)P(B =m- a) 
Ek P(A = k)P(B =m- k) 
where k ranges from min (0 ,m- n2) to max (m , nj). 
(n')ir (1 - 7r, )nl-a(nz-a)72 -a(1 - 7r2)n2-m+a P(A = alA -I- B= m) = Ek(kl)7ri (1 - 9rl)ni-k(ni k)7r2 -k(1 - 7rZ)nz-m+k 
Simplifying gives 
ni) n2 pa 
P(A=alA+B=m)= Ek(kl)(; i 
)k 
'/, k 
which is the noncentral hypergeometric distribution and depends only on the odds 
ratio, 1'. 
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Appendix B 
Peto one step method 
The likelihood function (L) for the noncentral hypergeometric distribution with 
exp(P) and n trials is given by 
L=n 1P(A1 = a, 1nis, n2i, ms, Q) 
ýäi)( 
, i-., 
)exp(pai) 
where k ranges from min (0 ,m- n2) to max (m , ni). 
with loglikelihood 1 
nnn 
l =Elogeýä{{)(mý; -a; 
)+Orai - 
Eloge(E(kii)(TN_k)exP(ßk)) 
i=1 i=1 i=1 k 
The Newton Raphson method for solving äJ =0 to obtain MLE is given by 
ßn+1 = On - jýý 
a 
where 1' _ and 1" = dä1(ß 
Differentiating 1 for ß 
nn E(nij)(n2i 
1= ýai - 
ý( 
Ek(ki. )(2-k)exp(, 6k) 
) 
M 
n 
= >(Oi - Ei) 
i=1 
nii (, 
k 
(k 
n 
_V 
i=1 
-k)exP(ßk) - 
(Ek kýk")(' 
-k)exp(ßk))2 
)exp(ßk))2 
) 
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If the initial estimate for Q, ßo, is equal to zero then the first iterative step of Newton 
Raphson is 
R1 /ý ' 
Yl = 
ßo - j,, 
ßl = 
Lei l(Oi - 
Ei) 
Ei-1 V 
which is the estimate of loge() obtained by Peto method. 
Appendix C 
Results of Medline search strategy 
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Table C. 1: Results of Medline search strategy to identify empirical publication bias 
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Appendix D 
Splus program for Hedges test 
This S-Plus program computes Hedges test for publication bias. It requires the cell 
counts of a 2*2 table to be read in to the program in vectors, and the cut points, 
excluding 0 but including 1, of the p-value range to be specified in a vector. 
hedges<-function (a, b, cl, d, aj) { 
n<-Iength(a) #unlike other programs this uses 
#n as number of studies 
k<-length(aj) #k is number of p-value segments 
for(i in 1: n){ 
if(a[i]==0) b[i]<-(b[i]+0.5) 
if(a[i]==O) cl[i]<-(cl[i]+0.5) 
if(a[i]==O) d[i]<-(d[i]+0.5) 
if(a[i]==O) a[i]<-(a[i]+0.5) 
} 
for(i in 1: n){ 
if(b[i]==0) cl[i]<-(cl[i]+0.5) 
if(b[i]==0) d[i]<-(d[i]+0.5) 
if(b[i]==0) a[i]<-(a[i]+0.5) 
if(b[i]==O) b[i]<-(b[i]+0.5) 
OR. i<-((a*d)/(b*cl)) 
logor<-log(OR. i) 
v<-(1/a)+(1/b)+(1/cl)+(1/d) 
se<-sgrt (v) 
tausq <- (var (logor)-sum (v) /n) 
if (tausq<O) tausq<-O 
# adjusts for zero cell counts 
#calculates odds ratio 
#calculates variance of 
#log odds ratio 
# gives estimate of 
# between trial variance 
delta<- (sum (logor/ (v+tausq)) /sum (1 / (v+tausq))) # gives estimate of 
#combined log odds ratio 
eta<-sgrt(v+tausq) 
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ajl<-gnorm(aj) #calculates SND 
b<-(t(t(-se))%*%t(aj 1)) 
B<-matrix(NA, n, k) 
B[, 1] <-1-pnorm((b[, 1]-delta)/eta) 
B [, k] <-pnorm ((b [, k-1]-delta) /eta) 
for (j in 2: k) { 
B[j] <-pnorm((b[, j-1]-delta)/eta)-pnorm((b[i]-delta)/eta) 
} 
E<-rep(NA, length=k) #E gives the number of expected p-values in the jth 
interval 
for a in 1: k) { 
E[j]<-sum(B[, j])} 
total<-sum(E) 
p <-1-pnorm (logor/se) 
breaks<-c(O, aj) 
ints<-cut(p, breaks) 
obs<-tabulate(ints) # gives number of observed 
# p-values in each range 
chi<-((obs-E)2)/E 
chistat<-sum(((obs-E)'2)/E) #value of chisquare test statistic 
pval<-pchisq(chistat, k-1) # gives p-value of chi-square test 
crudew<-obs/E # provides crude estimate of weights 
summary<-matrix(nrow=k, ncol=5) #builds output matrix 
summary[j] <-t(t(aj)) 
summary [, 2] <-t (t (obs) ) 
summary[, 3] <-t(t(E)) 
summary [, 4] <-t (t (crudew) ) 
summary [, 5] <-t (t (chi) ) 
dimnames(summary)<- list (NULL, c("cut", "obs", "exp", "crude w", "chi")) # 
assigns names to each column of output matrix 
return(summary) 
} 
Appendix E 
Splus program for Hedges weight 
function 
This program sets the likelihood function for obtaining combined estimates adjusted 
for publication bias using Hedge's semi-parametric weighted distribution. The 
estimates are obtained by typing: 
hedges -nlminb(start=c(0.5,0.5,0.5,0.5,0,1), objective=steps, lower=c(0,0,0,0; 
Inf, O), upper=c(rep(Inf, 6)), a=a, b=b, cl=cl, d=d) at the command prompt. The 
output is stored in hedges. 
steps< -function (startvals, a, b, cl, d) { 
aj< -c(0.05,0.10,0.30,0.50,1.00) 
n< -length(a) #unlike other programs this uses n as number of studies 
k< -length(aj) #k is number of p-value segments 
weights< -rep(NA, length=k) 
wl< -1 
w2< -startvals[1] 
w3< -startvals[2] 
w4< -startvals[3] 
w5< -startvals[4] 
delta< -startvals[5] 
tausq< -startvals[6] 
weights< -c(wl, w2, w3, w4, w5) 
for(i in 1: n) l 
if(a[i]==O) b[i]< -(b[i]+0.5) 
if(a[i]==O) cl[i]< -(cl[i]+0.5) 
if(a[i]==0) d[i]< -(d[i]+0.5) 
if(a[i]==O) a[i]< -(a[i]+0.5) 
} 
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for(i in 1: n){ 
if(b[i]==O) cl[i]< -(cl[i]+0.5) 
if(b[i]==0) d[i]< -(d[i]+0.5) 
if(b[i]==O) a[i]< -(a[i]+0.5) 
if(b[i]==O) b[i]< -(b[i]+0.5) 
} 
OR! < -((b*cl)/(a*d)) 
logor< -log(ORi) 
v< -(1/a)+(1/b)+(1/cl)+(1/d) 
se< -(v{}(1/2)) 
prec< -(1/se) 
eta< -sqrt(v+tausq) 
p< -1-pnorm(logor/se) 
breaks< -c(O, aj) 
ints< -cut(p, breaks) 
In< -matrix(O, n, k) 
for(j in 1: k){ 
for(i in 1: n){ 
if (ints[i]==j) In[i, j]< -1}} 
sel< -cbind(-se; se; se; se; se) 
qa< -qnorm(aj) 
bij< -matrix(NA, n, k) 
for(j in 1: k){ 
bij[, j]< -qa[j]*sel[, j]} 
B< -matrix(NA, n, k) 
B[, k]< -pnorm((bij [, k-1]-delta)/eta) 
for (j in 2: k-1){ 
B[j] < -pnorm((bij [, j-1]-delta) /eta)-pnorm((bij [, j]-delta)/eta) 
} 
B[, 1] < -1-pnorm((bij [, 1]-delta)/eta) 
w< -In 
A< -matrix(NA, n, k) 
for (j in 1: k) { 
A[, j]< -weights[j]*B[, j]} 
Ai< -rep(NA, n) 
for (i in 1: n) { 
Ai[i]< -sum(A[i, ])} 
249 
e< -sum (log(w))-(1/2)*sum(((logor-delta)/eta){}2)-sum(log(eta))- 
sum(log(Ai)) 
-1*e 
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Appendix F 
Splus program for logistic weight 
function 
This program sets the likelihood function for obtaining combined estimates adjusted 
for publication bias using a logistic parametric weighted distribution. The estimates 
are obtained by typing : igl< -nlminb(start=c(0.7,0,0), objective=ig, lower=c(- 
Inf; Inf, O), upper=c(Inf, Inf, Inf), a=a, b=b, cl=cl, d=d) at the command prompt. The 
output is stored in igl. 
ig< -function(startvals, a, b, cl, d) { 
n< -length(a) 
beta< -startvals[1] 
delta< -startvals[2] 
tausq< -startvals[3] 
for(i in 1: n){ 
if(a[i]==O) b[i]< -(b[i]+0.5) 
if(a[i]==O) cl[i]< -(cl[i]+0.5) 
if(a[i]==0) d[i]< -(d[i]+0.5) 
if(a[i]==O) a[i]< -(a[i]+0.5) 
} 
for(i in 1: n){ 
if(b[i]==0) cl[i]< -(cl[i]+0.5) 
if(b[i]==0) d[i]< -(d[i]+0.5) 
if(b[i]==0) a[i]< -(a[i]+0.5) 
if(b[i]==0) b[i]< -(b[i]+0.5) 
} 
ORi< -((b*cl)/(a*d)) 
x< -log(OR. i) 
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v< -(1/a)+(1/b)+(1/cl)+(1/d) 
se< -(v'(1/2)) 
eta< -sqrt(v+tausq) 
p< -(1-pnorm(x/se)) 
int< -rep(NA, Iength=n) 
ig< -function (x, beta, delta, se, eta) {2* (exp(beta* (1- 
pnorm (x/se))) / (1 +exp (beta* (1-pnorm (x/se))))) *dnorm ((x-delta) /eta)} 
for(i in 1: n){ 
inti< -integrate (ig; Inf, Inf, beta=beta, delta=delta, se=se[i], eta=eta[i]) 
int[i]< -inti$integral} 
e< -sum (beta*(1-pnorm(x/se)))-sum(log(1+exp (beta*(1-pnorm(x/se)))))- 
(0.5*sum(((x-delta)/etar2))-sum(log(int)) 
-1*e 
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